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ABSTRACT 
Poxviruses have many favourable characteristics that render them useful as 
vectors for the expression of genes encoding foreign antigens to be used for 
vaccination purposes. Several poxviral vaccines have been constructed by using 
vaccinia virus (VV) as vector. VV has a wide host range and may not be a suitable 
vector for veterinary vaccines where a vector would be preferred with a narrow 
host range which would be confined to the target species. Attempts to utilize 
lumpy skin disease virus (LSDV) as a vector with a narrow host range are the 
subject of the thesis. 
The first phase of this project was to grow LSDV. Problems were 
experienced in reaching high enough LSDV-titres, although higher titres were 
obtained with primary cell lines than with continuous MDBK-cells. Attempts to 
propagate the virus in eggs were unsuccessful. These results were similar to 
earlier reports. 
The next phase of the project was to investigate if foreign genes could be 
inserted into the LSDV-genome. Thymidine kinase selection cannot be used to 
select for recombinant LSDV, because there is no TK- cell-line available in which 
the virus can be propagated. Two other methods have been used with VV for the 
selection of recombinant virus. Recombinants expressing f3-galactosidase (~gal) 
produce blue plaques; alternatively, recombinants expressing the guanine 
phosphoribosyl transferase (Gpt) gene (encoding xanthine-guanine 
phosphoribosyl transferase) are capable of overcoming plaque inhibition by 
mycophenolic acid (MPA). It was decided to adapt each of these approaches for 
use in LSDV. 
Two plasmids were constructed, in which coding sequences for f3-gal and 
Gpt respectively, were placed under the control of a promoter derived from VV 
and flanked by sequences from the TK-gene of LSDV (to direct homologous 
recombination with the TK-gene of the LSDV-genome). Restriction enzyme 
mapping was performed to confirm the integrity of these constructs. Transient 
expression assays were done to check whether the ~gal or Gpt inserts were 
functional in vivo. The f3-gal-gene was not expressed strongly enough to be useful. 
The Gpt-gene appeared to be functional based on results obtained with indirect 
immunoperoxidase staining. However, no further evidence was obtained that the 
Gpt-gene was functional in this construct. Subsequent evidence showed that a 
mutational event occurred in the Gpt-gene itself which probably could effect it's 
functional expression. 
Upon completion of these experiments, attempts were made to obtain a 
LSDV or a VV recombinant expressing the viral protein 7 (VP7)-gene of 
bluetongue virus (BTV), using Gpt as selectable marker-gene. This involved the 
construction of a plasmid (designated pGS20-VP7:Gpt) containing both the Gpt-
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and the BTV 4 VP7-gene separately under the control of VV-promoters. The 
pGS20-vector, containing VV TK sequences, was used for the construction of the 
pGS20-VP7:Gpt construct. Restriction enzyme mapping was performed on the 
native pGS20 vector, the pGS20 vector containing the VP7 gene and subsequently 
the vector containing both the VP7- and the Gpt-gene. This was done to determine 
the orientation of the inserted genes as well as the integrity of the final construct. 
The digest showed that a plasmid has been selected in which the VP7 insert was 
correctly oriented under the control of the P 7.5 promoter. A cassette containing 
the Gpt-gene, also under the control of the VV P 7.5 promoter, was inserted in the 
pGS20 Hindl 11 site outside the TK-sequences. Restriction enzyme digests showed 
that the Gpt insert was oriented in the same direction as the VP7 insert. 
LSDV-infected CFK-cells were transfected with the pGS20-VP7:Gpt 
construct and the virus obtained was subsequently passaged through selection 
medium for up to six times. In parallel with this, the pGS20-VP7:Gpt construct 
was transfected into VV-infected CV-1 cells and passaged through selection 
medium. Total DNA was extracted from the cells infected with the obtained virus 
(presumed to contain recombinants). The DNA was then subjected to restriction 
enzyme digestion and Southern blot hybridization analysis. 
Recombinant LSDV could not be obtained from the heterologous 
transfection experiments with the pGS20-VP7:Gpt construct. One probable reason 
for the lack of LSDV-recombinant could be that the relative low level of nucleotide 
sequence similarity (68%) shared between the heterologous TK-genes present in 
the plasmid construct (VV TK) and the virus (LSDV TK) was not capable of 
directing recombination efficiently. 
In the case of VV, however, the recombination experiment was successful. 
This indicated that homologous TK-sequences may direct recombination at a 
higher frequency than heterologous sequences do, as would be expected. A 
mixture of recombinant and wild type VV was obtained from the pGS20-VP7:Gpt-
transfection experiment in VV-infected CV-1 cells, as shown by the size of the TK-
containing fragment observed following Hindl 11-digestion of total DNA-extracts 
and Southern Blot hybridization analysis. The presence of the Gpt-gene indicated 
by the ability of the virus to overcome MP A-selection, could be verified by 
Southern blot hybridization analysis of the harvested DNA. The VP7 gene could 
also be detected in the DNA harvested from the VV-infected CV-1 cells by probing 
with a DIG-labelled VP? BamHl-fragment. No plaque purification steps were 
included as this was only a preliminary screening for the presence of recombinant 
virus(es). The virus would need to be plaque purified and expression of the VP7-
gene should be further investigated before this recombinant could be tested in 
animal trials for efficiency. 
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CHAPTER 1. LITERATURE REVIEW 
1.1. General characteristics of poxviruses 
Poxviruses are well characterised. The general characteristics of poxviruses 
have been reviewed extensively (Esposito and Murphy, 1989; Moss 1990 and 
1991; and Piccini and Paoletti, 1986 and 1988). A summary of the aforementioned 
review articles and other sources of relevant literature (as cited) follows hereafter. 
1.1.1. Classification of poxviruses 
The poxvirus family consists of a large family of complex DNA viruses that 
infect both vertebrate and invertebrate hosts (Moss, 1990). Poxviruses have been 
classified as indicated in Table 1.1. on grounds of their morphology, serology and 
host range. 
1.1.2. Virion structure 
Poxvirus virions are oval or brick-shaped with a size of approximately 300 
x 240 x 100 nm. The outer surface contains ridges that may be arranged in parallel 
rows or as a single continuous helix. The core, containing the DNA genome, is 
dumbell-shaped. Two lateral bodies of unknown function are found in the 
concavities of the core. A lipoprotein bilayer, the outer membrane, surrounds the 
core. Extracellular forms of poxviruses contain an additional lipoprotein 
envelope. The two types of infectious virus particles are the intracytoplasmic 
naked virions and the extracellular enveloped virions (Engelstad and Smith, 1993). 
The extracellular enveloped virions are antigenically distinct because the 
envelopes are derived from modified plasma membranes. This distinct 
antigenicity of the envelope may direct tissue tropism, pathogenicity, 
immunogenicity and host range properties. Intracytoplasmic naked virions 
(without envelopes) are produced in infected cells and are released in vivo through 
cytolysis as extracellular enveloped virions. These extra-cellular enveloped 
virions are involved in virus dissemination in vivo and in vitro (Engelstad and 
Smith, 1993). Immunity to proteins located in the outer layer of the virion 
appears to be more important for protection against orthopoxviruses than 
immunity to naked intracellular virions (Engelstad and Smith, 1993). 
Protein, lipid and DNA (90%, 5% and 3.2% respectively of the dry weight) 
are the main components of vaccinia virus (W). The predominant lipid 
components are phospholipids and cholesterol. Spermine, spermidine and only 
small amounts of RNA are found in VV. The virion contains more than 100 
polypeptides. 
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1.1.3. Genome 
The genome of poxviruses is composed of a single, large, linear, double-
stranded DNA molecule (Keck, Baldick and Moss, 1990). The genome size of 
orthopoxvirus (vaccinia) is 186 kb (143-147 kb for capripoxvirus) and it has the 
capacity to encode between 150 and 200 proteins (Gershon and Black, 1988; Keck 
et al., 1990; Weir and Moss, 1983). Some restriction endonuclease cleavage sites 
are highly conserved within genera among orthopoxviruses (Esposito and Knight, 
1985) and capripoxviruses (Black, Hammond and Kitching, 1986). 
The central region of the genome is more highly conserved than the termini 
and appear to contain most of the genes essential for productive infection. Both 
ends of poxvirus DNA are covalently closed by A + T-rich hairpin loops so that 
the two DNA strands form one single stranded circle upon denaturation (Esposito 
and Knight, 1985; Stuart, Ellison, Graham and McFadden, 1992). Hairpin loops 
are a characteristic feature of all vertebrate poxvirus genera examined thus far. 
Inverted terminal repeats (ITRs) of variable lengths are found at the two ends of 
the genome. The ITRs are subjected to transcription by virus-encoded RNA 
polymerases and are prone to deletions and rearrangements. The hypervariability 
of the ITRs suggests that this region contains mostly nonessential genes. 
However, they may have important roles in vivo by enabling the virus to evade the 
host immune response and to spread from the initial site of infection (Turner and 
Moyer, 1992). Poxvirus pathogenesis studies indicate that many genes involved in 
host range and virulence are located within the terminal regions of the genome 
(Turner and Moyer, 1992). The mutability of the terminal region may be the key 
for virus adaptation. Tandemly repeated sequences (TRS) are located close to the 
ends of the genome or within the ITRs. One way of comparing the relatedness of 
poxviruses may be to compare the repeated units at the termini of their genomes 
(Baroudy and Moss, 1982). An apparent absence of introns, relatively short 
promoter sequences and the relatively small sizes of many open reading frames 
(ORFs) account for a high gene density in the genome. The functional elements of 
promoter sequences are conserved between poxvirus genera. Naked poxvirus 
DNA is not infectious and is not transcribed by cellular RNA polymerase 
(Scheiflinger, Dorner and Falkner, 1992). Transcription occurs from both strands 
of the viral DNA. 
1.1.4. Replication 
The reproductive cycle of poxviruses consists of: (a) virus entry, (b) 
regulated gene expression, (c) DNA replication, (d) virion assembly and (e) virus 
dissemination. Genes required for the replication of orthopox viruses in specific 
cell types have been mapped close to the left-hand termini of their genomes 
11 
(Gillard, Spehner and Drillien, 1985; Gillard, Spehner, Drillien and Kirn, 1986). A 
restriction of the host-range phenotype has been correlated with a loss of DNA 
from these regions (Dumbell and Archard, 1980; Moyer and Rothe, 1980). 
Poxvirus entry into cells occurs via plasma membrane fusion or via 
endophagocytosis. The extracellular form of W appears to be more rapidly and 
efficiently adsorbed to cells than the intracellular form and is important for spread 
of infection in cultured cells and animals. Fusion of the virion with the outer 
membrane leads to uncoating. The virion core is subsequently released into the 
cytoplasm of the cell. The nucleoprotein complex is liberated through breaks in 
the core wall. A complete transcription system consisting of virus-encoded 
enzymes (including a multisubunit DNA-dependent RNA polymerase, capping 
and methylating enzymes, a transcription factor and a poly(A) polymerase) is 
present within the core (Keck et al., 1990). Thus, protein or DNA synthesis is not 
required for the transcription of early genes (Keck et al., 1990). Poxviruses and 
African swine fever virus are the only known eukaryotic DNA viruses that encode 
their own RNA polymerase. During the early stages of infection approximately 
100 early genes are transcribed by the viral RNA polymerase. Messenger RNAs 
transcribed from early genes include DNA polymerase and other proteins 
involved in transcriptional activity of later genes. The primary transcripts are 
modified at the 5' end by virus-encoded capping and methylating enzymes and 
polyadenylated at the 3' end by the virus-encoded poly(A) polymerase (Gershon, 
Ahn, Garfield and Moss, 1991; Shuman, 1990). A shutdown of cellular protein 
synthesis occurs soon after infection. This is apparently due to viral protein(s) 
and/ or the production of polyadenylated nontranslated viral RNAs that effect 
ribosome function. Cellular DNA and RNA synthesis is also inhibited. 
Poxvirus replication occurs in the cytoplasm, a characteristic unique to 
poxviruses and African swine fever virus as far as DNA viruses are concerned. 
The discrete cytoplasmic foci of replication are called "virus factories". DNA 
replication, which plays an important role in the regulation of gene expression 
(Keck et al., 1990), occurs at different stages of the reproductive cycle depending 
on the type of poxvirus. Although the replication mechanism is still not well 
understood, it is thought to occur through semi-conservative replication. The 
process presumably involves a strand displacement mechanism which commences 
at each end of the genome by the introduction of nicks (Pogo, O'Shea and 
Freimuth, 1981). Short DNA fragments, covalently linked to RNA primers, are 
formed. An alternative self-priming mechanism at the 3' ends, generated by the 
formation of nicks is another possibility. This hypothesis accounts for the 
formation of incompletely base-paired loops and flip-flop sequence 
rearrangements. It seems as if poxviruses do not have a specific origin sequence 
for plasmid replication. Concatemeric intermediates resolved into unit-length 
genomes are formed during DNA replication. These replicated DNA molecules 
provide the templates for the expression of intermediate and late genes. 
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Each temporal class of genes has its own characteristic promoter sequences 
that are recognized by specific viral proteins. Viral proteins are used 
predominantly or exclusively for replication and there is no nuclear requirement 
except perhaps for virus maturation (Traktman, 1990). The replication process can 
be divided into distinctive early and late stages, flanking the peak of DNA 
replication. Transcriptional switch-over occurs as viral DNA accumulates. About 
100 proteins, which are primarily virion structural proteins, are produced in the 
late stage. 
Virion morphogenesis also becomes visible during the late stage. 
Condensing viral genomes surrounded by precursors of the virion outer 
membrane and immature virions are formed. The origin of the viral membrane is 
apparently not associated with any cellular organelle. The majority of virus 
particles produced are intracytoplasmic naked virions (INV) which are released by 
cytolysis (Engelstad and Smith, 1993). The molecular mechanism by which 
mature enveloped poxvirions exit from the cell is poorly understood (Duncan and 
Smith, 1992a; Dales and Pogo, 1981). A small proportion of INV acquire a double 
layer of Golgi-derived membrane, containing several virus proteins. This 
enveloped particles migrate to the cell surface. The outer membrane subsequently 
fuses with the cell plasma membrane and extracellular enveloped virus (EEV) are 
released from the cell (Duncan and Smith, 1992a; Engelstad and Smith, 1993; 
Payne and Kristensson, 1979). Some of these enveloped particals remain secured 
to the cell surface and are called cell-associated enveloped virus (CEV; Engelstad 
and Smith, 1993). Nuclear factors, like RNA polymerase 11, are thought to be 
involved with the formation of infectious, mature virions. Since the EEV form of 
VV is important in the dissemination of virus, the loss of a gene required for EEV 
formation would cause attenuation of the virus. An example of this is the VV gene 
BSR that encodes a 42-kDa envelope protein required for the envelopment of 
extracellular virus (Engelstad and Smith, 1993). The SalL4R gene in the WR strain 
of VV, encoding EEV envelope proteins, is also required for normal plaque 
formation (Duncan and Smith, 1992a). There is no evidence of integration of viral 
DNA into the cellular genome. 
1.1.5. Gene expression 
Viral gene expression may be regulated at various levels. Different 
promoter and termination sequences are found for early and late genes. 
Transcription occurs bidirectionally and no particular direction is favoured by 
early or late RNAs. The regulatory sequences are A-T rich (Mackett, Smith and 
Moss, 1985). The leader sequences (30-100 bases) from early mRNAs of VV are 
different from one another and also from prokaryotic and eukaryotic mRNA 
leader sequences. 
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The considerable nucleotide variability in individual promoters may have a 
role in regulating the level of gene-expression. The functional elements of 
promoter sequences are conserved amongst poxvirus genera. The early promoter 
was divided into three regions based on the analysis of the VV 7.5 kDa early 
promoter: (a) a 16 bp critical region where single nucleotide substitutions has a 
major effect on expression, (b) an 11 bp T-rich sequence which is less critical and 
(c) a 5 to 7 bp region where initiation usually occurs with a purine (Davison and 
Moss, 1989a). The site of transcriptional initiation is specified by the critical region 
of the early promoter. This critical region serves as a binding site for a 
transcription factor (analogous to the eukaryotic TATA box) and is thus involved 
in transcriptional regulation (Davison and Moss, 1989a). Consensus TATA and 
AA TA promoter sequences, separated by about 25 bp, were identified for several 
early and late VV genes. 
The sequence TTTTTNT (N representing any nucleotide) together with an 
additional termination factor or protein are necessary for early termination of 
transcription. It appears as if the termination signal is recognized as an RNA 
sequence, UUUUUNU, instead of a DNA sequence. This sequence is apparently 
not recognized by the late transcription complex. Termination of early 
transcription also occurs within or near the tandemly repeated CTATTC sequence 
(Venkatesan, Baroudy and Moss, 1981). In vitro transcription studies suggest that 
only a free 3' hydroxyl end is required for polyadenylation of vaccinia early 
mRNAs. A specific virus-encoded early transcription factor (VETF), which is 
required for the initiation of transcription by the polymerase, was detected in VV 
(Broyles S.S., Yuen L., Schuman S. and Moss B., 1988; Hagler and Shuman, 1992). 
This transcription factor binds specifically to early promoter sequences within a 
30-bp region upstream of transcription initiation sites and apparently leads to 
bending of the DNA template in the vicinity of the transcriptional start sites 
(Hagler and Schuman, 1992). The DNA-protein complex that is formed is 
presumably an intermediate in transcription initiation. VETF has a DNA-
dependent ATPase activity and may be a functional homolog of the eukaryotic 
TAT A-binding factor. 
Late promoter sequences are dependent on DNA replication for activity. 
The role of DNA replication is to provide naked DNA templates for the 
transcription of intermediate and late genes (Keck et al., 1990). Vaccinia virus gene 
expression are regulated by a cascade mechanism. The progeny DNA of 
replication serves as a template for the transcription of intermediate genes. The 
products of these genes then trans-activates the transcription of late genes (Keck et 
al., 1990). Factors required for intermediate gene-expression are probably present 
in the infected cells prior to DNA replication, although they have not been 
identified (Keck et al., 1990). 
All or nearly all of the genome is transcribed during the late stage of 
replication (Keck et al., 1990). Many late protein genes occur in clusters in the 
central region of the genome. Early and late genes reside close to the 
termini and are overlapping. Transcripts of these genes are known to be 5' 
capped. Late RNAs have the ability to self-anneal or anneal with early 
RNA to form ribonuclease-resistant hybrids. The stability of mRNA may 
also influence gene expression. Late mRNAs do not have defined 3' ends. 
This often results in size variation amongst individual mRNA species 
encoding a particular protein. 
Sequences required for the expression of late genes are located 
within 100 bp of the mRNA start site (Bertholet, Drillien and Wittek, 1985). 
The leader sequences of most late genes are remarkably short (Rosel, Earl, 
Weir and Moss, 1986). A highly conserved TAAATG sequence is found at 
the beginning of each ORF of several late genes. Transcription is initiated 
within the A-triplet and translation commences from the ATG c9don in 
the motif (Rosel et al., 1986; Roseman and Hruby, 1987). 
Late mRNAs have a long (25-100 base) poly(A) tract at their 5' ends 
which is a unique feature of poxviruses (Davison and Moss, 1989b). The 
poly(A) leader is important for RNA stability during the late stage after 
infection. The function of the capped 5' poly(A) leader may be to provide 
a binding site for initiation factors and the 40S ribosomal subunit. This 
subunit can then move unimpeded by antisense RNA to the first AUG 
codon where ribosome assembly and translation occur (Davison and 
Moss, 1989b). 
A gradual decrease in the expression of a reporter gene was 
observed as 5' to 3' deletions were made in late promoters. Late promoters 
can be divided into three regions: a more or less 20 bp A-T rich upstream 
sequence and a highly conserved TAAAT sequence within which 
transcription initiates, separated by a region of about 6 bp (Davison and 
Moss, 1989b). The TAAAT sequence is required for promoter function 
and for poly(A) leader formation. Reductions in promoter strength was 
observed with the addition of an extra A or single nucleotide substitutions 
within the three A residues of the TAAAT sequence (Davison and Moss, 
1989b). 
It appears as if similar RNA polymerases are used for early and late 
transcription, or that they at least share subunits. Transcription by 
poxvirus RNA polymerase is controlled by cis-acting elements. Gene 
regulation may also occur at the translational level by suppressor proteins. 
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1.1.6. Immune response to poxvirus infection and 
vaccination 
Poxviruses are transmitted by contact and by the respiratory route. 
Some can be transmitted by arthropods. Infection (also after vaccination) 
is initiated in epithelial cells at the site of virus entry. The progression of 
the infection is influenced by several factors like the virulence and 
biological characteristics of the virus and the host response. The nature of 
the W proteins involved in the activation of the immune respons of the 
host is not yet known. Demkowicz, Maa and Esteban (1992) identified 
four highly antigenic W proteins in the virus core and two in the virus 
envelope. According to Czerny and Mahnel (1990) orthopoxviruses can 
potentially stimulate the specific immune system (T and B cell-mediated) 
and non-specific defence ·mechanisms (e.g. macrophage-, interferon-, 
interleukin- and natural killer cell-mediated). Poxviruses have developed 
ways of impeding the host immune mechanisms. Wis relatively resistant 
to interferon in several cell-lines. This is propably due to the production 
of a W factor early in infection which prevents interferon from inhibiting 
protein synthesis. W can also rescue more sensitive viruses, like 
vesicular stomatitis virus, from the effects of interferon. 
Protection and recovery from poxvirus infections are dependent on 
the cell-mediated immune response to viral proteins, but little is known 
about this response to poxviruses (Blanden, 1970; Gardner and Blanden, 
1976; Kempe, 1960; Littaua, Takeda, Cruz and Ennis, 1992). The cell-
mediated immune response occurs via soluble mediators, produced by T 
cells and specifically activated macrophages, that affect virus, infected 
cells and the local environment of the infection site. The B-cell response 
generates non-neutralizing and neutralizing antibodies in pathogenic 
poxvirus infections and in vaccinated individuals respectively. It appears 
as if specific neutralizing antibodies are not required to recover from 
poxvirus infections (Kempe, 1960; O'Connell, Karzon, Barron, Plaut and 
Ali, 1964). Specific immunity, which is T and B cell-mediated (Czerny and 
Mahnel, 1990) is the principal mechanism for developing resistance 
against poxviruses. The long-term nature of the resistance to smallpox or 
W after vaccination may be due to the presence of a large number of 
cross-reactive memory cytotoxic T-lymphocytes which would become 
activated and rapidly eliminate infected cells after challenge (Littaua et al. 
1992). It is very likely that vectored poxviruses will behave generally like 
their parents. 
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1.2. The use of poxviruses as vectors for live 
recombinant viral vaccines 
1.2.1. Historical overview and general perspective of live 
viral vaccines 
As early as the tenth century live-virus immunization or variolation 
was practiced in China and India, when previously uninfected people 
were inoculated with pustular fluid from a smallpox-patient. Natural 
smallpox infection had a mortality rate of 25%, whereas variolation caused 
infection of varying severity and 1-2% mortality. Edward Jenner 
successfully vaccinated an 8-year old boy with pustular fluid from a 
milkmaid's pox lesion in 1796, after he observed that people who h~d been 
previously infected with the pox from the teats of cows, failed to show 
characteristic symptoms following variolation. Louis Pasteur proposed 
the term "vaccination" instead of "inoculation" in 1881. The inoculum later 
became known as VV, but after it's long history through man and animals 
the precise derivation of VV as it is known today is unknown. VV was 
shown to be distinct but closely related to cowpox virus, variola virus and 
other naturally occurring members of the poxvirus family on the basis of 
DNA analysis. 
The use of live-virus vaccines is recommended in cases where there 
is systemic invasion of the host, only a few antigenic types of the etiologic 
agents are present and a highly effective immunity follows a natural 
infection (Kucera and Myrvik, 1985). Active humoral and local cellular 
immunity can be induced with live virus (Czerny and Mahnel, 1990). This 
activation of all phases of the immune system is an important 
characteristic of live virus vaccines, and thus also of live recombinant viral 
vaccines. The result is a balanced response, systemic and local immunity, 
humoral and cell-mediated immunity (Murphy and Chanock, 1990). This 
is particularly important for infections in which cell-mediated immunity 
plays a role and for mucosa! infections in which both local and systemic 
immunity are required for optimal resistance (Murphy and Chanock, 
1990). An immune response is stimulated to each of the protective 
antigens of a virus by a live virus vaccine, whereas destruction of some of 
the antigens may occur during the preparation of an inactivated vaccine 
(Murphy and Chanock, 1990). Immunity induced by live virus vaccines is 
generally more durable, more effective, and more cross-reactive (due to 
the fact that all phases of the immune system is stimulated and that T-cells 
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display a broader cross-recognition of related viral strains than B-cells) 
than that induced by inactivated vaccines (Murphy and Chanock, 1990). 
The latter phenomenon is particularly important for viruses such as 
influenza that undergo progressive antigenic variation. Even when 
immunity levels have declined with time, natural subclinical re-infections 
can serve as harmless boosters. 
Through the years live viral vaccines against several diseases 
proved to be effective, reasonably safe and cost-effective (Murphy and 
Chanock, 1990). Notwithstanding its proven track record, there has been 
some serious problems with some live viral vaccines. These problems 
include the back-mutation to virulence of, for example, poliovirus vaccine; 
the genetic instability of 17D yellow fever virus vaccine; inadequate 
attenuation leading to complications or overattenuation leading ts> a lack 
of protection in the case of small pox vaccine; the need for storage and 
transport of measles vaccine at low temperature and thus a short shelve 
life (Murphy and Chanock, 1990). The presence of defective interfering 
particles can modify the clinical response to the vaccine and can result in a 
variation in immunogenicity and level of attenuation among successive 
lots of vaccine (Murphy and Chanock, 1990). If vaccine progeny virus 
should spread from a vaccinated individual to unvaccinated individuals it 
may appear to be an advantage, but this progeny virus might be mutated 
and cannot be tested for safety and licensed for use in the general 
population (Melnick, 1990). This prompted research to develop more 
stable recombinant vaccines which are generally regarded as being safer, 
less costly to produce, easy to administer and have an extended shelf-life 
(Kucera and Myrvik, 1985). 
1.2.2. General concepts regarding vaccines derived from 
virus vectors 
The concept for the construction of a live, recombinant viral vaccine 
is based upon the exploitation of a non-pathogenic virus vector to express 
one or more antigens from a pathogen or pathogens. The immunogenic 
proteins are thus presented to the host immune system in an authentic 
way and cause the body to mount a lasting immune response to it. The 
aim is to genetically manipulate a virus vector to such a degree that it will 
only contain the genetic material for replication and lack those parts of the 
genome responsible for pathogenesis. 
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1.2.3. Poxviruses and their potential for use as vectors in 
live recombinant vaccines with special reference to VV 
A recombinant poxvirus vaccine would offer all the advantages of a 
live pox vaccine and more (section 1.2.1.). Poxviruses have many 
favourable characteristics that render them useful as vectors for the 
expression of genes encoding foreign antigens to obtain vaccines. Apart 
from the use of W vaccine against smallpox in humans, poxvirus vaccines 
have also been used in veterinary medicine for the protection of animals 
and birds. An example of this is the use of W for the prevention of 
rabbitpox and other orthopoxvirus infections of captive and domestic 
animals. 
It has been shown that poxvirus DNA is subject to extensive genetic 
recombination during its ·replicative cycle (Ball, 1987; Spyropoulos, 
Roberts, Panicali and Cohen, 1988). Analysis of the viral products of 
recombination has shown that both single and double crossover events 
occur with high frequency and the unstable tandem repeat products of 
single crossover events are rapidly processed via second crossover events 
into more stable structures (Ball, 1987; Spyropoulos et al., 1988). Efficient 
recombination has been observed between coinfecting viral genomes as 
well as between viral genomic DNA and homologous sequences in 
transfected plasmid DNA (Fenner and Comben, 1959; Nakano, Panicali 
and Paoletti, 1982). In 1981 Sam and Dumbell demonstrated the 
occurrence of marker rescue of a fragment of W DNA by homologous 
DNA recombination in cells infected with ectromelia virus or 
thermosensitive mutants of VV, and transfected with intact W DNA 
fragments (marker+ DNA). They obtained ectromelia/vaccinia and 
recombinant viruses. This meant that W genes could be mapped by 
marker rescue and that foreign genes could be inserted into the viral 
genome by homologous packaging. 
The aforementioned facts render poxviruses suitable as vectors for 
the introduction of foreign genes into mammalian cells. The insertion of 
the herpes simplex virus thymidine kinase gene into W stimulated 
tremendous interest in inserting foreign genes into W (Mackett, Smith, 
and Moss, 1982; Panicali and Paoletti, 1982). 
Naked viral DNA is noninfectious when transfected into 
permissive cells. Therefore recombinant poxviruses were hitherto 
constructed by in vivo homologous recombination. The recombination 
occurred following the transfection of virus-infected cells with plasmids 
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that shared homologous sequences with the resident virus. However, 
Scheiflinger et al. (1992) demonstrated heterologous packaging of modified 
orthopox (VV) genomic DNA into avipox (fowlpox) helper virus-infected 
avian cells. (Foreign DNA is inserted into the viral genomic DNA by 
direct cloning before packaging). Viable fowlpox virus is not formed in 
mammalian cells. Although infection can occur, it is not followed by 
complete replication. This provides a selection step for packaged 
orthopoxvirus. Heterologous packaging could be a useful technique for 
the construction of recombinant poxviral vaccines provided unsheared 
viral DNA can be purified, and that restriction sites with a single 
recognition sequence in a non-essential location in the genome can be 
identified. 
Another advantage of poxviruses as a live recombinant yaccine 
vector, are their large genome sizes which allows the insertion of relatively 
large fragments of DNA. Several foreign viral genes can be inserted and 
expressed in the large genome of VV without significantly altering the 
virus's ability to replicate (Moss, 1993; Murphy and Chanock, 1990). 
Several non-essential loci have been identified in the vaccinia genome, 
presenting more that one target site for gene insertion. Viable deletion 
mutants of VV can also be generated from these non-essential loci, 
extending the ability of vaccinia to hold considerable quantities of foreign 
genetic material (Smith and Moss, 1983). Foreign genes can be inserted 
anywhere within these areas where DNA that are not essential for viral 
replication has been deleted. This allows the simultaneous expression of 
multiple foreign genes, which facilitates the construction of polyvalent 
vaccines (for immunization against multiple pathogens). Polyvalent 
recombinant vaccines can include the coordinated expression of a family 
of related gene products or the production of a variety of biologically 
active molecules from a single vaccinia infection. It is also possible to 
construct infectious vectors that contain genes from more than one virus, 
thus providing several immunizations simultaneously (Hollinger, 1990). 
An infectious VV recombinant, expressing multiple foreign antigens, has 
already been constructed. The genes encoding the influenza virus 
hemagglutinin, the hepatitis B virus surface antigen and the herpes virus 
type-1 glycoprotein D were inserted into a VV vector, yielding a triple 
recombinant (Perkus, Piccini, Lipinskas and Paoletti, 1985). 
VV strains with a more limited host range have been produced 
after three host range genes were identified and deleted (Duncan and 
Smith, 1992b). A more limited host range is desirable to prevent 
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inadvertent interspecies transmission of the recombinant virus. Virus 
attenuation can also be achieved by the identification and deletion of 
genes encoding glycoproteins that affect virus spread (Duncan and Smith, 
1992b; Engelstad and Smith, 1993; Lee, Roos, McGuigan, Smith, Cormier, 
Cohen, Roberts and Payne, 1992). At high immunization doses most 
mutants could induce an immune response similar to that of the wild-type 
virus (Lee et al., 1992). Two novel, highly attenuated poxvirus vectors, 
NYV AC and AL V AG, have been developed (Tartaglia, Cox, Taylor, 
Perkus, Riviere, Meignier and Paoletti, 1992). Strong immunological 
responses against extrinsic immunogens have been obtained with these 
vectors (Tartaglia et al., 1992). NYVAC was derived from the 
COPENHAGEN VV strain by the deletion of genes implied in virus 
virulence. AL V AG, a canarypoxvirus-based vector system, is rep~cation-
restricted in mammalian cells. Thus, genetically engineered, stable, 
attenuated VV strains can be produced to serve as vectors for the 
construction of live recombinant vaccines. 
The defined, identifiable attenuating mutations or gene 
constellations in these genetically engineered vaccine viruses can be 
monitored during the development, manufacture and utilization in 
humans or animals (Murphy and Chanock, 1990; Moss, 1993). 
An advantage of VV as a vector for live recombinant viral vaccines 
is that it is not oncogenic and does not cause latent infections (Hollinger, 
1990). VV vaccine is stable and induces a relatively long-lived immunity. 
The host range of vaccinia and other poxviruses make them suitable for 
veterinary and human vaccines. 
Theoretically any poxvirus can potentially be used as a vector. The 
choice of virus may for instance depend on the host-range requirements. 
An example of this is the case where a raccoon poxvirus has been used as 
a vector for the rabies virus glycoprotein gene. This construct was 
developed as an oral, bait-delivered vaccine and used successfully to 
vaccinate raccoons against rabies (Esposito, Knight, Shaddock, Novembre 
and Bauer, 1988). An oral bait form of a thymidine kinase-negative VV 
vector, expressing the glycoprotein gene of rabies virus, has also been 
found to be effective for wildlife including foxes and raccoons (Blancou, 
Kieny, Lathe, Lecocq, Pastovet, Soulebot and Desmettre, 1986; Brochier, 
Kieny, Costy, Coppens, Bauduin, Lecocq, Languet, Chappuis, Desmettre, 
Afiademanyo, Libois and Pastoret, 1991). 
Dogs developed virus-neutralizing antibody titers 
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when vaccinated intradermally with VV recombinants expressing the rabies virus 
glycoprotein (Fekadu, Sumner, Shaddock, Sanderlin and Baer, 1992). 
1.2.4. Disadvantages and potential hazards of live recombinant 
poxviral vaccines 
As mentioned before (Section 1.2.1.) the motivation for making more stable 
recombinant vaccines is problems experienced with some of the currently 
available live viral vaccines. Some of the disadvantages of live viral vaccines, and 
also of live recombinant poxviral vaccines, is that there is always the potential of 
contamination with live adventitious agents, although this has rarely been a 
problem. Contaminating DNA in live recombinant viral vaccines has a potential 
tumour risk, because its integration into the cell genome can cause the inactivation 
of suppressor genes or the activation of proto-oncogenes (Temin, 1990; 
Hofschneider, 1990). An amount of 100 pg heterogeneous DNA per single dose of 
vaccine are accepted as tolerable (Hofschneider, 1990). It can also be assumed that 
injected DNA is degraded quickly and inactivated biologically in vivo 
(Hofschneider, 1990). Contamination of vaccines with transforming proteins, like 
growth factors, is not a long-term risk as their effect is transient and their 
biological half-life is short (Hofschneider, 1990). 
Back-mutations and intertypic recombination between vaccine strains may 
lead to restoration of a varying degree of virulence (Murphy and Chanock, 1990). 
If vaccine progeny virus should spread from a vaccinated individual to 
unvaccinated individuals it may appear to be an advantage, but this progeny virus 
might be mutated and cannot be tested for safety and licensed for use in the 
general population (Melnick, 1990). The majority of buffalopox virus (BPV) 
outbreaks, a sporadic cause of morbidity among cattle and humans in India, may 
have originated from the widespread use of the smallpox vaccine before 1977 
(Dumbell and Richardson, 1993). Buffalocalves were used for smallpox vaccine 
production in India and the virus presumably adapted to survive in partially 
immune or immune hosts (Dumbell and Richardson, 1993). It was also suggested 
that VV strains, used as smallpox vaccine in Africa, may have been maintained for 
at least a short period in nature by transmission (Carra and Dumbell, 1987). This 
virus may have resulted in the occurrence of sporadic human orthopoxvirus-
infections (Carra and Dumbell, 1987). 
Genetic recombination between poxvirus genomes has occurred in nature 
in the absence of laboratory selection or screening (Gershon, Kitching, Hammond 
and Black, 1989). A possible hazard could thus arise from the use of vaccines 
based on poxviruses. If genetic recombination should occur between a 
recombinant poxvirus vaccine and a naturally occuring poxvirus a novel virus 
with altered pathogenicity might be generated (Gershon et al., 1989). This risk 
would be even greater if the new virus was highly transmissible with a broad host 
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range. These hazards cast a shadow over the use of VV (an orthopoxvirus) as a 
vector for live recombinant vaccines (Massung and Moyer, 1991). Orthopoxviruses, 
with special reference to VV, are well known for their broad host range and it may 
be even wider than is presently realized. There is also strong evidence that 
orthopoxviruses can be transmitted from animals to humans (Dumbell and 
Richardson, 1993; Duncan and Smith, 1992b; Gershon et al., 1989). Field trials with 
baits for the oral distribution of vaccines based on VV should hopefully cast some 
light on this problem. 
Naturally occurring wild-type viruses may interfere with infection by a live 
virus vaccine (Murphy and Chanock, 1990). Existing immunity within the target 
population to a potential vector, or to any of the expressed antigens, may restrict 
replication of the vector and reduce the overall immune response to the vaccine 
(Littaua et al., 1992; Old and Primrose, 1989). For example, VV vectors might not 
be effective in people who had a smallpox vaccination. To avoid this problem of 
immunity to the vector in previously unvaccinated people, different VV-based 
vaccines will have to be administered simultaneously, or a polyvalent virus should 
be constructed. 
However, Yamanouchi, lnui, Sugimoto, Asano, Nishimaki, Kitching, 
Takamatsu and Barrett (1993) reported the vaccination of cattle (that were 
inoculated with a VV strain three weeks earlier) with a recombinant vaccine, 
constructed by the insertion of the rinderpest virus haemagglutinin gene into an 
attenuated VV strain. Upon challenge with virulent rinderpest virus the cattle 
appeared to be protected. Antibodies to rinderpest virus developed in the cattle. 
This showed that the vaccine was effective in animals with pre-existing immunity 
to VV. An accidental human vaccination with a recombinant VV has been reported 
by Jones, Ristow, Yilma and Moss in 1986. A researcher accidentally inoculated a 
small cut on his finger with a recombinant VV expressing the vesicular stomatitis 
virus (VSV) nucleoprotein. Although a non-vaccine strain of VV was involved, the 
researcher only experienced mild symptoms. This could be due to the fact that he 
had been vaccinated about 30 years before or to attenuation of the virus by the 
insertional inactivation of the tk gene. A high antibody titre against the VSV 
nucleoprotein could be detected in the serum from the researcher. This showed 
that a new immune response was elicited against the foreign VSV nucleoprotein in 
man, despite his previous vaccination (Old and Primrose, 1989). A recombinant 
vaccine may thus be effective in humans with pre-existing immunity to the viral 
vector employed. 
Live virus vaccines, and thus also live recombinant viral vaccines are 
contraindicated in people with immunodeficiency diseases or undergoing 
immunosuppressive therapy and in their household associates, because vaccination 
in these cases can result in systemic infections (Dorozynski and Anderson, 1991; 
Redfield, Wright, James, Jones, Brown and Burke, 1987). An example of this is ·the 
case of a HIV-seropositive U.S. military recruit who developed disseminated 
vaccinia after routine vaccination (Redfield et al., 1987). 
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Studies indicated that a factor(s) present in VV infected cells is capable of 
activating gene-expression under the direction of the long terminal repeat (LTR) of 
human immunodeficiency virus type 1 (HIV-1) (Stellrecht, Sperber and Pogo, 
1992). The mechanism by which VV activates the HIV LTR is still unknown. It is 
therefore essential to identify genes in the VV genome that are responsible for 
virulence and HIV-1 activation. 
Because of all the disadvantages related to the use of VV as vector other 
poxviruses, like for instance capripoxviruses and avian poxviruses, are considered 
for use as vectors mainly for safety reasons (see Section 1.3.9. for a discussion of 
the advantages of using capripoxviruses as vectors). Avian poxviruses share the 
advantages of other poxvirus vectors but are incapable of complete replication in 
mammalian cells (Cadoz et al., 1992). However, early gene products are presented 
to the immune system (Cadoz et al., 1992). A rabies glycoprotein G gene was 
inserted into a canarypox virus and was tested for efficacy and safety in animals 
and humans. This vaccine was found to be safe and well tolerated (Cadoz et al., 
1992). In VV recombinants pre-existing immunisation against smallpox can block 
the immune response. No blocking effect on responses to booster vaccination 
with the canarypox vaccine could be observed by pre-existing immunity to either 
the canarypox-virus vector or the rabies glycoprotein (Cadoz et al., 1992). This 
proved that non-replicating poxvirus vectors can be used for the construction of 
live recombinant vaccines for use in humans. Non-replicating poxvirus vectors 
have the advantages that disseminated infection within the vaccinee or spread to 
contacts or the general environment should be eliminated. These vectors can also 
be used in immuno-compromised animals or humans. Capripoxviruses may also 
have potential for use as non-replicating vectors. 
1.3. Capripoxviruses and their potential as vectors for 
live recombinant vaccines with special reference to 
lumpy skin disease virus (LSDV). 
The general characteristics of lumpy skin disease virus (LSDV) have been 
reviewed extensively by Davies (1991). A summary of the aforementioned article, 
together with other sources of information (as cited) follows hereafter. 
1.3.1. Classification. 
The genus capripoxvirus consists of the species lumpy skin disease 
(Neethling) of cattle, sheep pox and goat pox (Gershon and Black, 1987). Based on 
the restriction enzyme analysis of the genomes of 26 capripoxvirus isolates, they 
have been divided into four types: (1) isolates only from sheep, (2) isolates only 
from goats, (3) isolates restricted to Africa from sheep, goats and cattle, and (4) 
isolates from either sheep or goats in Africa or the Middle East (Gershon et al., 
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1989). It has been suggested that the type 4 isolates arose by genetic 
recombination between type 2 and type 3 isolates (Gershon et al., 1989). Very little 
is known about the molecular biology of capripoxvirus genomes (Gershon and 
Black, 1987). 
1.3.2. Clinical signs and diagnostic features of LSD. 
LSD often occurs in epizootic form and is characterized by the eruption of 
nodules (5 - 50 mm or more in diameter) in the skin which may cover the whole of 
the animal's body. Lesions develop, which become necrotic and cause permanent 
damage to the hides. Infection results in spread to and lesions within internal 
organs (Massung and Moyer, 1991). The necrotic lesions furnish ideal oviposition 
sites for flies which may further the prosperity of other pests or diseases. The 
lesions are often also found in the mouth and respiratory tract. Systemic effects 
and complications include fever, pneumonia, abortion, infertility, anorexia, 
dysgalactia and disinclination to move. Histological characteristics of lesions of 
LSD as well as sheep and goat pox are oedema, hyperplasia of the epidermis and 
infiltration with an epithelioid cell. The important diagnostic features are 
thrombosis of the blood vessels in the dermis and subcutis, the cellular infiltration 
and typical intracytoplasmic pox inclusion bodies in cells associated with the 
nodules. Brick shaped poxvirus particles can be seen in tissue fragments from 
skin biopsies by electron microscopy, which is the most rapid way to demonstrate 
virus in LSD (Davies, Krauss, Lund and Taylor, 1971). Contamination of the 
material with herpesviruses is a recurring problem when identification of the 
virus particles by electron microscopy or isolation of the virus in tissue culture are 
attempted. Cattle recovering from the disease may remain in a very poor 
condition for 4-6 months. 
1.3.3. Transmission and host range of LSD. 
The precise mode of transmission of LSD is not known, but it has been 
suggested that arthropod vectors like mosquitoes, tabanids, Culicoides and Glossina 
species may be involved by mechanical transmitting the disease (Kitching and 
Mellor, 1986). Transmission by contact with infected cattle does not readily occur 
in insect-proofed cattle pens or under natural conditions (Kitching, 1983; Kitching 
and Mellor, 1986). LSD has a fairly narrow host range. Cattle of all ages are 
susceptible to LSD, but the severity of the disease varies between breeds and 
strains of cattle. Serum antibody to capripoxviruses have been found in African 
buffalo where LSD had been prevalent, but no antibody could be identified 
specifically to LSD. Natural infections have not been observed in any other 
ruminant species during outbreaks of LSD, except for five cases in the Asian water 
buffalo in Egypt. The development of LSD-like skin lesions could be produced by 
experimental infections in impala, Thomson's gazelle and the giraffe. Rodents and 
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lagomorphs are refractory to experimental laboratory infection while camels are 
insusceptible. 
1.3.4. Areas and ecotypes affected by LSD. 
LSD is mainly confined to sub-Saharan Africa (including Madagascar). 
LSD was first identified in Zambia in 1929. Capripoxvirus isolates are usually 
designated by their country and species of origin, for e.g. "Kenya cattle-1" (KC-1) 
was isolated from infected cattle during an outbreak of LSD in Kenya in 1958 
(Black and Gershon, 1987). The spread of the disease has been related to the 
movement of insect-vectors or the movement of cattle from areas where there 
have been recent outbreaks of LSD. Shortly after the importation of cattle from 
Somalia, where LSD had occurred, the disease appeared in Egypt in 1988 where it 
is now enzootic. An extension of the disease has occurred towards Israel in 1989 
which was probably due to the aerial movement of infected insect vectors. 
Enzootic situations exist in sub-Saharan African countries in which LSD has 
appeared with periodic cycles of sporadic and epizootic virus activity. LSD has 
the ability to spread rapidly in a wide range of ecotypes anywhere and the 
potential exists that it may spread to North Africa, the Middle East and northern 
Mediterranean countries. It has already occurred in high altitude temperate 
grasslands, wet and dry bushed and wooded savannah, semi-desert and irrigated 
areas. 
1.3.5. Genomic relations~ip between capripoxviruses. 
Serological (direct and indirect fluorescent antibody and serum 
neutralization tests) and restriction enzyme studies failed to indicate any 
differences between strains of LSDV and sheep and goat pox viruses (Black et al., 
1986; Davies and Otema, 1981). Schumperli et al. (1977) calculated that if the 
restriction patterns of two DNAs digested with a six nucleotide recognizing 
restriction enzyme, contain comigrating fragments, a genomic homology of 
greater than 80% can be inferred (Black et al., 1986). The DNAs of capripoxvirus 
field isolates and vaccine samples were analysed by restriction enzyme digestion 
with Hindlll (a six nucleotide cutter) and agarose gel electrophoresis. This 
showed that the capripoxviruses are closely related and, based on the calculations 
of Schumperli et al. (1977), it can be concluded that the genome homology must be 
more than 80% (Black et al., 1986). This conclusion was supported by the high 
level of sequence homology between capripoxvirus isolates detected by Southern 
Cross hybridization (Black et al., 1986). Gershon and Black (1988) showed that 
even the most divergent genomes are 95.8-97.0% homologous at the nucleotide 
sequence level. However, a correlation between restriction profiles and the virus 
host type was evident, which appeared to form a sheep pox group and a goat pox 
group. The molecular weights of the genomes estimated for different isolates also 
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varied from 73 to 91 MDa despite the high sequence homology (Black et al., 1986). 
Of the capripoxvirus field isolates and vaccine strains analysed by restriction 
enzyme analysis, LSD and the Kenya sheep and goat pox isolate were found to be 
the closest related to one another (Black et al. 1986). Serological studies by virus-
serum neutralization and immunofluorescence also did not show any differences 
between LSDV and Kenya sheep and goat poxvirus (Davies and Otema, 1981). It 
was suggested that LSD had arisen following a change in the host affinities of the 
Kenya sheep and goat poxvirus (Kitching, Hammond and Black, 1986a). LSDV 
strains also appear to be identical according to serological and restriction enzyme 
studies (Kitching et al., 1986a). It is suspected that the sheep and cattle isolates 
diverged from the goat isolate prior to diverging form one another (Gershon and 
Black, 1988). A close epidemiological relationship was also observed between the 
capripoxviruses (Kitching et al., 1986a; Kitching and Mellor, 1986). A major 
common precipitating antigen with a molecular weight of 67K was detected in four 
isolates of capripoxvirus (sheep pox, goat pox, sheep and goat pox and LSDV) and 
are probably shared by all isolates of capripoxvirus (Kitching et al., 1986a). 
Preliminary work using detergent-treated purified virus preparations showed that 
this antigen was located on the outer membrane of the virus particle (Kitching et al., 
1986a). This casted doubt on the justification for the continued classification of the 
capripoxviruses into distinct types (Kitching et al., 1986a). The sheep and goat pox 
viruses from the Middle East and elsewhere, however, display some differences 
from LSDV (Black et al., 1986; Davies and Otema, 1981). In South Africa sheep pox 
has not been observed despite large numbers of sheep and outbreaks of LSD in 
cattle, suggesting a different host range (Dr. A-L Williamson, Department of 
Medical Microbiology, Medical School, UCT - personal communication). 
1.3.6. Genomic relationship between capripoxviruses and 
orthopoxviruses. 
The capripoxviruses and the orthopoxviruses appear to be closely related on 
grounds of their morphological and physical properties (Davies and Otema, 1981). 
However, no apparent relationship was evident between the Hindlll restriction 
pattern of VV DNA (representative of the orthopoxviruses) and those of 
capripoxvirus DNA (Black et al., 1986). It is thus possible to identify a 
capripoxvirus on the basis of its Hindl 11 DNA restriction profile (Black et al., 1986). 
Although the capripoxviruses have a smaller genome size than the 
orthopoxviruses, their Hindl 11 DNA restriction profiles exhibit more fragments 
(Black et al., 1986). This suggests that the capripox virus genome sequences are 
highly divergent from orthopox viral genomes (Black et al., 1986). The size of the 
vaccine strain of LSDV was found to be 7 kb bigger than the size stated by Black et 
al. in 1986 (L. Perlman, Department of Medical Microbiology, Medical School, UCT 
- personal communication). Restriction analysis is a useful method for the 
identification and classification of poxvirus isolates (Muller, Wittek, Schaffner, 
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Schumperli, Menna and Wyler, 1977). The DNA of capripoxvirus contains covalent 
terminal cross links. This was indicated by the presence of two rapidly re-annealing 
fragments in the Hindl 11 digest upon denaturation (Black et al., 1986). 
1.3.7. Vaccines and immunity to LSD. 
A Kenyan sheep and goat pox virus (KSGPV) strain and the South African 
Neethling strain of LSDV have been used successfully to protect cattle against LSD 
(Kitching, Hammond and Taylor, 1986b). Two further strains of vaccine virus have 
been used more recently. A Romanian sheep pox vaccine strain produced in sheep 
was used successfully to immunize cattle in Egypt in 1989. Sheep and goat pox 
virus (SGPV) strains appear to be similar to LSD and a cross-protection capacity has 
been observed between SGPVand LSD. 
The KSGPV strain was used as a freeze dried live virus vaccine against SGPV 
and LSD after it was cultured in lamb testis or fetal muscle cells for 16 passages. 
This vaccine is absolutely safe in Bos indicus cattle, but on occasion mild LSD skin 
lesions and regional lymph node enlargements have been observed in 
approximately 0.02% of Bos taurus cattle. This complication could not be 
reproduced under experimental conditions and it may be due to needle 
transmission of virulent LSD in the field . 
The South African Neethling strain of LSD proved to be a satisfactory 
immunogenic modified live virus vaccine, after it was passaged 60 times in lamb 
kidney cells and then 20 times in embryonated eggs. This vaccine is unpopular with 
some cattle owners, because in up to 50% of cattle it causes a granulomatous lump 
at the inoculation-site. 
Good protection is normally obtained with an immunizing dose of 
approximately 102 tissue culture infective dose 50s (TCID50) in the field, but 103.5 
TCID50 is used for both vaccines. The KSGPV vaccine apparently induces immunity 
for at least 2 years and the South African vaccine for 3 years. It is possible that life-
long immunity is induced as in the case of other poxvirus vaccines. Calves born to 
cows which have recovered from the disease, have a passive immunity for up to 6 
months. Serological methods (indirect fluorescent antibody and virus serum 
neutralization tests) and/or an hypersensitivity test (developed at Kabete) can be 
applied to assess immunity. 
No correlation could be detected between neutralizing antibody and the 
immune status of animals. It was suggested that a hypersensitive reaction occurs 
and that cell-mediated immunity contributes significantly to the development of full 
immunity against capripoxviruses (Kitching, 1983). Attempts to replace live 
capripox vaccines with inactivated (or dead) preparations have been unsuccessful. 
The shortage on information on the immunity to pox virus infections makes it 
difficult to tell whether it will be possible to use inactivated (or dead) vaccine 
preparations in future (Kitching et al., 1986b). 
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1.3.8. Control and eradication of LSD. 
The OIE classified LSD as a group A infectious disease and it ranks with foot 
and mouth disease as an economically important disease of cattle. Poxviruses are 
resistant viruses and may remain viable in tissue or scab for a long time. Infected 
animals and in-contact animals should be slaughtered and the carcases burned or 
buried immediately after the disease has been identified for the first time in a 
country. It appears as if LSD has been successfully eradicated in a country for the 
first time when the Israeli authorities reacted rapidly in the diagnosis of the disease 
and the slaughtering of the diseased and in-contact cattle. No antibiotic or 
chemotherapeutic agent has any effect upon the course of the disease. Control 
regulations for an area at risk include the restriction of animal movement, 
vaccination repeated after 4-6 months and close surveillance of the cattle for at least 
6 months. Annual vaccinations should be maintained for 2-3 years. It is unsafe to 
import animals from areas where LSD occurred within the previous 3 years. 
1.3.9. Advantages and disadvantages of capripoxviruses as 
vectors for live recombinant vaccines. 
Most of the general advantages and disadvantages of using poxviruses as 
vectors for live recombinant vaccines (refer to Sections 1.2.3. and 1.2.4.) can also be 
applied to LSDV, except for, or in addition to the following: 
A vaccine strain of LSDV has been used successfully to protect cattle against 
LSDV and it should thus be safe to use this strain as a vector for the construction of 
live recombinant vaccines. This vaccine is easy to use and stable in the freeze-dried 
form. The narrow host range of LSDV and the fact that it is not easily transmitted 
by contact, opposed to VV, is another big advantage since the spread of the virus to 
unvaccinated animals, animals of different species or humans should pose a 
diminished risk. It was found that the capripoxvirus vaccines was not transmitted 
horizontally from vaccinated to unvaccinated animals, or vertically during 
pregnancy (Kitching et al., 1986b). A potential problem for the use of LSDV is the 
potential for damage to the host brain, spleen, liver and other internal organs, since 
infection of susceptible hosts results in spread of the virus to internal organs 
(Massung and Moyer, 1991). However, this is not a problem with the vaccine strain 
of LSDV. Recently, a recombinant capripoxvirus expressing rift valley fever virus 
(RVFV) glycoproteins has been obtained U.C. DeMartini personal 
communication). A single capripoxvirus recombinant vaccine for the protection of 
cattle against rinderpest and lumpy skin disease has also been reported (Romero et 
al., 1993). A big disadvantage is that to date very little is known about the 
molecular biology of the capripoxviruses, including LSDV. 
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1.4. Project motivation 
Due to the problems encountered with live viral vaccines and the 
disadvantages associated with live VY-based recombinant vaccines (as discussed in 
Sections 1.2.1. and 1.2.4.), it is desirable to develop LSDV as a vaccine vector. 
Thymidine kinase selection cannot be used for this virus, because there are no TK-
negative cell-lines available in which LSDV can be propagated. Two other methods 
have been used with VV for the selection of recombinant virus. Recombinants 
expressing f3-galactosidase (f3-gal) produce blue plaques; alternatively, 
recombinants expressing the guanine phosphoribosyl transferase (Gpt) gene are 
capable of overcoming plaque inhibition by mycophenolic acid. 
It will be useful to adapt each of these approaches for use in LSDV. The first 
step was to construct two plasmids, in which coding sequences for either f3-gal or 
Gpt were placed under the control of a promoter derived from VV. This construct 
was flanked by non-essential LSDV sequences from the TK-gene of LSDV and the 
whole incorporated into an appropriate plasmid. 
The next step was to set up transfection experiments to allow in vivo 
recombination between LSDV and the plasmid constructs. The products of these 
transfections were screened for blue plaques or for growth in the presence of 
mycophenolic acid. Once these experiments were completed, attempts were made 
to make a LSDV recombinant expressing the viral protein 7 (VP7)-gene of 
bluetongue virus (BTV). In parallel it was also attempted to make a VV 
recombinant expressing the VP7-gene of BTV to test the credibility of the 
construct(s) made and of the methods used. 
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CHAPTER 2 - METHODS 
2.1. Nucleic Acid Methods 
2.1.1. Preparation of plasmid DNA 
2.1.1.1. Small scale extraction of plasmid DNA 
2.1.1.1.1. LiCl-Boiling method 
The LiCl-boiling method for the small scale extraction of plasmid DNA was 
adapted from the method of Wilimzig (1985). 
An overnight culture of Escherichia coli (E.coli) cells harbouring the plasmid 
to be isolated were harvested by centrifugation for three minutes at 11 600 g in a 
Beckman Microfuge E™ (Beckman, Irvine, USA). The cells were suspended in 
lOOul TELT-buffer (50 mM Tris-HCl, 62.5 mM EDTA, 0.4% Triton X-100, 2.5 M 
LiCl, pH 7.5) in which lysozyme was freshly dissolved to a concentration of 
1mg/ml. The tube was left at room temperature for 15 minutes so that lysis of the 
cells could occur. After incubation in a waterbath at 80°C for 2 minutes the tube 
was immediately put on ice for 5 minutes. Following centrifugation at 11 600 g for 
15 minutes, the DNA in the supernatant was transferred to a fresh tube and 
precipitated by the addition of 3 volumes (1 volume = original volume of 
supernatant obtained) water and 2.5 volumes (1 volume = volume obtained after 
the addition of water to the supernatant) absolute ethanol. After chilling on dry 
ice for 15 minutes the DNA solution was centrifuged for 15 minutes at 11 600 g. 
The DNA-pellet was washed with 70% ethanol by spinning the tube in the 
opposite orientation such that the pellet migrated through the 70% ethanol. The 
supernatant was discarded. The pellet was then dried in a Speedivac drier 
(Eppendorf, Germany) for 10 to 15 minutes and dissolved in 60 µl of sterile ultra 
pure water (BDH Laboratory Supplies, England). 
To obtain DNA preparations that were free of contaminating RNA, 
DNAase-free pancreatic RNAase was added to the dissolved DNA to a final 
concentration of 10 ug/ml. The mixture was incubated for 1 hour at room 
temperature. After phenol/ chloroform extractions to remove the RN Aase and 
protein-contaminants, the DNA was re-precipitated, washed with 70% ethanol 
and dissolved in sterile ultra pure water. 
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2.1.1.1.2. Alkaline DNA extraction method 
The alkaline DNA extraction method for the small scale preparation of 
plasmid DNA was adapted from the method of Crouse, Frischauf and Lehrach 
(1983). 
An overnight E. coli-culture (1.5 ml), harbouring the plasmid to be isolated, 
was centrifuged in a microfuge tube at 11 600 g for 10 minutes to pellet the cells. The 
cell-pellet was suspended in 180 µl 50 mM glucose, 10 mM EDTA and 25 mM Tris-
HCl (pH 8,0). A few grains dry lysozyrne was added, mixed gently and the tube put 
on ice for 10 minutes. Thereafter 400 µl NaOH/SDS (0,2 N NaOH; 1 % SDS) was 
added, mixed gently and the tube was again put on ice for 10 minutes. The solution 
cleared at this stage due to the denaturing and dissolving of protein and DNA. The 
chromosomal DNA and protein was precipitated with 300 µI high salt (3 M 
Potassium acetate; 1,3 M Formic acid). After mixing gently it was left on ice for 15 
minutes or longer, centrifuged at 11 600 g for 15 minutes and the supernatant 
containing the plasmid DNA transferred to a fresh tube. The DNA was extracted 
twice with phenol-chloroform before it was precipitated by the addition of an equal 
amount cold isopropanol. After thorough mixing the tube was put on dry ice for 30 
minutes. The DNA was then pelleted and dissolved in sterile ultra pure water as 
described in section 2.1.1.1.1. Contaminating RNA was removed from the DNA 
preparation as described in section 2.1.1.1.1. 
2.1.1.2. Large scale extraction of plasmid DNA. 
The method used for the preparation of large quantities of plasmid DNA was 
adapted from that of Greenaway and Dale (personal communication). The 
incubation times were modified to produce greater yields and the chloramphenicol 
amplification step was omitted. 
A single bacterial colony was inoculated into 10 ml Luria-broth containing an 
appropriate selective antibiotic. If the cells were not actively growing they were 
inoculated into 10 ml of Luria-broth without antibiotic and grown up for an hour at 
37°C with shaking to get expression of the antibiotic-resistance gene. The 
appropriate antibiotic was then added and cultures were incubated for a further 4-8 
hours. The 10 ml culture was then added to 200ml pre-warmed Luria-broth 
containing antibiotic. A large flask with a capacity of about 500-lOOOml was used 
for this step to maximize surface aeration in order to get a good plasmid yield. It 
was left shaking at 37°C for about 15-18 hours or overnight. 
The cells were harvested by centrifugation at 4 400 g in a Beckman centrifuge 
(Model J2-21; Beckman, Irvine, USA) for 15 minutes at 4°C. The cell-pellet was 
suspended in 2,6 ml 25% sucrose in 0,05 M Tris-HCI, pH 8.0, transferred to a chilled 
polypropylene centrifuge tube and put on ice. A spatula tip of dry lysozyme was 
added to the cell-suspension and it was swirled on ice for 5 minutes. To this was 
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added 2.6 ml of 0.25 M Na2EDTA (pH 8.0) to provide an isotonic solution and to 
chelate divalent metal~ations and it was swirled on ice for another 5 minutes. Then 
4 ml Triton-x-100/DOC (1 % Triton, 0.4% Sodium deoxycholate in 0.01 M Tris, 0.001 
M Na2EDTA, pH 8.0) was added rapidly with a 10 ml pipet and mixed by drawing 
up and expelling three times. It was left on ice for 20 to 30 minutes to allow maximal 
cell lysis to occur. 
Centrifugation was carried out at 27 ioo g in a Beckman Model J2-21 
centrifuge for 45 minutes at 4°C to pellet the cell debris and chromosomal DNA. 
The chromosomal DNA is known to be associated with the cell-membrane and will 
pellet together with the membrane in a detergent solution. 
The supernatant was removed and the volume made up to 10 ml with Triton-
x-100/DOC. To this 9.5 g of CsCl and 0.2 ml of ethidium bromide (10 mg/ml) was 
added. Two Quick-Seal polyallomer tubes (Beckman), suitable for centrifugation in 
a Beckman VTi 65 rotor, were filled to the neck with the solution and heat-sealed. 
lsopycnic gradient centrifugation was carried out at 239 000 gin a Beckman L7-55 
ultracentrifuge (Beckman, Irvine, USA) for 18-20 hours at 20°C. 
The DNA was visualized under an ultraviolet light of 375 nm wavelength. 
Two bands were visible: a higher band consisting of chromosomal and nicked 
plasmid DNA, and a lower band consisting of covalently closed supercoiled 
plasmid DNA which resided at an equilibrium position corresponding to its 
buoyant density. Ethidium bromide intercalates less efficiently into DNA in the 
supercoiled configuration than into DNA in the relaxed configuration. Supercoiled 
DNA thus contains less ethidium bromide resulting in a higher density (ethidium 
bromide unwinds DNA when it intercalates), which facilitates its separation from 
nicked and chromosomal DNA by ultracentrifugation in CsCl (Ausubel et al., 1987; 
Sambrook et al., 1989). 
Both the top and the bottom of the tube were punctured with a needle and 
the plasmid bands were collected under long wave UV-light through the bottom of 
the tube. The RNA which had collected at the bottom of the tube was eluted first. 
Denatured protein was sometimes visible against the side of the tube. 
Ethidium bromide was removed by extraction with an equal volume of 
isoamylalcohol. After thorough mixing, the phases were separated by 
centrifugation for 2 minutes at 11 600 g. The upper organic layer was disgarded 
and the extraction was repeated until no pink colour could be seen in either phase. 
The DNA in the remaining aqueous phase was precipitated by the addition 
of 3 volumes (1 volume = volume of DNA-solution obtained) of sterile distilled 
water and 2.5 times the v~lume obtained after the addition of water, of absolute 
ethanol. The microfuge tubes were put on dry ice for 5 minutes or overnight at -
20°C. Polypropylene tubes were put on dry ice for 2 hours or overnight at -20°C. 
The DNA in the polypropylene tubes was pelleted by centrifugation at 3 000 gin a 
Beckman model J2-21 centrifuge for 45 minutes at 4°C. (The DNA in the microfuge 
tubes was pelleted by centrifugation at 11 600 g for 15 minutes at 4°C.) The DNA-
pellet in the polypropylene tube was washed with chilled 70% ethanol 
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by centrifugation at 3 000 g for 30 minutes at 4°C (or at 11 600 g for 15 minutes at 4°C 
when using microfuge tubes), dried in a Savant speedvac and resuspended in sterile 
distilled water. 
The dialysis step (in order to remove excess CsCl-salt) as described in the 
original method (Greenaway and Dale - personal communication) was omitted after 
the removal of ethidium bromide. This reduced the loss of DNA, saved time and no 
adverse effects on subsequent DNA manipulations were evident. The CsCl 
concentration was sufficient to precipitate the DNA without the addition of any more 
salt. 
2.1.2. PhenoVchloroform extractions. 
Phenol/chloroform extractions (Ausubel, 1987; Sambrook et al., 1989) were 
performed to remove contaminating proteins from nucleic acid preparations during 
purification or for the removal of enzymes after enzymatic manipulations of DNA or 
RNA. Deproteinization is more efficient when two different organic solvents are 
used instead of one. Isoamyl alcohol, used in combination with chloroform, helps to 
separate the organic and acqueous phases (Perbal, 1988). When nucleic acids were 
purified from complex mixtures such as cell lysates, additional measures were 
required. In these cases most of the protein was removed by digestion with 
proteinase K before extracting with phenol/ chloroform. 
A volume of phenol (equal to half that of the DNA solution) (Appendix A.11.) 
was added and the solution was vortexed. Chloroform:isoamylalcohol (24:1) was 
added at the same ratio as the phenol and the solution was mixed by vortexing. The 
phases were separated by centrifugation for 2 minutes at 11 600 g and the upper 
aqueous phase, containing the nucleic acid, was retained. These steps were repeated 
at least one more time or until no precipitate was visible on the aqueous/organic 
interphase. A subsequent extraction was sometimes carried out with an equal 
amount of water-saturated diethyl-ether to remove any traces of phenol, but it was 
not required for routine purification of DNA (Ausubel, 1987). The DNA was 
precipitated as described in section 2.1.3. 
2.1.3. DNA precipitations. 
DNA was precipitated after purification by phenol/chloroform extractions. 
This was usually done by the addition of LiCl to a final concentration of 0.4 M, or 
Na-acetate to a final concentration of 0.3 M and 2.5 volumes of ice-cold absolute 
ethanol (Ausubel, 1987; Sambrook et al., 1989). LiCl was preferred because of its 
solubility in ethanolic solutions and its selectivety in precipitating DNA as opposed 
to RNA at this particular concentration (Sambrook et al., 1989), but Na-acetate 
precipitated poxvirus-DNA more effectively. The DNA was kept on dry ice for 5-30 
minutes or overnight at -20°C for maximum precipitation. It was then 
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pelleted by centrifugation at 12 000 g for 15 minutes at 4°C. The pellet was 
washed by centrifugation with chilled 70% ethanol in the opposite direction so 
that the DNA migrated through the ethanol, dried in a speedivac (Eppendorf, 
Germany) and resuspended in sterile distilled water. The resuspended DNA was 
stored at 4°C. 
2.1.4. Restriction endonuclease digestion. 
Restriction endonuclease digestions were performed on small- and large-
scale DNA preparations as recommended by the suppliers. The correct salt 
concentrations were used and the glycerol concentration was kept low enough to 
prevent inhibition of the reaction. The enzyme volumes used never exceeded one 
tenth of the total reaction volume. 
Digestions of plasmid DNA were usually done by incubation at 37°C in a 
waterbath for 60 to 120 minutes, except when different incubation temperatures 
were recommended by the suppliers. Digestion periods were kept to a minimum 
for enzymes such as EcoRl which could exhibit star activity according to 
Boehringer Mannheim. Digestions of genomic- or poxviral-DNA were incubated 
for two to three hours at 37°C in a waterbath or overnight for about 18 hours at 
37°C in a humidified incubator to minimize the evaporation-rate which would 
result in a change of the reaction-concentrations. Multiple digestions were done 
simultaneously when the temperature- and buffer-requirements of the enzymes 
involved were compatible. If however, the reaction conditions were not 
compatible, they were done sequentially (starting with the enzyme with the lowest 
salt requirement). In this case phenol/ chloroform extractions and ethanol 
precipitations of the DNA were done between digestions. A small aliquot of 
digested DNA was routinely checked for complete digestion by agarose gel 
electrophoresis (Ausubel et al., 1987). 
The enzyme-reactions were terminated by one of the following ways: 
(l)phenol/chloroform extraction and ethanol precipitation; (2)heating to 75°C for 
15 minutes in a waterbath; (3)adding 10 X Stop buffer (50% v/v glycerol, lOOmM 
Na2EDTA pH 8.0, 1 % w /v SDS, 0.1 % w /v bromophenol blue, 0.1 % cyanol) to the 
reaction mixture (methods adapted from Ausubel et al., 1987). The fragments 
generated from the digests were separated by agarose gel electrophoresis, stained 
with ethidium bromide and visualized on a 254 nm UV transilluminator. 
2.1.5. Agarose gel electrophoresis. 
Agarose gel electrophoresis was performed using a horizontal submerged 
slab gel system. Agarose (0.8% or 1.0%, depending on the sizes of the fragments 
to be separated) was dissolved in TAE (40 mM Tris-acetate; 2 mM EDTA pH 8.0; 
Appendix A.15.) or TBE (90mM Tris-borate; 2 mM EDTA pH 8.0; Appendix A.16.) 
buffer by melting in a microwave oven, and cooled to approximately S6°C before 
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pouring. Gels were run either with ethidium bromide (0.5 µg/ml) already added 
to the agarose before the gel was poured or they were stained after electrophoresis 
with ethidium bromide at a concentration of 1 to 2 µg/ml for 30 minutes. In case 
of overstaining gels were destained in distilled water for 30 minutes. When very 
accurate size estimations of DNA were necessary, gels were stained afterwards, 
because the fluorescent ethidium bromide intercalates with the DNA and reduces 
the electrophoretic mobility of linear DNA by about 15% (Ausubel et al., 1987). 
Horizontal gel slabs, about 5 mm thick, were poured in a mold with the 
comb already in position. Once the gel had set (after about 30 minutes) the comb 
was removed and the gel submerged in a tank filled with T AE or TBE buffer. The 
samples of DNA, which were mixed with gel-loading buffer (Appendix A.6.) were 
loaded into the slots of the gel. A marker DNA with known sizes was also loaded 
into the gel (Ausubel et al., 1987). 
Electrophoresis of minigels (75 x 50 x 3 mm) was carried out for 30 to 60 
minutes at 5-20 V / cm until the bromophenol blue and xylene cyanol FF had 
migrated the required distance. Electrophoresis of large analytical gels (200 mm 
long x 150 mm wide x 5-7 mm thick) was carried out for 5 hours at a potential 
difference of 4 V / cm or for 18-20 hours at a potential difference of 1.6-2.0 V / cm. 
A higher resolution of the bands were attained when electrophoresis was carried 
out at 2 V /cm for 18-20 hours at 4°C. DNA bands were visualized (due to the 
presence of ethidium bromide) and photographed on a 254 nm UV 
transill uminator. 
2.1.6. Isolation of DNA fragments from agarose gels. 
DNA fragments were isolated from agarose gels according to the method of 
Seth (1984). 
An amount of DNA that would yield approximately 1 µg of the fragment of 
interest, was digested with a suitable restriction enzyme. The fragments were 
separated by agarose-gel electrophoresis and stained with ethidium bromide. The 
band of interest were located with a hand-held long-wavelength (375 nm) 
ultraviolet light (to minimize the nicking of the DNA) and cut out with a scalpel 
blade. The slice of agarose containing the band of interest was cut into small 
pieces in a petridish using a scalpel blade and transferred to a microfuge tube(s). 
An equal amount of phenol was added and mixed thoroughly by vortexing. It 
was kept on dry ice for 30 minutes or overnight at -20°C before it was centrifuged 
for 15 minutes at 11 600 g in a bench-top microfuge. The upper aqueous phase 
was transferred to a clean tube and the DNA was further purified by phenol 
extraction. The upper phase was again transferred to a clean tube and an equal 
amount of chloroform:isoamylalcohol (24:1) was added, mixed and separated by 
centrifugation at 11 600 g for 5 minutes. The DNA was precipitated as described 
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in section 2.1.3. The DNA was subjected to agarose-gel electrophoresis to examine 
the quality and estimate the quantity. 
2.1.7. Cloning 
In principle, the plasmid DNA or vector was cleaved with a restriction 
enzyme and ligated in vitro to a piece of foreign DNA with compatible ends. 
Products of the ligation mixture were introduced into competent E. coli cells and 
transformants, harbouring the desired DNA molecule, were identified (Ausubel 
et.al., 1987; Sambrook et.al., 1989; Perbal 1988). 
2.1.7.1. Preparation of insert and vector DNA 
The insert-DNA was prepared as described in section 2.1.6. The plasmid-
vector was linearized with a restriction enzyme which generated the appropriate 
sticky ends for ligation. The linearized plasmid was phenol/ chloroform extracted 
(to remove the enzyme), alcohol precipitated and redissolved in sterile distilled 
water. 
A vector digested with only one restriction enzyme is capable of 
recircularizing under ligation conditions. This can be limited to some extent by 
adjusting the concentrations of the vector DNA and the foreign DNA in the 
ligation reaction so that they will be optimized for the formation of the "correct" 
ligation products. An additional method to prevent this recircularization of the 
vector is to remove the 5'-phosphate group of the DNA molecule, necessary for 
self-ligation and recircularization, by treatment with calf intestinal phosphatase 
(CIP). This 'dephosphorylation'-reaction was performed for the preparation of the 
pGS20-VP7 vector cut with Hindlll (Chapter 4.2.3.3.). Ligation to foreign DNA 
would still be possible, since the foreign DNA would still contain a phosphate-
group. At each end only 1 of the 2 strands will be covalently joined in vitro, but E. 
coli can repair the single-stranded nicks in vivo to generate the desired DNA 
molecules (Ausubel et al., 1987; Sambrook et al., 1989). 
'Dephosphorylation' of the vector was done as follows (Sambrook et al., 
1989): after phenol/chloroform extraction and alcohol precipitation of the 
linearized DNA (10-20 µg), it was resuspended in 90 µl sterile distilled water to 
which 10 µl of 10 x CIP buffer (10 mM ZnC12, 10 mM MgC12, 100 mM Tris.Cl pH 
8.3) was added. For protruding 5' termini, one unit of CIP /100 pmoles of free 
ends were used and incubation was done for 30 minutes at 37°C. For blunt or 
recessed termini, 1 unit of CIP /2 pmoles was used and incubated for 15 minutes at 
37°C, after which another aliquot of CIP was added. The reaction was then 
incubated for a further 45 minutes at 55°C, after which the following were added: 
5 µl 10% SDS, 1 µl 0.5 M EDTA and 0.5 µl (20 mg/ml) proteinase Kand mixed 
well. Incubation was done for 30 minutes at 56°C after which two 
phenol/chloroform extractions were performed. The DNA was ethanol 
precipitated and washed with 70% ethanol. The pellet was resuspended in sterile 
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distilled water. (The CIP must be removed completely for the ligation reactions to 
be efficient.) 
Short DNA fragments are more likely to circularize than large fragments, 
and high concentrations (20 to 100 µg/ml) should be used to favor intermolecular 
ligation (Ausubel et.al., 1987). Intramolecular ligation of insert fragments does not 
generally affect the background of unwanted colonies as the insert fragment does 
not contain the selectable marker. 
2.1.7.2. Ligation 
Samples of the vector and the insert were run on an agarose-gel to verify 
the integrity of the DNA and to estimate the relative concentrations. 
The ligation reaction were set up so that the molar concentration of the 
termini of foreign DNA was approximately two- to threefold the molar 
concentration of the termini of the plasmid DNA to obtain the maximum yield of 
monomeric plasmid:insert DNA chimeras. The absolute concentration of termini 
should be high enough to favour intermolecular ligation, but low enough to 
prevent extensive oligomeric molecule formation. To the vector and insert DNA, 2 
µl of 5 x ligase buffer (obtained from Boehringer Mannheim) and 1 µl of T4 DNA 
ligase (1 unit, Boehringer Mannheim) were added in a total reaction volume of 10 
µI. The final DNA concentration in the reaction mixture should not exceed 5 
ng/ µl, because the PEG in the ligase buffer tends to concentrate DNA (Sambrook 
etal.1989) . 
Two additional control ligation-reactions were set up in the case of 
dephosphorylated vector DNA, one with only dephosphorylated plasmid DNA 
and the other with linearized plasmid DNA that was not treated with CIP. The 
absence of transformants in the case of dephosphorylated DNA subjected to "self-
religation", was an indication of a successful CIP treatment. 
Ligation was carried out at 15°C in a waterbath overnight (18 to 20 hours), 
after which bacterial cells were transformed with the mixture. The ligation-
temperature should be high enough for the enzyme to be active, but also low 
enough to permit hydrogen bonding between the sticky ends of DNA. 
2.1.7.3. Preparation of competent E.coli cells 
A single bacterial colony (E. coli strain JM109, LK-111 or DK-1) was picked 
from a minimal media plate, inoculated into 10 ml of Luria-broth (Appendix A.7.) 
and grown overnight at 37°C with shaking. From this culture, 100 µl was used to 
inoculate 100 ml of pre-warmed Luria-broth and allowed to grow to an early log 
phase (OD600 = 0.5). (All manipulations were carried out aseptically.) The cells 
were transferred to sterile, ice-cold polypropylene tubes, cooled on ice for 10 
minutes and harvested by centrifugation at 2831 g for 10 minutes at 4°C. 
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The cell-pellet was carefully resuspended in 10 ml of ice-cold TSB buffer 
(Luria-broth containing 5% (v /v) DMSO, 10 mM MgC12, 10 mM MgS04 and 10% 
(w /v) PEG Mr 4 000) and left on ice for 10-15 minutes. 
Competent cells were used immediately for transformation or 100 µl 
aliquotes were snap-frozen in a dry-ice/ ethanol bath and stored at -70°C (Chung 
and Miller, 1988). 
2.1.7.4. Transformation of competent E.coli cells 
Approximately 50 ng DNA from the ligation mixture in a volume of no 
more than 5 µl, were transferred to a sterile Greiner-tube and flooded with 100 or 
200 µl competent cells (immediately after they were thawed). Two control 
reactions were set up in parallel: one with competent cells transformed with 1 ng 
of pUC19 DNA and the other with only competent cells. 
After gentle mixing and incubation on ice for an hour, the cells were heat 
shocked for 90 seconds at 42°C in a waterbath. The cells were put on ice for 2 
minutes and 1 ml of 37°C Luria-broth (Appendix A.7.) was added to each tube, 
mixed and incubated for 1 hour at 37°C to get expression of the antibiotic 
(ampicillin)-resistance gene. Of each of the transformation mixtures, different 
aliquots were plated out onto three separate Luria-agar plates containing 
ampicillin (50 µg/ml), left to absorb and incubated in an inverted position at 37°C 
overnight. Ampicillin-resistant colonies secrete !3-lactamase into the medium 
surrounding the colonies which inactivates ampicillin (Sambrook et.al., 1989). 
Therefore transformed cells should be plated out at low density and the plates 
incubated for no longer than 20 hours at 37°C to prevent the appearance of 
ampicillin-sensitive satellite colonies when selecting for ampicillin-resistance. The 
number of resistant colonies do not increase in a linear way to the number of cells 
plated out as cells killed by ampicillin might release growth-inhibiting substances 
(Sambrook et al., 1989). When the inactivation of the !3-gal gene of the pUC vector 
was used as marker, 250 µl of a 20 mg X-gal/ml N,N-dimethylformamide 
solution, 50 µl of a 23.8 mg IPTG/ml distilled water solution and 100 µI (50 
mg/ml) ampicillin was added per 100 ml pre-cooled ( <54°C) Luria-agar before the 
plates were poured. 
2.1.7.5. Screening for recombinants 
The three methods used to screen for bacterial colonies containing 
recombinant plasmids were the following: restriction analysis of small-scale 
plasmid-preparations; insertional inactivation of the E. coli lacZ gene, which 
encodes the glycoside hydrolase !3-D-galactosidase (f3-gal), and in situ 
hybridization of bacterial colonies. 
A number of separate bacterial colonies were randomly picked (when blue-
and-white selection could not be performed as discussed in the following 
paragraph) and each colony was streaked onto a grid plate with Luria-agar and 
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inoculated into 10 ml of Luria-broth. After incubation at 37°C overnight, the grid 
plate was stored at 4°C for future ~eference and the liquid cultures were used for 
small-scale plasmid-preparations. The plasmid-DNA obtained was analyzed by 
restriction enzyme digestion and gel-electrophoresis. This was done when there 
was a relatively good chance of finding a recombinant within a small number of 
colonies, for example when the control ligation with only dephosphorylated 
vector-DNA yielded far less colonies than the actual ligation reaction. 
When plasmids containing the [3-lactamase gene from pBR (which confers 
ampicillin-resistance upon the host cell) were used as vectors, it allowed for the 
selection of transformed cells in the presence of ampicillin. A vector containing 
the amino-terminal fragment of the f3-gal gene (with a multiple cloning site within 
this gene) will allow expression of f3-galactosidase in host cells containing the 
carboxy-terminal fragment of this gene through a-complementation. IPTG 
(isopropyl-f3-D-thiogalactopyranoside), a synthetic inducer of the lac operon, was 
included in the medium. The enzyme [3-galactosidase hydrolyses the 
chromogenic substrate X-gal (5-bromo-4-chloro-3-indolyl-[3-D-galactoside) to 
generate galactose and soluble indoxyl molecules (MacGregor et al., 1991). The 
soluble indoxyl molecules are oxidized to form bromochloroindole, an insoluble 
blue dye which gives the colonies a blue appearance on Luria-agar plates 
containing ampicillin, X-gal and IPTG. When foreign DNA is cloned into the 
multiple cloning site, functional f3-galactosidase cannot be produced and the 
colonies will appear white (MacGregor et al., 1991; Sambrook et al., 1989). The 
presence of inserts in white colonies was verified by subjecting DNA from 
minipreparations to restriction analysis. 
Screening for recombinants was also done by colony hybridization 
(Sambrook et al., 1989). Plates which had been incubated until the bacterial 
colonies were about 0.1-0.2 mm in diameter, were placed at 4°C for 1 to 2 hours in 
an inverted position. A replica plate was prepared which was stored at 4°C until 
needed. The bacterial colonies were transferred to a nylon-membrane (Hybond 
N+, Amersham, UK) by placing the dry membrane on the surface of the agar-
medium in contact with the colonies. The membrane and the underlying agar was 
marked in three asymmetric positions by stabbing through the filter with a needle. 
The wet membrane was peeled off and put, colonies facing up, on a filter paper 
disk (Whatman 3MM paper) saturated with 10% SDS for 3 minutes to lyse the 
bacteria. The agar-plate was wrapped in Saran-wrap and stored at 4°C until 
further use. The membrane was transferred to a second piece of filter paper 
saturated with denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 5 minutes. 
After this the membrane was transferred to a third piece of filter paper that has 
been saturated with neutralizing solution (1.5 M NaCl, 0.5 M Tris.Cl pH 8.0) and 
left for 5 minutes. The DNA was fixed to the membrane by transferring the 
membrane to a filter paper saturated with 0.4 N NaOH for 10 minutes. After 
being washed with 6 x SSC the filter was sealed in a plastic bag for hybridization. 
As many as 104 colonies per 150-mm plate can be screened using this technique 
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(Sambrook et al., 1989). The diffusion of the plasmid DNA during denaturation 
and neutralization is limited by putting the membrane on filter papers wetted 
with the appropriate solutions. After hybridization with an appropriate non-
radioactively labelled DNA probe and immunological detection (Sections 2.1.8.2. 
and 2.1.8.3.), the colonies harbouring recombinant plasmids could be identified by 
coloured precipitate formation on the nylon membrane. By re-alignment of the 
membrane with the agar-plate corresponding colonies were picked from a replica 
plate onto a new grid plate with Luria-agar for future storage. These colonies 
were also subjected to mini-scale DNA plasmid preparations. 
2.1.7.6. Storage of bacterial cells 
After identification of the colonies harbouring the recombinant plasmid, the 
corresponding colonies on the grid plate were used to inoculate 10 ml Luria-broth 
(Appendix A.7.) containing 50 µg/ml ampicillin, and the cultures were grown up 
for 3 to 4 hours at 37°C with shaking. From this culture, about 3 x 0.85 ml was 
mixed with glycerol to a final concentration of 15%. Cells were then frozen in a 
dry ice/ ethanol bath, stored at -70°C and used as stock cultures (Maniatis et al., 
1982). 
2.1.8. Hybridization 
DNA was immobilized on nylon membranes and then hybridized to 
appropriate labelled nucleic acid probes to detect DNA sequences of interest. 
Nylon membranes were preferred because of their durability and the fact that they 
can withstand several rounds of hybridization, washing, stripping and reprobing 
at elevated temperatures. 
2.1.8.1. DNA transfer to membrane 
The DNA was digested with one or more restriction enzymes and the 
fragments separated by gel-electrophoresis in an agarose gel. This DNA was then 
denatured in situ and transferred from the gel to a nylon membrane by 
unidirectional Southern blotting (Perbal, 1988; Smith & Summers, 1980; method 
modified slightly) as follows: 
After electrophoresis, the gel was photographed and cut such that only the 
lanes of interest were transferred. The gel was then soaked in a volume of 0.25 M 
HCl for 2 minutes with gentle shaking to induce chemical cleavage of the DNA. 
The gel was rinsed with distilled water and soaked in buffer 1 (1.5 M NaCl, 0.5 M 
NaOH) for 20 minutes with gentle shaking to denature the DNA fragments. 
Weight 
Rigid Support 
Paper Towels 
--- Sheets of 
Whatn1an paper 
Hybond N 
'~--- Gel with DNA 
Sheet of plastic 
Fig. 2.1. Diagrammatic representation of Southern Blot transfer of DNA to Hybond-N/N+ 
membrane for hybridization. 
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Neutralization followed after rinsing the gel with distilled water by soaking in 
buffer 2 (1 M Ammonium acetate, 0.02 M NaOH) with gentle shaking for at least 
40 minutes. 
A Southern blot was set up as demonstrated in Fig. 2.1. (Sambrook et al. 
1989, modified). The gel was transferred to an used X-Ray film and the excess 
solution removed. A piece of Nylon membrane (Hybond N or Hybond N+, 
Amersham), cut to the same dimensions as the gel, was carefully placed on top of 
the gel such that no bubbles were trapped between the gel and the membrane. 
The sides of the gel were covered with cling film so that the buffer would not be 
absorbed directly into the paper towels. Three pieces of Whatman 3 MM paper, 
also cut to the same dimensions as the gel and wetted in buff er 2, were put on top 
of the membrane followed. by a stack of dry paper towels. A flexiglass with a 0.75 
to 1.0 kg weight was put on top of this and the DNA transfer was allowed to 
proceed overnight. All the steps were carried out at room temperature. 
Before removing the membrane from the gel, the slot positions were 
marked with pencil on the membrane. After rinsing the membrane briefly with 2 
x SSC, it was air-dried slightly and UV-illuminated for a few seconds (1 200 x 100 
microjoules) to facilitate co-valent cross-linking of the DNA to the membrane. 
Thereafter it was used directly for hybridization or sealed in a plastic bag and 
stored at 4°C until further use. 
2.1.8.2. Non-radioactive labelling of DNA 
Non-radioactive labelling of DNA with digoxigenin-dUTP was performed 
as described in the protocol supplied with the DNA Labelling Kit (Boehringer 
Mannheim, Cat. No. 1175 033). 
2.1.8.3. Hybridization and detection 
For non-radioactive labelling the membranes were prehybridized with at 
least 20 ml hybridization solution (50% (v /v) formamide, 5 x SSC, 2% (w /v) 
blocking reagent, 0.1 % (w /v) N-lauroylsarcosine, 0.02% (w /v) SDS) per 100 cm2 of 
filter at 42°C with shaking overnight. (Protocol supplied with the Nucleic Acid 
Detection Kit, Boehringer Mannheim, Cat. No. 1175 041). This was replaced with 
about 2.5 ml of hybridization solution per 100 cm2 of filter to which the denatured 
probe was added. The probe was denatured by boiling in a waterbath for 15 
minutes and quickly chilled in a dry ice/ ethanol bath for 5 minutes. 
Hybridization was carried out at 42°C overnight with gentle shaking. The 
membrane was washed as follows: two 5 minute washes with 2 x SSC, 0.1 % SDS 
(w /v) and three 15 minute washes with 0.5 x SSC, 0.1 % SDS (w /v) at room 
temperature with shaking. Hybridized DNA was detected by chemiluminescent 
or immunological detection. 
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Chemiluminescent detection was performed as described in the updated 
protocol using maleate buffer, provided with the DIG Luminescent Detection Kit 
(Boehringer Mannheim, Cat. No. 1363 514). The anti-digoxigenin-AP, Fab 
fragments were diluted to 150 mU/ml (1:5000) in buffer 2. Tween 20 was not 
added to buffer 1 for washing purposes. 
Immunological detection instead of chemiluminescent detection was 
performed for colony blots as described in the protocol provided with the DIG 
Nucleic Acid Detection Kit (Boehringer Mannheim, Cat. No. 1175 041). 
Chemiluminescent detection was found to be more sensitive than colorimetric 
detection. 
2.1.8.4. Autoradiography 
Labelled blots, sealed in a plastic bag, were exposed to Curix RP 1 X-ray 
film (Agfa, West Germany) in X-ray cassettes with intensifying screens. Blots 
hybridized with non-radioactive labelled probes were exposed for about 30 
minutes at room temperature. Autoradiographs were processed after exposure by 
developing for 3-8 minutes, washing for 1 minute (in a 2% acetic acid stop bath) 
and fixing and hardening for 5 minutes using Agfa chemicals as prescribed by the 
manufacturer. The X-ray was air-dried after being rinsed in running tap water for 
15 to 20 minutes. 
2.1.8.5. Re-use of blots 
The digoxigenin-dUTP probe was removed (if the membrane was kept wet) 
by first washing the membrane in sterile water, then 2 x 15 minutes in 0.2 M 
NaOH, 0.1 % SDS (w /v) at 37°C followed by a short wash in 2 x SSC (protocol 
supplied with the Nucleic Acid Detection Kit, Boehringer Mannheim, Cat. No. 
1175 041). 
The removal of the probe was tested by exposure to X-ray film and the 
membranes were only re-used when no signal could be detected. 
2.2. Tissue Culture Methods And Virus Propagation 
Tissue cultures have been applied in virology for three main purposes due 
to their ability to support the growth of viruses and to reveal their presence by a 
cytopathic effect (CPE) which are sometimes specific: (1) virus production for 
vaccine manufacturing purposes, (2) detection and identification of viruses and (3) 
the study of host-parasite relationships. The techniques used depended on the 
task to be performed and are varied and specialized. 
2.2.1. Propagation of virus in fertilized eggs of domestic hens 
( Gallus domesticus) 
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Virus was propagated by a method adapted from Westwood et al. (1957) 
and McCarthy and Dumbell (1961). The virus purification method was adapted 
from Joklik (1962). 
2.2.1.1. Preparation of chorioallantioc membranes (CAMs) 
Twelve day old embryonated chicken eggs were candled to determine the 
position of the air-sac (on the blunt end of the egg) and a region near the main 
blood vessels on the dorsal side of the egg was marked. A small hole through the 
eggshell was made with a spring-loaded bore at the markings. A mixture of 
paraffin wax and petroleum jelly was melted and a drop was placed next to the 
hole on the dorsal side of the egg. A drop of sterile physiological saline was 
placed onto the hole on the dorsal side of the egg and allowed to go in between 
the membranes by carefully pushing the membrane down through the hole with 
the nib of a witch pen. An air-lock was created by breaking the shell membrane 
and thus allowing saline penetration. The eggs were re-candled and the air was 
extracted from the air-sac with a rubber suction bulb so that the chorioallantoic 
membrane (CAM) dropped and a new air-sac formed above it at the hole on the 
dorsal side of the egg. The eggs were left at 37°C for about 2 hours so that the 
membranes could equilibrate. 
2.2.1.2. Inoculation of CAMs 
An appropriate virus dilution (0.1 ml) was inoculated onto the prepared 
CAM through the hole on the dorsal side of the egg, using a one ml syringe with a 
thin short (22 gauge) needle. After this the hole was sealed with the mixture of 
wax and petroleum jelly. The egg was swirled around for a few seconds for the 
inoculum to spread evenly and incubated at 37°C for three days. The virus-
inoculum was diluted in sterile physiological saline to which PSN (each antibiotic 
at a concentration of 200 µg/ml; Appendix A.13.) was added. 
2.2.1.3. Harvesting of virus from CAMs 
After three days incubation the CAMs were harvested as described below: 
The egg was held so that the inoculation site pointed upwards and was cut 
open along the midline with a pair of sterile scissors. While holding on to the 
upper half of the eggshell the egg-contents were dropped into a bin containing 
Biodan disinfectant. The infected area of the membrane was peeled away from the 
eggshell with sterile forceps and washed in physiological saline. After examining 
it for the presence of focal lesions, the membranes were transferred to sterile pre-
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cooled McCarthy-bottles, containing glass beads to about a fourth of its volume, 
and the bottles were kept on ice to keep enzyme activity to a minimum. 
One ml of pre-cooled 4 mM Mcllvains buffer, pH 7.4 (Appendix A.9.), was 
added per membrane. A paper towel was wrapped around each bottle (for heat-
isolation and to detect possible leakage) and it was vigorously shaken for 1 
minute. The culture was centrifuged in a swing out rotor at 110 g for 8 to 10 
minutes at 4°C and the supernatant (containing the virus) was retained on ice. A 
second volume of Mcllvain's buffer was added to the membranes in the bottles 
and the process was repeated. The supernatant fluids were pooled and incubated 
on ice for 1,5 hours. Virus suspensions were clarified by centrifugation at 1 200 g 
for 15 minutes at 4°C. The virus in the supernatant was concentrated by 
centrifugation at 17 418 gin a swing-out rotor for 1,5 hours at 4°C. The virus was 
cushioned by 1 ml of 36% sucrose in TE-buffer, pH 9, (Appendix A.17.) which was 
added to the bottom of the tube prior to centrifugation. The virus pellet was 
resuspended in 1 ml of TE-buffer, pH 9, and layered onto a density gradient 
consisting of 1 volume of 36% sucrose and 2 volumes of 10% Dextran TlO (w /v in 
TE-buffer, pH 9). Centrifugation was performed at 17 418 g for 1 hour at 4°C. The 
viral pellet was resuspended in 1 ml of Mcllvain's buffer, pH 7.4. For long term 
storage glycerol was added to a concentration of 80% and virus aliquots were 
stored at -70°C. Working stocks were stored at -20°C. 
2.2.2. Preparation of primary cells 
Primary cells were prepared according to the method by Freshney (1987). 
The bovine fetal calf kidneys or the lamb testis were obtained from the 
abattoir in Maitland and processed immediately after it was aseptically removed 
from the animal. Embryonic tissue disperses more readily and gives a higher 
yield of proliferating cells than newborn or adult tissue. The kidney /testis was 
rinsed in physiological saline containing appropriate antibiotics and the fat, 
connective tissue and capsule were removed. The remaining tissue was rinsed 
again and cut into small 2 to 3 mm pieces with crossed scalpels. These pieces were 
rinsed several times in crude trypsin (0.25% trypsin in PBS; Appendix A.12) to get 
rid of excess blood and transferred to a sterile glass bottle. Crude trypsin was 
added and stirred at 4°C overnight to allow penetration of the enzyme with little 
tryptic activity. Crude trypsin is tolerated quite well by most cells and is effective 
for a variety of tissues. However, to preserve maximum viability it is better to 
minimize the exposure of cells to active trypsin (Freshney, 1987). The trypsin was 
removed and the tissue digested at 37°C for 30 minutes. Tissue culture media 
(DMEM; Appendix A.3.), supplemented with 0.5% PSN (Appendix A.13) and 10% 
fetal calf serum (FCS), was added and the cells dispersed by pipetting. Any 
residual tryptic activity left will be neutralized by the serum in the media 
(Freshney, 1987). After counting the cells with a haemocytometer as described 
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below, the cells were diluted to 106 per ml in growth medium and flasks were 
seeded with approximately 2 x 1Q5 cells per cm2. The cells were incubated at 37°C 
in a COrincubator until confluent. The medium was changed at regular intervals. 
2.2.3. Quantitation of cells 
Of a cell suspension in 10% FCS tissue culture medium, 0.1 ml was added 
to 0.15 ml of physiological saline and 0.25 ml of a Trypan blue solution (Appendix 
A.18.) and mixed. This gave a dilution factor of 5. A small amount of the Trypan 
Blue-cell suspension was transferred to both chambers of a haemocytometer 
(Neubauer, Brand, Blaubrand, Germany) with the coverslip in place. The viable 
cells were counted in a 1 mm center and four corner squares of both chambers 
separately. (Live cells exclude the dye whereas dead cells take it up to stain blue). 
If less than 20 or more than 50 cells were counted per square, the entire procedure 
was repeated adjusting the cell dilution. To calculate the viable cell-concentration 
per ml, the average reading per square was multiplied with the dilution factor and 
with 104 (the total volume of the 1 mm square with the cover slip in place is 0.1 µl). 
2.2.4. Growth and maintenance of cell cultures 
The cells were grown at 37°C under CO2 atmosphere in medium 
supplemented with 10% FCS, PSN (100 units/ml Penicillin, 100 mg/ml 
Streptomycin and 100 mg/ml Neomycin; Appendix A.13.) and 3 mM sodium 
bicarbonate. The enriched medium, Dulbecco's Minimum Essential Medium 
(DMEM; Appendix A.3.), does not require supplementary sodium bicarbonate. 
Confluent cell monolayers were maintained with the appropriate medium 
supplemented as above with PSN and sodium bicarbonate, but with a reduction in 
the FCS-concentration to 2 or 4%, depending on the cell-line. (Mitosis is not 
stimulated by this reduced serum-concentration in most untransformed cells. 
Transformed cells, however, do not block in a regulated fashion in the G1 phase of 
the cell cycle and may either deteriorate or continue to divide. Continuous cell 
lines and some embryonic cells also deteriorate at high cell densities (Freshney, 
1987). The cell-lines were not kept on maintenance medium for longer than a 
week.) 
The cell- monolayers were grown and maintained in tissue culture flasks or 
in multi-well tissue culture dishes. Confluent cell-layers were subcultured by 
rinsing the monolayer with PBS and with activated trypsin versene (ATV; 
Appendix A.1.) . A second small volume of ATV (3 ml/75 cm2) was added and the 
flask was incubated at 37°C for about 10 minutes for the cells to dissociate. 
Growth medium was added to a final volume of 10 ml and the cells were 
dispersed by repeated pipetting for a few times. Cells were re-seeded by the 
addition of the appropriate amount of cells to growth medium. The medium was 
changed on a regular basis (about every third or fourth day) depending on the 
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cell-density or cell-line, or when indicated by a change in the pH or signs of 
morphological deterioration. 
2.2.5. Storage and preservation of cells 
Stocks of cells were frozen away to serve as a back-up in case of accidental 
loss of cells due to contamination or a limited life span (Freshney, 1987; Lennette 
and Schmidt, 1979). 
Cells were grown up to the late log phase of the cell-cycle (3+) in growth 
medium that was frequently changed. After trypsinization and centrifugation at 
100 g for 10 minutes, the cells were resuspended in cell-freezing medium 
(Appendix A.2.) to a concentration of 1 x 106 viable cells/ml. (DMSO presumably 
protect the cells during freezing by binding water so that less are available to form 
ice-crystals and intracellular electrolyte build-up is reduced.) One ml aliquots 
were slowly frozen down by putting the vials at -70°C for 3 hours after which they 
were rapidly transferred to liquid nitrogen. Although the cooling rate could not 
be controlled, reasonably good viability of the cells was retained by this method. 
(Cells should be frozen down at a cooling rate of 1 °C per minute to retain 
maximum viability of the cells. Ice crystals form extracellularly rather than 
intracellularly by slow freezing so that the cells are not disrupted.) 
To thaw the frozen cells, vials were put at 37°C in a waterbath immediately 
after removing it from the liquid nitrogen. As soon as it was thawed the vial was 
swabbed with 70% ethanol, growth medium was slowly added to the cell-
suspension (sudden dilution can cause severe osmotic damage to the cells) and 
centrifugation was carried out at 100 g for 10 minutes. The cells were resuspended 
in fresh growth medium, seeded into a tissue culture flask and incubated at 37°C. 
After 24 hours the medium was replaced. 
2.2.6. Propagation of virus in mammalian cells 
The mammalian cells used for the propagation of virus were prepared and 
maintained as described in sections 2.2.2. to 2.2.4. The most suitable cell-line for 
the propagation of the specific virus was selected. 
Cells were grown in 150 cm2 tissue culture flasks in DMEM, supplemented 
with 10% FCS and PSN (Appendix A.13.), at 37°C under CO2 atmosphere. When 
the cell-sheet was about 80% confluent, the culture medium was removed. The 
cells were then rinsed three times with PBS (Appendix A.12.) to remove any 
remaining serum which may contain substances that inhibit virus infectivity 
(Mahy, 1985). The virus was diluted in virus diluent (Appendix A.21.) to obtain 
the desired multiplicity of infection and added to the rinsed cells. For the 
multiplication of LSDV, MDBK-cells were infected at a concentration of 1 foci 
forming units (FFU)/ cell. After incubation at 37°C for 1 hour, the virus inoculum 
was replaced with DMEM supplemented with 4% FCS and PSN. Incubation was 
continued at 37°C under CO2 atmosphere. 
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The third day after infection, or when maximum cpe (cytopathic effect) was 
observed, the cells were disrupted by · three cycles of freeze/thawing. The 
disrupted cells were incubated on ice for 1 hour. The cell-debris was pelleted by 
low speed centrifugation in a swing out rotor at 800 g for 15 minutes at 4°C. The 
supernatant (containing the virus) was retained. The virus in the supernatant was 
concentrated by centrifugation at 14 636 g for 2 hours at 4°C, having added a 1.0 
ml cushion of 36% sucrose in TE buffer (pH 9; Appendix A.17.) to the bottom of 
the centrifuge tube. The viral pellet was resuspended in 2 ml of Mcllvain's buffer, 
pH 7.4. (Appendix A.9). Purification by density gradient centrifugation was not 
applied as this resulted in a significant reduction in virus yield. Working stocks 
were stored at -20°C. For long term storage, virus aliquots were stored at -70°C 
after glycerol was added to a concentration of 80%. A Sigma 301K centrifuge 
(Sigma Products, Saint Louis, United States of America) was used for the low 
speed centrifugation step. High speed centrifugation steps were done in a swing-
out rotor in a Beckman centrifuge, Model J2-21 (Beckman, Irvine, United States of 
America). 
Virus yield does not increase by overloading of the cells with virus. For 
optimum virus multiplication it is best to add sufficient virus to the cells to infect 
between 1 % and 10% of the cells in a monolayer (Mahy, 1985). When the virus 
titre was unknown, this was achieved empirically by using two or three different 
dilutions for infection. The rate of virus multiplication in tissue culture is 
dependent on the particular virus strain and type of cell. Virus multiplication and 
release is generally accompanied by cell-degeneration, and a CPE is most readily 
seen in cells grown as a monolayer. With some viruses, when maximum CPE is 
observed the virus is completely released from the cells, while other viruses tend 
to remain more cell-associated. The harvest stage is crucial in some instances, 
since degenerating cells release nucleases which can degrade viral nucleic acids. 
2.2.7. Virus Titration 
(Adapted method from Paul, 1975) 
Serial ten-fold dilutions of the virus to be titrated was made in virus diluent 
(Appendix A.21.). The growth medium was removed from 80% confluent cell-
monolayers in a 24-well tissue culture dish and the cell-layers were rinsed three 
times with PBS to remove any remaining serum. Each well was inoculated with 
0.2 ml of a virus dilution, two wells per dilution. (Dilutions in the range 10-2 to 10-
7 were used for infection.) After 1 hour incubation at 37°C, the virus-inoculum 
was removed from the cells and they were rinsed once with PBS to remove any 
unadsorbed virus. To each well with infected cells, 1 ml of DMEM supplemented 
with 4% FCS and PSN (Appendix A.13.) was added. The cells were incubated at 
37°C for 48 hours and stained with ZN Carbolfuchsin (Appendix A.5.) as follows: 
The medium was removed from the cells and they were covered with ZN 
Carbolfuchsin and left at room temperature for a period ranging from 30 to 60 
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seconds. Each well was held under slowly running tap water until the metallic 
blue-green precipitate was washed off. The water was disgarded and the wells 
were again filled up with tap water and left for 5 minutes. The water was 
disgarded and the stained cells were air-dried by leaving the tissue culture plate 
upside down on a paper-towel. The plaques were counted in the wells and the 
virus concentration was calculated as follows: 
pfu (plaque forming units)/ml = average amount of plaques (for a specific 
dilution)/well x dilution factor x volume of inoculum per well 
Vaccinia virus (VV) was titrated using this method. It was more difficult to 
titrate Lumpy Skin Disease Virus (LSDV) as it appeared that some cell-lines were 
more susceptible to the virus, for example a higher titer was observed if CFK-cells 
were used instead of MDBK-cells with the same virus-stock. The cytopathic effect 
(CPE) was also difficult to distinguish after staining with ZN Carbolfuchsin, as the 
virus does not form plaques like VV but causes swelling of cells which forms 
clumps. Due to the reasons mentioned, LSDV was titrated using CFK-cells and 
the sites of infection or cell-clumps (foci) were counted without staining. 
Bushar and Sagripanti (1990) found that only a small percentage of virus in 
the inoculum is adsorbed onto the cells and thereby detected in the titration assay 
under conditions currently used for virus titration. No release of infective virus 
occurs during the 1 hour period of infection; thus, it cannot account for the 
presence of unadsorbed virus. They found that the volume of the inoculum is one 
of the most important factors and should be kept as small as possible to limit virus 
diffusion to the cell surface. Best results were obtained when dilutions were 
chosen so as to obtain between 30 and 150 plaques per well. Maximal plaque 
number was obtained after 1 hour of virus adsorption and little gain in sensitivity 
was obtained by increasing the adsorbtion time beyond 1 hour. 
2.2.8. Infections and transfections of cell-cultures 
(Methods adapted from Mackett et al., 1985; Old and Primrose, 1989; 
Felgner, 1991; Singer and Berg, 1991.) 
Mammalian cells have the ability to take up exogenously added DNA and 
to express genes encoded by this DNA. A vector that replicates independently as 
an extrachromosomal element, can be used to transform animal cells by infection 
or transfection, for example a virus genome that yields virions with recombinant 
genomes. These vectors are frequently unstable during the subsequent cell 
generations after the initial transfection, even when selective pressure is applied. 
However, some vectors do form stable, replicating, extrachromosomal elements in 
animal cells. 
Infections of 80% confluent monolayers of cells with virus were performed 
as described in section 2.2.6. Animal cells were transfected essentially as 
described in the protocol provided with the Lipofectin ™ Reagent (Bethesda 
Research Laboratories Life Technologies, Inc., Cat. No. 8292SA.). Liposomes are 
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small single bilayer vesicles prepared from a cationic lipid, which interacts 
spontaneously with poly-anions such as DNA or RNA to form a Lipofectin™ 
reagent-DNA or RNA complex. This complex transform animal cells in culture 
efficiently, probably by fusion with the plasma membrane (Old and Primrose, 
1989) or by phagocytic uptake (Felgner, 1991). Some of the advantages of this 
method are the following: it is relatively simple to perform; it is unaffected by pH 
between 6.0-8.0; other factors like precise mixing protocols, the level of DNA and 
the presence of low levels of contaminants are less important; and large DNA 
molecules can be transfected. 
For transfection, cells were infected with the appropriate wild-type virus as 
described in section 2.2.6 at a concentration of about 0.05 PFU / cell. (It has been 
found that when the wild-type virus input in the transfections are increased the 
total overall yield may be increased, however, the percentage of recombinants 
produced tends to decrease (Mackett, 1991). This will give an unnecessarily high 
background of wild-type virus.) 
For each 30-mm dish (containing about 1 x 106 cells), 1 to 13 µg DNA and 24 
to 32 µg LipofectinTM reagent was each diluted separately to 60 µI with ultra pure 
water to avoid DNA and liposome aggregation. The solutions were combined in a 
polystyrene tube, mixed gently and left at room temperature for 15 minutes. 
(Polystyrene tubes are preferred because they attract the aggregates that can form 
less than glassware or plastic. Optimum transfection activity occurs when the 
Lipofectin™ reagent/DNA ratio is in the range of 2:1-10:1 (w/w), so that the net 
negative charge of DNA is substantially reduced (Feigner, 1991). 
After infection of the cell-monolayer for an hour, the virus-inoculum was 
removed from the cells and the cell-layer was rinsed twice with Opti-MEM 
l(GIBCO/BRL) to remove any unadsorbed virus. Opti-MEM was added to the 
cells, 500µ1/30 mm dish, and the DNA-liposome complex was added dropwise 
and uniformly to this while swirling the dish gently. Incubation was performed at 
37°C for 5 to 24 hours, depending on the condition of the cells which was 
microscopically monitored with regular intervals. 
Medium, containing 4% FCS and PSN (Appendix A.13.), was added to the 
cells with/without selection medium after removal of the opti-MEM mixture and 
incubation was continued at 37°C. 
To be able to determine the amount of background virus that could be 
expected with selection medium, controls were kept with uninfected cells and also 
with cells that were infected with the same concentration of wild-type virus but 
were not transfected. 
2.2.9. Determination of cell-tolerance to mycophenolic acid 
(MPA) and the MP A-concentration required for virus-inhibition 
Almost confluent monolayers of cells were prepared in 24-well Nunclone 
tissue-culture plates, cells seeded at the same concentration in all the wells. A 
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series of different MP A-concentrations was prepared in medium containing 4% 
FCS. The cell-monolayers were rinsed three times with PBS and medium 
containing different MPA concentrations (Appendix A.10.) were added to the 
cells, each different MPA-concentration in duplicate. 
The cells from a second plate were infected with a standard virus-
concentration for an hour at 37°C. After removal of the virus-inoculum, media 
containing different MP A-concentrations was added as above. 
Control wells with uninfected and infected cells were kept in duplicate to 
which medium without any MPA was added. 
The cells were incubated at 37°C for several days (up to a week) during 
which time the cells were monitored daily by microscope for any signs of 
morphological changes. According to the data from this experiment the MPA-
concentration which would inhibit untransformed virus without damaging the 
cells could be determined. 
By harvesting the virus from transfected cells and passaging it on to new 
cells with fresh medium containing the pre-determined MPA-concentration for a 
few times, background untransfected virus should be eliminated to a fairly good 
extent. 
2.2.10. Stains/assays of transf ected cells 
After transfection, the cells were stained at regular intervals in order to 
determine how successful the cells were transfected. 
2.2.10.1. The X-gal stain 
When the £. coli lacZ gene, which encodes the glycoside hydrolase, (3-D-
galactosidase (f3-gal), was used as a reporter gene, a histochemical stain 
(MacGregor et al., 1991) was used to detect f3-gal activity in situ within cells in 
culture. 
Subcellular localization of f3-gal activity is facilitated by the deep blue 
colour generated by the hydrolysis of X-gal by (3-gal (Section 2.1.7.5.). 
The cell-layer was washed three times with PBS and fixed with 4% 
paraformaldehyde (Appendix A.14.) for 5 minutes at room temperature. The 
monolayer was covered with the substrate solution (Appendix A.14.) and left for 
half an hour to 18 hours at 37°C. Cells expressing (3-gal would stain different 
grades of blue which can be visualized by the naked eye or by low-power 
microscopy (MacGregor et al., 1991). 
The pH of the system is buffered and sodium ions, which activate the f3-gal 
enzyme, are provided by PBS. Potassium ferrocyanide and potassium 
ferricyanide enhance localization of the blue colour by increasing the rate of 
conversion of the indoxyl molecules to the indigo form. Magnesium ions act as 
co-factors for the enzyme and X-gal is the chromogenic indicator substrate. 
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This method can detect a single cell expressing f3-gal within a population of 
non-expressing cells, although it is not as sensitive as immunocytological 
methods. 
2.2.10.2. Assay for f3-galactosidase activity in mammalian cell-
extracts 
The assay was done according to the method described in Sambrook et al. 
(1989), except that the volumes given were adapted for cells grown in a monolayer 
in a 35-mm tissue culture dish. 
2.2.10.3. Indirect immunoperoxidase stain 
The most sensitive and specific methods for the detection of the protein 
products of genes make use of antibodies. Immunohistochemistry examines 
individual cells which make it very suitable for analyzing transfection in vitro. 
The immunoperoxidase method is generally more sensitive than the 
immunofluorescence method, although the latter is easier to perform and the 
conjugated antibody is generally more stable and thus more reliable (Morris, 
1991). 
The cells were gently washed three times with PBS, fixed in cold acetone for 
10 minutes at 4°C and air-dried. (The precipitating fixative, acetone, leaves the 
protein microenvironment maximally flexible and solubilizes or destroys the 
membrane barrier which allows penetration of the antibody. Cells can be stored 
air-dried at 4°C, but the degree of preservation of morphology might be 
diminished.) 
The fixed cells were rinsed with PBS, 2% ovalbumin in PBS were added to 
the cells and blocking was performed at room temperature for 20 minutes or 
longer. The blocking solution was removed and the appropriate dilution of 
primary antibody, in PBS containing 2% ovalbumin, was added to the cells. The 
ovalbumin served as a carrier protein to stop adsorption of the very low 
concentration of antibody to the plastic of the tissue culture dish. Incubation was 
carried out for 2 hours at room temperature. 
The cells were washed once with PBS containing 0.5% Tween 20 and twice 
with only PBS (5 minutes each) at room temperature. The appropriate conjugate-
dilution, in PBS containing 2% ovalbumin, was added to the cells and incubation 
was performed at room temperature for 1 hour. The cells were again washed 
three times as described before. 
A working solution of the substrate, diaminobenzidine tetrahydrochloride 
(0.5 mg DAB/ml, 0.03% H20 2 in PBS,filtered), was added to the cells and 
incubation was carried out for 3 to 10 minutes at room temperature until the 
desired degree of brown precipitate has formed or a general background staining 
started to develop. The reaction was stopped by washing with tap water. 
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The cell-nuclei were counterstained with haematoxylin to distinguish the 
cell-nuclei from the cytoplasm as follows: the cells were covered with the 
haematoxylin solution (Morris, 1991), left for 1 - 2 minutes and rinsed with tap 
water. The cells were mounted and viewed under the microscope. 
2.2.11. Extraction of total DNA from infected cell-cultures 
(Method adapted from Bailey and Possee, 1991.) 
Almost confluent cells in tissue culture dishes (35-mm diameter) were 
infected with the presumed recombinant virus, which has been taken through 
several rounds of selection (at least five) after the transfection of cells. After one 
hour infection at 37°C, the virus inoculum was removed from the cells and 
selection medium was added. Incubation was continued for 24 hours at 37°C. 
The medium was removed from the cells (about 106 cells/35-mm dish) and 
the cell-layer was rinsed three times with PBS. Lysis buffer (Appendix A.8.), 500 
µ1/ dish, was added to the cells. Ribonuclease A was added to a final 
concentration of 40 µg/ml and incubation was carried out at 37°C for one hour. 
The lysate was transferred to an Eppendorf tube and Proteinase K was added to a 
final concentration of 100 µg/ml. Incubation was performed at 55°C for three to 
four hours or overnight at 42°C. Vigorous pipetting or shaking was avoided once 
the cells were lysed to prevent shearing of the DNA. The lysate was extracted 
twice with pre-warmed phenol (37°C) and once with chloroform:isoamyl (24:1). 
The DNA was precipitated by the addition of sodium acetate (to 0.3 M) and two 
volumes of absolute ethanol and incubated at-20°C overnight. Centrifugation was 
carried out at 4°C for 15 minutes at 11 600 gin a microfuge. The pellet was washed 
twice with cold 70% ethanol, dried and resuspended in ultra pure water at 4°C 
overnight. 
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CHAPTER 3. CONSTRUCTION OF LSDV-BASED 
REPORTER/SELECT ABLE MARKER-GENE VECTORS 
AND THEIR TRANSFECTION INTO MAMMALIAN 
CELLS 
3.1. Introduction 
3.1.1. Rationale for the construction of LSDV-based 
reporter/selectable marker-gene vectors 
Lumpy skin disease virus (LSDV; as discussed in Chapter 1.3.) is a 
Capripoxvirus with a fairly narrow host range which includes sheep and cattle, 
but excludes humans (Davies, 1991). In South Africa LSDV has not been 
encountered in sheep even though the disease periodically occurred in cattle 
(personal communication - Dr. Anna-Lise Williamson). An attenuated strain has 
been widely used as a live vaccine for many years, and may prove to be a useful 
vector for the construction of recombinant veterinary vaccines for use in cattle and 
sheep (Davies, 1991; Kitching, Hammond and Taylor, 1986b; refer to Chapter 
1.3.7. and 1.3.9.). Vaccinia virus (VV) has been used successfully as a vector in 
several recombinant vaccine trials, but has several disadvantages (discussed in 
Chapter 1.2.4.). One of the major disadvantages is the possible spread of the virus 
to non-vaccinated individuals due to the broad host-range of VV (Massung and 
Moyer, 1991), which make the construction of recombinant LSDV vaccines a 
desirable proposition. 
Due to the low efficiency of the transfection process highly discriminatory 
selection procedures are required to isolate recombinants to be used as vaccines. 
The few commonly used selection systems rely on the use of mutant or normal 
recipient animal cell-lines. If the DNA, used for the transfection of cells, carries 
the wild type allele of a gene that occurs in a mutant form in the recipient cells, 
growth conditions that discriminate between the wild and the mutant type 
phenotype can be used to select for the desired transformants. For example, cells 
with a mutant thymidine kinase gene (TK- cells) will only grow in the presence of 
thymidine and aminopterin if transformed by DNA containing a functional 
thymidine kinase gene. Aminopterin blocks the de novo thymidine 
monophosphate synthetic pathway (Fig. 3.1.), making cells dependent on the TK-
gene to salvage free bases and nucleosides (thymidine) from the culture medium 
for the synthesis of DNA (Szybalski, 1992). Unfortunately there are no ovine or 
bovine TK- cell-lines available, therefore this approach could not be applied. 
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Fig . 3.1. Purine and pyrimidine salvage pathways. 
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A. Purine salvage pathway showing enzymes and inhibitors of interconversions (taken from Meuth and 
Harwood, 1991). Mycophenolic acid inhibits inosinate (IMP) dehydrogenase. This block can be overcome 
by the E.coli Gpt gene that encodes xanthine-guanine phosphoribosyltransferase. Xanthine is a poor 
substrate for the analogous animal enzyme hypoxanthine-guanine phosphoribosyl transferase (hgprt). 
PRPP is phosphoribosyl pyrophosphate. 
B. The de nova and salvage pathways for deoxy-thyrnidine-5'-monophosphate (dTMP) synthesis. Aminopterin 
blocks de nova synthesis, making dTMP synthesis dependent on thymidine and thyrnidine kinase (TK) . 
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A second approach relies on rendering virus multiplication in the presence 
of mycophenolic acid dependent on a dominant selectable transfected gene, like 
the E. coli xanthine-guanine phosphoribosyl transferase ( Gpt) gene (Boyle and 
Coupar, 1988; Falkner and Moss, 1988) or by using a reporter gene of which the 
product can be visualized fairly easily, like the f3-galactosidase (f3-gal) gene 
(Chakrabarti, Brechling and Moss, 1985). The reporter gene should encode a 
product that is stable, innocuous to the cell in which it is being expressed, and 
readily detectable even in small quantities. The Gpt- and the f3-gal-gene will be 
discussed in the following sections. 
3.1.2. The xanthine-guanine phosphoribosyl transf erase gene 
(Gpt-gene). 
The functional dominant selectable E. coli-gene, Gpt, encodes xanthine-
guanine phosphoribosyl transferase. Refer to Fig. 3.1. Cells are normally unable 
to synthesize guanylic acid (GMP) in a medium containing mycophenolic acid 
(MPA). MPA specifically inhibits inosinate (IMP) dehydrogenase preventing the 
formation of xanthosine monophosphate (XMP) in a manner similar to its action 
on W (Boyle and Coupar, 1988). By supplying a Gpt-gene under the control of a 
suitable promoter (such as the P 7,5 promoter of W) and xanthine, this block can 
be overcome. Xanthine is a poor substrate for the analogous animal enzyme, 
hypoxanthine-guanine phosphoribosyl-transferase, and is therefore not normally 
used by animal cells as a precursor to guanine nucleotides. Medium containing 
MPA and xanthine (without guanine) can therefore be used to selectively grow 
cells transformed with a functional£. coli Gpt-gene (Singer and Berg, 1991; Old 
and Primrose, 1989). By supplying guanine, this inhibition by MPA can be 
overcome. When the Gpt-gene is coupled in tandem with another gene of interest, 
it is possible to positively select for recombinant W carrying both genes (Boyle 
and Coupar, 1988). The co-expression of Gpt and a gene of interest was 
demonstrated with the construction of recombinant W's that expressed f3-
galactosidase (Falkner and Moss, 1988). 
The Gpt-gene offers several advantages over other selectable markers which 
are the following: 
TK- cell-lines are not required; 
it will operate in most if not all eukaryotic cell types and can thus be used 
for other host-specific poxviruses; 
it is ideally suitable for the construction of recombinants based on slow-
growing host-specific poxviruses; 
it allows selection at both the recombination and subsequent steps which 
makes it possible to construct recombinants where the frequencies of 
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recombination may be low, for e.g. when inserting large fragments of 
foreign DNA (Boyle and Coupar, 1988); 
it provides one-step plaque isolation without the need for enrichment; 
no background of spontaneously occurring Gpt+ virus has been observed 
(absence of spontaneously selectable mutants); 
MP A is nonmutagenic in the Ames test and in the related SOS test and this 
absence of mutagens should ensure virus stability; 
the Gpt-gene can be inserted into any non-essential region of the poxvirus 
genome as a dominant selectable marker-gene (Falkner and Moss, 1988). 
3.1.3. The [3-D-galactosidase gene ([3-gal gene). 
The E. coli lacZ gene (3081 bp) encodes the glycoside hydrolase, f3-D-
galactosidase ([3-gal, refer to Chapter 2.1.7.5.). Commercially available antibodies 
to f3-gal and a number of chromogenic and fluorogenic substrates and biochemical 
assays enable rapid and sensitive detection of f3-gal. As little as 5 mol of f3-gal can 
be detected in a single viable cell (MacGregor et al., 1991). Falkner and Moss 
(1988) used plasmid constructs containing both the Gpt-gene and the lacZ gene to 
produce viral recombinants. The isolation of a stable, double VV recombinant 
containing both the Gpt- and the [3-gal gene was also reported by Alexander, Moss 
and Fuerst (1992). All the plaques obtained under selective conditions exhibited 
[3-gal activity, which indicated the coexpression of the selected marker gene [Gpt) 
and the gene of interest (lacZ). The lacZ gene activity is relatively independent of 
the orientation and of the neighbouring sequences in the virus (Falkner and Moss, 
1988). Expression of the f3-gal gene is a simple and reliable method for the 
identification of recombinant viruses and it is routinely used for the detection of 
VV recombinants (Rodriguez et al., 1992). 
3.1.4. Further requirements for the insertion of foreign genes 
into the LSDV genome 
Some further requirements for the insertion of foreign genes into the VV 
genome, and thus also for the insertion of foreign genes into the LSDV genome, 
are the following: 
The flanking vaccinia sequences upstream of the foreign gene must contain 
cis-acting vaccinia or other modified transcription promoter signals so that 
the viral RNA polymerase can recognize and transcribe the foreign gene. 
The chimeric plasmids should thus be constructed so that the flanking 
DNA provides promoter and transcript leader sequences correctly 
upstream of the foreign gene (Esposito and Murphy, 1989; Piccini and 
Paoletti, 1988). The promoter from the VV gene encoding the 7.5 K 
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polypeptide (referred to as P 7.5) is active early and late in poxvirus 
infection (Falkner and Moss, 1988). Therefore it is a very useful promoter 
for the expression of foreign genes in the early and late stages of infection. 
Evidence was reported that W promoters work as general poxvirus 
promoters in that they can be controlled by lSDV trans-activating factors. 
Apparently non-poxvirus 
(heterologous) promoters are poorly transcribed by the vaccinia RNA 
polymerase. According to Boyle (1992) the difference in promoter function 
in different poxviruses may be due to small differences in promoter 
sequences from different poxviruses and the recognition of these sequences 
by the DNA-dependent RNA polymerase of the different viruses. Boyle 
(1992) found that there were differences in the recognition of promoters by 
W and fowlpox virus (FPV). The FPV P E/L promoter expressed the 
highest level of product of any of the poxvirus promoters tested in FPV 
recombinants. The level of product expressed by the FPV P E/L promoter 
in W recombinants was one-third to one-half the level expressed by the W 
P Lll promoter and four to five times the level expressed by the WP 7.5 
promoter. The FPV P E/L promoter should thus be an ideal candidate for 
the expression of foreign genes in poxvirus recombinants (Boyle, 1992). 
However, Binns, Boursnell, Tomley and Campbell (1989) recommended 
that homologous promoters, i.e., FPV promoters in FPV vectors should be 
used in order to reduce the possibility of recombination occurring between 
different poxviruses in the environment. 
All of the sequences must be in the proper reading frame, with the stop 
codon appropriately followed by a poxvirus transcript terminator (in the 
case of early transcription). After insertion of the foreign gene into the 
virus genome by in vivo recombination, the expression of essential virus 
functions should not be interrupted (Esposito and Murphy, 1989; Piccini 
and Paoletti, 1988). 
Foreign genes must not contain introns because splicing does not occur in 
the cytoplasm (Moss, 1991). 
When early gene promoters are used, the cryptic termination sequences in 
foreign genes should be altered, because early poxvirus genes signal 
transcriptional termination 20 to 50 nucleotides downstream of l"l l'l l NT 
sequences in the noncoding strand (Moss, 1991). The poxvirus promoter 
sequences determine when and to what extent the foreign ,gene will be 
expressed. Presumably the highest amounts of protein would be obtained 
with late promoters, since the late poxvirus encoded proteins are the most 
abundant (Mackett et al., 1985; Moss, 1991). 
3.1.5. Proposed strategy for the insertion of foreign genes into 
LSDV. 
3.1.5.1. Outline of general strategy 
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The initial phase of this project was to construct suitable LSDV-based 
reporter/ selectable marker-gene vectors for the insertion of foreign genes into 
LSDV and to prove that foreign genes could be inserted successfully into the 
LSDV genome. This would then serve as a basis for the development of a LSDV-
based recombinant vaccine. 
To date very little is known about the molecular biology of LSDV. 
However, on the basis of morphological and physical properties, capripoxviruses 
are in the same family as orthopoxviruses, of which VV is the prototype. It was 
therefore decided to use the general approach for the insertion of foreign genes 
into VV as a model for the insertion of foreign genes into LSDV. 
The proposed strategy for the insertion of foreign genes into LSDV is as 
follows (Fig. 3.2.): The isolated foreign gene of interest is doned into a cloning 
vector so that non-essential LSDV sequences, for example sequences derived from 
the TK-gene (discussed in section 3.1.5.1.), will flank the foreign gene. These 
flanking LSDV sequences (approximately 100 to 1000 bp on either side of the 
foreign gene) are necessary to "direct" the insert to the homologous sequences 
present in the LSDV genome so that recombination can occur (Mackett, Smith and 
Moss, 1985). This construct will be introduced into tissue culture cells as follows: 
Cells will be infected with viable infectious LSDV, the recombinant plasmid 
containing the chimeric insert will then be transf ected into the cells via standard 
procedures (Mackett et al., 1985). Whole virus must be used because the DNA of 
poxviruses requires the enzymes and factors necessary for virus replication of the 
poxvirus core (Moss, 1991). In the cytoplasm, the DNA of the uncoated and 
replicating virus can come into contact with the DNA sequences of the 
recombinant plasmid and thus allow in vivo recombination to occur between the 
homologous sequences present on the viral genome and on the plasmid. The viral 
genome would presumably rescue the foreign gene by incorporating it into its 
own DNA. Replication of the recombinant DNA should then continue, followed 
by maturation and release of the recombinant virus (Mackett et al., 1985; Sam and 
Dumbell, 1981). 
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Fig. 3.2. Schematic representation of the general approach followed for the insertion of foreign genes 
into the lumpy skin disease virus (LSDV) genome. (Adapted from Mackett, Smith and Moss, 1985.) 
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3.1.5.2. Employing the thymidine kinase gene. 
The thymidine kinase (TK) gene was exploited as a target-site for the 
insertion of foreign DNA into the LSDV genome in this chapter, as described in 
section 3.1.5. The enzyme TK catalyses the conversion of thymidine to thymidine-
5'-monophosphate (TMP), an intermediate in pyrimidine biosynthesis (Meuth and 
Harwood, 1991; Singer and Berg, 1991). There are two synthetic pathways (Fig. 
3.1.) for the production of deoxy-thymidine-5'-triphosphate (dTTP), a de novo 
synthetic pathway and a salvage pathway (Old and Primrose, 1989). The latter 
pathway requires TK. A loss of one of these two pathways is not lethal for the 
cells (Old and Primrose, 1989). Although the TK gene is not essential for poxvirus 
multiplication in tissue culture cells, inactivation of the gene causes significant 
attenuation of the virus although it does not seem to alter the replication efficiency 
(Gentry, 1992; Lee et al., 1992; Moss, 1991; Taylor, Stott, Wertz and Ball, 1991). 
Plasmid vectors were constructed to contain full length or partial copies of 
the TK-gene interrupted by multiple restriction endonuclease sites adjacent to a 
suitable poxvirus promoter. (The VV P 7.5 promoter is 30 times more efficient 
than the one associated with the TK-gene - Mackett, Smith and Moss, 1984.) A 
foreign gene can be inserted into any of these unique restriction sites. This 
plasmid can then be used to transfect cells that were pre-infected with poxvirus 
(Mackett, Smith and Moss, 1984). The TK-gene is present in all poxviruses studied 
so far (Gentry, 1992). 
3.2. Materials and methods 
3.2.1. Viruses, mammalian cells and eggs 
The vaccine strain of LSDV was obtained from the Onderstepoort 
Veterinary Institute (OVI) at Pretoria. LSDV was propagated and maintained in 
Madin-Darby bovine kidney (MDBK) cells (Chapter 2.2.6.). Titrations were done 
according to the standard procedure (Chapter 2.2.7.) on foetal calf kidney (CFK) 
and MDBK cells. Virus propagation was also attempted on the CAM's of eggs of 
domestic hens according to the methods described in Chapter 2.2.1. 
Primary LT and CFK cells were prepared and stocks were frozen away as 
described in Chapter 2.2.2 to 2.2.5. The lamb testis and foetal calf kidney used for 
this purpose was aseptically removed at the abattoirs in Maitland, Cape Town. 
The continuous MDBK cell-line is derived from a healthy bovine (Bos taurus) 
kidney (ATCC catalogue, ref. CCL 22) and was obtained from Dr. A. van Dijk, 
OVI, Pretoria. Fertilized eggs of domestic hens ( Gallus domesticus) were supplied 
by the Golden Grove Poultry Farm, Cape Town. 
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3.2.2. Genes, vectors and host bacterial cells 
The plasmid, p 182, containing the E. coli lacZ (f3-gal) gene under the control 
of the 7.5 K vaccinia promoter was provided by Dr. M. Mackett, Paterson 
Laboratories, Christie Hospital & Holt Radium Institute. Dr. Mackett also 
supplied the plasmids pox-48B, containing the f3-gal gene under the control of the 
4B promoter of VV, and pal-1, containing the ()-gal gene under the control of the 
11 K promoter of VV, used as controls in the f3-galactosidase assay. The plasmid 
pGpt07 /14 containing the E. coli Gpt-gene linked to the 7.5 K promoter (Boyle and 
Coupar, 1988) was obtained from Dr. D.B. Boyle, CSIRO, Australian Animal 
Health Laboratory, Geelong, Victoria, Australia. 
Competent E. coli JM109-cells were prepared as described in Chapter 
2.1.7.3. The competent E. coli LKlll cells were supplied by the Department of 
Medical Microbiology, Medical School, UCT. The pMTL25 vector was obtained 
from the Microbiology Technology Laboratory, Public Health Laboratory Service, 
Salisbury, UK. The pMTL25 cloning vector which was used in the sub-cloning 
steps has the f3-lactamase (ampR) gene, which allows selection of the plasmid in 
medium containing ampicillin, and a palindromic multiple cloning site within the 
f3-galactosidase gene (Chambers et.al., 1988). Potential recombinant clones can be 
identified as white colonies on LB-agar plates containing X-gal, due to insertional 
inactivation of the ()-gal gene of pMTL25 (Chapter 2.1.7.5.). The pMTL vectors are 
analogous to the high-copy-number pUC plasmids except that they are smaller by 
300 bp, carry more versatile polylinker regions within the lacZ gene and exhibit 
improved plasmid stability (Chambers et.al., 1988). Dr. Anna-Lise Williamson of 
the Department of Medical Microbiology, Medical School, UCT, supplied the 
pLSDTK vector. 
3.2.3. General approach for the· insertion of foreign genes into 
lumpy skin disease virus 
The pLSDTK-vector was constructed by the cloning of a 2.5 kb Hindl 11-
fragment, containing the TK gene from LSDV, into the plasmid pEcoR252 by Dr. 
A-L. Williamson (personal communication). The Kpnl site within the TK gene of 
the pLSDTK-vector was utilized to make two further constructs into which either 
a ()-gal or a Gpt gene, linked to a poxvirus promoter, was cloned. As mentioned in 
section 3.1.5., the TK sequences flanking the cloned gene were necessary for 
homologous insertional recombination with the TK gene resident in the native 
LSDV. These recombinant plasmids were transfected into cells infected with 
LSDV. The progeny were screened for in vivo LSDV recombinants which 
expressed ()-gal activity or which could be positively selected for in the presence of 
mycophenolic acid . 
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3.2.4. Construction of recombinant plasmids containing the f3-
gal gene 
The sub-cloning of the [3-gal gene into pMTL25 and the subsequent cloning 
thereof into pLSDTK is schematically depicted in Figs. 3.3a. and 3.3b. The cassette 
consisting of the E. coli f3-gal-gene, driven by the vaccinia P 7.5 promoter, was 
excised from the original plasmid, p182, with EcoRl and gel purified (Chapter 
2.1.4 - 2.1.6.). The pMTL25 vector was cut with EcoRl and after being checked for 
complete digestion the enzyme was removed by phenol/ chloroform extraction 
and ethanol precipitation (Chapter 2.1.2.-2.1.5.). 
The [3-gal containing EcoRl fragment was subsequently ligated into the 
EcoRl site of the pMTL25 plasmid (Chapter 2.1.7.2.). An equimolar ratio of vector 
and insert was used in the ligation reaction. Transformation of the ligation 
mixture into competent E. coli JM109 cells and screening for recombinants were 
performed as described in Chapter 2.1 .7.4 and 2.1.7.5. Identification of the 
colonies harbouring the recombinant plasmid were done by restriction enzyme 
digestion with EcoRl of small-scale DNA preparations. Stock cultures of the 
bacterial cells harbouring the recombinant plasmid were frozen away (Chapter 
2.1.7.6.). A large-scale plasmid preparations was performed on one of these 
identified colonies as described in Chapter 2.1 .1.2. This construct was referred to 
as pMTL25-f3-gal. 
The pLSDTK plasmid was cut with Kpnl, phenol-chloroform extracted 
twice, ethanol precipitated and resuspended in ultra-pure water. The pMTL25-f3-
gal construct was digested with Kpnl and the Kpnl-fragment, containing the [3-gal 
gene under the control of the VV P 7.5 promoter, was gel-purified (Chapter 2.1.4.-
2.1.6.). 
The [3-gal containing Kpnl fragment was ligated into the resident Kpnl site 
inside the TK-gene of the pLSDTK plasmid (Chapter 2.1.7.2.). A colony blot was 
made and screened for recombinant colonies by probing with a DIG-labelled [3-gal 
gene as described in Chapter 2.1.7.5., 2.1.8.2. and 2.1.8.3 (Fig. 3.4.). The washed 
membrane was subjected to immunological detection. Colonies hybridizing to the 
[3-gal probe, were identified by coloured precipitate formation on the Hybond N+. 
Small scale DNA preparations of identified colonies were checked for the presence 
of the insert by digestion with Kpnl followed by agarose-gel electrophoresis. The 
orientation of the [3-gal gene in the plasmid was not checked. Stock cultures of the 
bacterial cells harbouring the recombinant plasmid were frozen away (Chapter 
2.1.7.6.). One of the recombinants was selected for large scale DNA plasmid 
preparation ( Chapter 2.1.1.2.) . This plasmid, consisting of the pLSDTK vector 
harbouring the [3-gal gene insert, was designated pLSD-[3-gal. 
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Fig. 3.3a. Schematic representation of the cloning of the EcoRl-fragment, containing the (3-gal 
gene under the control of the VV P 7.5 promoter, into the pMTL25-vector (refer to Fig. 3.3b.). 
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Fig. 3.3b. Schematic representation of the cloning of the Kpnl-fragment, containing the b-gal 
gene under the control of the VV P 7.5 promoter (isolated from the pMTL25-f3-gal construct), 
into the pLSDTK-vector. 
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Fig. 3.4. Colony blot for detection of bacterial colonies harbouring the pLSD-!3-gal construct by 
hybridization to a DIG-labelled !3-gal gene-containing fragment. 
3.2.5. Construction of recombinant plasmids containing the 
Gpt-gene 
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The cloning of the fragment, containing the Gpt-gene under the control of 
the VV P 7.5 promoter, into the various plasmids is schematically depicted in Figs. 
3.5a. and 3.5b. The cassette containing the E. coli Gpt-gene, linked to the VV P 7.5 
promoter, was excised from the pGpt07 /14 plasmid (Boyle and Coupar, 1988) 
with EcoRl . The Gpt containing fragment was isolated and purified by agarose-gel 
electrophoresis (Chapter 2.1.4. - 2.1.6.). The pMTL25 vector was linearized with 
EcoRl and prepared as described for the construction of the f3-gal containing 
vector (Section 3.2.4.). 
The Gpt-gene containing EcoRl-fragment was subcloned into the EcoRl site 
of the pMTL25 vector (Chapter 2.1.7.2., 2.1 .7.4. and 2.1.7.5.) . The insert to vector 
ratio used for the ligation reaction was 3:1 and competent E. coli JM109 cells were 
used for the transformation reaction. Small scale DNA preparations from white 
colonies (see blue- and white selection, Chapter 2.1.7.5.) were digested with EcoRl 
and agarose-gel electrophoresis was performed with appropriate markers to verify 
the presence of the Gpt-gene. Stock cultures were prepared and frozen away of 
colonies harbouring the recombinant plasmid (Chapter 2.1.7.6.). A large scale 
DNA preparation was performed on one of these colonies (Chapter 2.1 .1.2.) . This 
recombinant plasmid, with the Gpt-gene fragment cloned into the EcoRl site of the 
pMTL25 vector, was designated pMTL25-Gpt. 
Due to the presence of an internal Kpnl site within the Gpt-gene, the 
' pMTL25-Gpt construct was partially digested with Kpnl and the ca. 2 kb fragment 
containing the intact Gpt-gene, linked to the P 7.5 promoter, was isolated and 
purified as described in Chapter 2.1.4. - 2.1.6. The pLSDTK vector was linearized 
with Kpnl and prepared for ligation as described for the construction of the f3-gal 
construct (Section 3.2.4.). The isolated Gpt containing Kpnl-fragment was ligated 
into the Kpnl site of the pLSDTK vector (Chapter 2.1.7.2.). The insert to vector 
ratio used for the ligation reaction was 4:1. Competent E. coli JM109 cells were 
used for the transformation reaction (Chapter 2.1.7.4.). Screening for recombinants 
were performed by small scale DNA preparations on randomly picked colonies 
(Chapter 2.1.1.1.1. and 2.1 .7.5.). The DNA was checked for the presence of the Gpt-
gene by digestion with Kpnl and agarose gel-electrophoresis. Glycerol stock 
cultures were prepared of colonies harbouring recombinant plasmids ( 2.1.7.6.). A 
large scale plasmid preparation was performed on one of these identified 
recombinant colonies (Chapter 2.1.1.2.). This recombinant plasmid, consisting of 
the pLSDTK vector with the Gpt-gene containing fragment cloned into the Kpnl 
site, was designated pLSD-Gpt. 
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Fig. 3.Sa. Schematic representation of the cloning of the EcoRJ-fragment, comprising the Gpt-
gene under the control of the VV P 7.5 promoter, into the pMTL25-vector (refer to Fig. 3.Sb.). 
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Fig. 3.Sb. Schematic representation of the cloning of the Kpnl -fragment, containing the Gpt-
gene under the control of the VV P 7.5 promoter (isolated from the pMTL25-Gpt construct), into 
the pLSDTK-vector. 
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3.2.6. Titration of MP A to determine the concentration needed 
for the inhibition of LSDV-growth 
The tolerance of CFK-cells to different concentrations of MPA, and the 
concentration of MPA required to inhibit LSDV multiplication in CFK cells, were 
determined as described in Chapter 2.2.9. 
The range of MP A concentrations tested on the uninfected cells and the 
virus-infected cells varied from 0.25 µg MPA/ml to 50 µg MPA/ml. For the virus-
inhibition assay cells were infected with 1 PFU (plaque forming unit) of LSDV /cell 
before the addition of the MP A-containing medium. 
3.2.7. Transfection of pLSD-f3-gal into LSDV-infected LT-cells. 
Infections and transfections of LT cells were performed as described in 
Chapter 2.2.8. with the following modifications. Monolayers of LT-cells in 35 mm 
tissue culture dishes that were 80% confluent, were infected with 0.1 PFU of LSDV 
per cell. The amount of pLSD-[3-gal DNA (Section 3.2.4.) used for the transfection 
reaction was 2 µg/35 mm tissue culture dish. Incubation of the virus-infected cells 
with the Lipofectin™ reagent-DNA complex was performed for 5 hours at 37°C. 
Control cells (cells infected with 0.1 PFU of LSDV per cell, and uninfected cells) 
were treated exactly the same as the cells that were transfected. After incubation 
for three days with DMEM supplemented with 4% FCS and PSN (Chapter 2.2.8.), 
the medium was removed from the cells and the X-gal stain was performed in vivo 
as described in Chapter 2.2.10.1. 
A second additional assay for f3-galactosidase activity was performed on 
cell-extracts as described in Chapter 2.2.10.2. Monolayers of CFK-cells in 35 mm 
tissue culture dishes that were almost confluent, were infected with LSDV at a 
concentration of 1 PFU / cell for 1 hour at 37°C. A tissue culture dish with 
uninfected cells was kept as a negative control, together with one of the dishes 
with LSDV infected cells. Three separate transfections were put up 
simultaneously with 1.7 µg of DNA of each of the following plasmids: pLSD-[3-
gal, pal-1 and pox-48B. The transfections with pal-1 and pox-48B were done as 
positive controls. The transfections were done according to the protocol described 
in Chapter 2.2.8., except for the following modifications. The DNA and 20 µl of 
Lipofectin™ reagent were diluted separately for each transfection reaction, each 
with 250 µl of opti-MEM (Gibco/BRL) . These dilutions were added together and 
left at room temperature for 15 minutes before adding to the cells. After 5 hours at 
37°C, the DNA-containing opti-MEM was removed from the cells and replaced 
with DMEM, containing 4% FCS and PSN. After 48 hours incubation at 37°C, the 
[)-gal assay (Chapter 2.2.10.2.) was performed on the cell-extracts. The reactions 
were incubated at 37°C for 2 hours and observed for colour development. The 
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optical densities were spectrophotometrically determined with a Beckman DU-40 
spectrophotometer (Beckman, Irvine, USA) at a wavelength of 420 nm. 
3.2.8. Transfection of pLSD-Gpt into LSDV-infected CFK-cells. 
Infection and transfection of CFK-cells were performed as described in 
Chapter 2.2.8., except for the following modifications. Almost confluent 
monolayers of CFK-cells in 35 mm tissue culture dishes, were infected with 0.1 
PFU of LSDV per cell and transfected with 2 µg of pLSD-Gpt DNA (Section 3.2.5.) 
per dish. The cells were incubated for 5 hours at 37°C with the Lipofectin ™ 
reagent-DNA complex. The DNA-containing opti-MEM was removed from the 
cells and DMEM, supplemented with 4% FCS and PSN, was added to the cells. 
After 24 hours the medium was replaced with selection medium (Appendix A.10.) 
containing 2.5 µg MPA/ml and incubation was continued for 48 hours. Following 
this the medium was removed from the cells and used for the infection of new, 
almost confluent cells. After 1 hour infection, selection medium was added to the 
newly infected cells and incubation was carried out at 37°C for three days. The 
control cells (cells infected with LSDV but incubated with/without MPA-
containing selection-medium) were treated in exactly the same way. An in vivo 
indirect immunoperoxidase stain (Chapter 2.2.10.3.), using sera harvested from 
cattle previously infected with LSDV, was performed on the virus-infected cells, as 
well as the control cells, at passage no. 6 after 3 days incubation with/without 
selection medium. 
3.3. Results 
3.3.1. Virus propagation 
Primary LT- and CFK-cells were successfully established and stocks were 
frozen away at -70°C. LSDV, which was propagated in MDBK-cells, was 
harvested at the third day after infection. MDBK-cells were used for the 
propagation of LSDV because primary cell-lines were still being established at the 
time. As mentioned before (Chapter 2.2.7.), LSDV does not form plaques but 
causes swelling of cells which forms clumps. It was assumed that a focus of cells, 
just as a plaque, was caused by one virus-particle or plaque-forming unit (PFU). 
Many virus foci or cell-clumps could be seen in the MDBK cell-monolayer (in 
contrast to uninfected cells) at the third day after infection. The LSDV titre 
obtained (of the virus-stock used in the transfection-reaction) was 3 x 106 PFU/ml 
when CFK cells were used for the titration-reaction. A titre of 1 x 106 PFU/ml was 
obtained with the same virus stock when MDBK-cells was used for the titration. 
The titre obtained with the CFK-cells was used for the calculation of the virus-
concentration required for the transfection-experiment. The attempt to propagate 
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LSDV on the CAM's of domestic hens' eggs was unsuccessful. Small pox-like 
lesions could be seen on the CAM's when it was harvested, but no virus could be 
isolated. The pox-like lesions could have been due to other unknown causes. 
3.3.2. Construction of recombinant plasmids 
3.3.2.1. Construction of the pLSD-j3-gal plasmid 
The original plasmid, p182, containing the f3-gal gene under the control of 
the W P 7.5 promoter, digested with EcoRl is shown in Fig. 3.6. lane 2. (The 
expected fragment sizes are indicated in Table 3.1.). 
The lower band, comprising the j3-gal gene linked to the P 7.5 promoter, 
was isolated and purified and this EcoRl-fragment can be seen in lane 1 of the 
same figure. The j3-gal-containing EcoRl-fragment was subcloned into the unique 
EcoRl site of the pMTL25-vector. The EcoRl linearized pMTL25-vector is shown 
in Fig. 3.6. lane 4. An EcoRl digest of the aforementioned clone is shown in Fig. 
3.6 lane 5. Two bands, one corresponding to the size of the linearized pMTL25 
vector (ca. 2.8 kb) and the other corresponding to the size of the f3-gal containing 
insert (ca. 5.3 kb) were obtained. This result served to verify that the gel-purified 
EcoRl-fragment, encompassing the f3-gal gene linked to the P 7.5 promoter, was 
cloned successfully into the EcoRl site of the pMTL25 vector. This construct, 
designated pMTL25-f3-gal (Figure 3.3a.), was digested with Kpnl (Fig. 3.6. lane 6) 
and the top band encompassing the f3-gal gene linked to the P 7.5 promoter, was 
isolated and purified. The pLSDTK-vector was linearized with Kpnl (Fig. 3.6 lane 
7). The gel-purified j3-gal containing Kpnl-fragment was then cloned into the 
unique Kpnl site of the pLSDTK vector. Kpnl digested DNA of this clone obtained 
is shown in lane 8 of the same figure. Two bands, one corresponding to the size of 
the linearized pLSDTK vector (ca. 5.9 kb) and the other band corresponding to the 
size of the j3-gal containing Kpn1-fragment (ca. 5.3 kb) were evident. This served 
to confirm the successful cloning of the Kpn1-fragment, comprising the f3-gal gene 
linked to the P 7.5 promoter, into the unique Kpnl site of the pLSDTK-vector. The 
construct was designated pLSD-j3-gal (Fig. 3.3b.). Hindlll digestion of the pLSD-
j3-gal plasmid (Fig. 3.6 lane 9) resulted (as expected) in two bands of sizes ca. 3.3 
kb and ca.7.8 kb respectively, which served as further confirmation of the integrity 
of this construct. 
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TABLE 3.1. Expected fragment sizes of plasmid constructs digested with different 
restriction enzymes. 
Plasmid construct Restriction enzyme(s) 
pMTL25 EcoRl 
Kpnl 
pLSDTK Kpnl 
p182 EcoRl 
pMTL2S-~gal EcoRl 
Kpnl 
pLSD-~gal Kpnl 
Hind111 
pGpt07 /14 EcoRl 
pMTL2S-Gpt EcoRl 
Kpnl 
pLSD-Gpt Kpnl 
Hind111 
# Fragment sizes shown were estimated by restriction mapping 
Expected fragment size(s) 
(bp)# 
2800 
2800 
5900 
7600 + 5300 
5300 + 2800 
5300 + 2800 
5900 + 5300 
3350 + 7850 
4300 + 2000 
2800 + 2000 
2800 + 1500 + 500 
5900 + 1500 + 500 
3350 + 2275 + 2275 
Fig. 3.6. 
Fig. 3.7. 
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LEGENDS 
Gel-electrophoresis of DNA employed in the construction of pLSD-!3-gal. 
Lane 1, EcoRl -fragment, containing the !3-gal gene under the control of the 
VV P 7.5 promoter, isolated from p182. Lane 2, p182 digested with EcoRl . 
Lane3, ')... DNA digested with Styl. Lane 4, pMTL25 digested with EcoRl. 
Lane 5, pMTL25-j3-gal digested with EcoRl. Lane 6, pMTL25-j3-gal 
digested with Kpnl. Lane 7, pLSDTK digested with Kpnl. Lane 8, pLSD-
!3-gal digested with Kpnl. Lane 9, pLSD-{3-gal digested with Hindlll. 
Lane 10, ')... DNA digested with Hindlll. 
Gel-electrophoresis of DNA employed in the construction of pLSD-Gpt. 
(a) Lane 1, ')... DNA digested with Styl . Lane 2, Original plasmid, 
containing the Gpt-gene under the control of the VV P 7.5 
promoter, digested with EcoRl . Lane 3, EcoRl fragment isolated 
from the original plasmid and containing the Gpt-gene under the 
control of the VV P 7.5 promoter. Lane 4, pMTL25 digested with 
EcoRl. Lane 5, pMTL25-Gpt digested with EcoRl. Lane 6, 
pMTL25-Gpt digested with Kpnl. Lane 7, pLSDTK digested with 
Kpnl. Lane 8, ')... DNA digested with Hindlll . 
(b) Lane 1, ')... DNA digested with Styl. Lane 2, pLSD-Gpt digested 
with Hindll 1. Lane 3, pLSD-Gpt digested with Kpnl. 
(bp) 
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3.3.2.2. Construction of the pLSD-Gpt plasmid 
EcoRl-digestion of the pGpt07 /14 plasmid containing the Gpt-gene under 
the control of the VV P 7.5 promoter (Boyle and Coupar, 1988), resulted in a ca. 4.3 
kb band representing the native plasmid and a ca. 2 kb fragment (comprising the 
Gpt-gene linked to the VV P 7.5 promoter - Fig. 3.7a. lane 2). This ca. 2 kb-
fragment was gel-purified (Fig. 3.7a. lane 3) and sub-cloned into the unique EcoRl 
site of the pMTL25-vector. (In Fig.3.7a. lane 4 the EcoRl-linearized pMTL25-vector 
can be seen as a ca. 2.8 kb fragment). EcoRl-digestion of the pMTL25-Gpt 
construct (Fig. 3.5a.) resulted in a ca. 2.8 kb fragment representing the native 
pMTL25-plasmid and a ca. 2 kb Gpt-containing fragment (Fig. 3.7a. lane 5). Due to 
the presence of an internal Kpnl site within the Gpt-gene, the pMTL25-Gpt plasmid 
(Fig. 3.5a.) was partially digested with Kpnl and the ca. 2 kb fragment (comprising 
the intact Gpt-gene linked to the P 7.5 promoter) was gel-purified. In Fig. 3.7a. 
lane 6 the pMTL25-Gpt plasmid digested with Kpnl can be seen as a ca. 2.8 kb 
fragment representing the native pMTL25-plasmid and two additional fragments 
of ca. 0.5 kb and 1.5 kb respectively. In Fig. 3.7a. lane 7 the Kpnl linearized 
pLSDTK-vector is shown as a ca. 5.9 kb fragment. 
The ca. 2 kb Gpt-containing Kpnl-fragment was cloned into the unique 
Kpnl site within the pLSDTK-vector. The integrity of the resulting pLSD-Gpt 
plasmid construct was determined by restriction enzyme analysis. The pLSD-Gpt 
plasmid (Fig. 3.5b.) digested with Kpnl (Fig. 3.7b. lane 3) showed two bands, one 
corresponding to the size of the ca. 5.9 kb linearized pLSDTK-vector and the other 
band corresponding to the size of the intact (ca. 2 kb) Gpt-containing fragment. 
This verified the presence of the 2 kb Cpl-containing fragment in the pLSDTK-
vector. However, it appeared as if the Gpt-gene within this construct had suffered 
a mutation resulting in the loss of the internal Kpnl site. Digestion of the pLSD-
Gpt plasmid construct with Hindl 11 yielded fragments of the expected sizes as 
follows: a ca. 3.35 kb fragment representing the native pEcoR252 plasmid used in 
the construction of the pLSDTK vector, and a doublet band consisting of two 
fragments of approximately 2.27 kb each (Fig. 3.7b. lane 2). Although the Gpt-
containing fragment flanked by the TK sequences (Fig. 3.Sb) would be expected to 
yield a 4.55 kb fragment, this fragment is essentially cleaved in half by HindIII due 
to the presence of a HindIII site immediately downstream of the Gpt fragment. 
The latter HindIII site is derived from the original pGpt07 /14 construct (Boyle and 
Coupar, 1988). 
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3.3.3. Transf ection of pLSD-f3-gal into LSDV-inf ected LT cells 
When performing the X-gal stain in situ on LT-cells infected with wild-type 
LSDV and transfected with the pLSD-[3-gal construct, blue-gray foci developed in 
the cells indicating the presence of [3-galactosidase activity (Fig. 3.8a.). Slight blue 
foci developed in the control cells (LSDV-infected and uninfected cells). Refer to 
Figs. 3.8b. and 3.8c. However, the cells had to be left for a relatively long period of 
time (ca. 12 - 24 hours at room temperature) with the substrate solution (refer to 
the protocol in Chapter 2.2.10.1.) to obtain a clear difference between the positives 
and the negatives. Therefore it was decided to perform a second assay to 
quantitate the expression of [3-galactosidase from the P 7.5 promoter and also to 
compare the expression of the gene to other genes in order to show that the gene 
in pLSD-B-gal is active. This second assay with a soluble substrate was a transient 
expression assay designed to test VV promoter activity in LSDV. 
During the second assay of cell-extracts for [3-galactosidase activity, a 
yellow colour developed in reactions with extracts from cells infected with LSDV 
and transfected with pLSD-[3-gal or pox-48B after a few minutes. The enzyme [3-
galactosidase hydrolysis the substrate, o- nitrophenol-[3-D-galactosidase (ONPG), 
to yield o-nitrophenol and galactose (MacGregor et al., 1991). 
The optical density of o-nitrophenol can be determined 
spectrophotometrically. The reaction with the extracts of cells infected with LSDV 
and transfected with pal-1 formed an immediate intense yellow colour. No yellow 
colour development could be observed with the negative controls (extracts from 
uninfected and LSDV infected cells) . This assay was done in duplicate. All the 
reactions were incubated for 2 hours at 37°C, during which time no further change 
in colour could be observed. The optical densities of the reactions were read at a 
wavelenght of 420 nm after the addition of Na2C03. The values obtained were as 
indicated in Table 3.2. 
According to the protocol the linear range for [3-galactosidase activity is 0.2 
- 0.8 OD 420nm (Sambrook et al., 1989) . Therefore the [3-gal gene in the pLSD-[3-gal 
construct appeared to be functional. However, a much higher level of f3-
galactosidase activity was observed with cell-extracts from LSDV-infected CFK-
cells transfected with the pal-1 construct. 
Fig. 3.8a. X-gal stain of LT -cells 
infected with LSDV and 
transfected with the pLSD-!3-gal 
construct. 
Fig. 3.8b. X-gal stain of LT-cells 
infected with LSDV. 
Fig. 3.8c. X-gal stain of 
uninfected LT-cells. 
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Table 3.2. Assay for f3-galactosidase activity in extracts of CFK-cells. 
OD420nm 
Cells Assay 1 Assay2 
Uninfected CFK-cells 0.074 0.074 
LSDV-infected CFK-cells 0.075 0.041 
LSDV-infected CFK-cells 
transfected with pLSD-j3-gal 0.232 0.224 
LSDV-infected CFK-cells 
transfected with pox-48B 0.347 0.346 
LSDV-infected CFK-cells 
transfected with pal-1 1.979 1.980 
3.3.4. Determination of the MP A concentration required for 
virus-inhibition 
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The concentration of MPA required to inhibit the proliferation of wild-type 
virus in order to select for recombinant virus containing the Gpt-gene, without 
having a harmful effect on the cells, was determined. During the monitoring 
period the selection medium with which the cells were incubated was not 
replaced with fresh medium. 
A slight difference between uninfected CFK cells, incubated with different 
concentrations of MP A, could only be observed from 2 days onwards (results not 
shown). A reciprocal relationship between MPA concentration and cell-growth 
rate could be observed. 
It appeared as if the maximum MP A concentration that could be used was 
30 µg/ml for the specific batch of cells. 
Two days after infection of cells with LSDV (Table 3.3.), nearly 50% of the 
cells without selection medium had died, whereas the infected cells with 0.25 µg 
MPA/ml were still surviving although they were heavily infected as indicated by 
CPE. Virus multiplication thus seemed to be slowed down by MPA. No definite 
foci could be observed in the infected cells incubated with a MP A-concentration of 
1,5 µg/ml and higher after 2 days. After three days definite virus foci could be 
observed in cells infected with virus and incubated with MPA concentrations of 
up to 2 µg/ml. However, although definite virus foci could not be observed in 
cells incubated with MPA-concentrations of 2.5 µg/ml and higher after 3 days 
there seemed to be infected cells present. It appeared as if the percentage infected 
cells decreased reciprocally with rising MPA-concentrations. The control infected 
cells without selection medium died off completely after 3 days. 
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After 6 days definite virus foci could be detected in all the wells with cells 
which had been incubated with different MPA-concentrations. 
Table 3.2. Determination of MP A concentration required for LSDV inhibition 
[MPA] Dayl Day2 Day3 Day4 DayS Day6 
µg/ml 
0.00 +++ ++ +, 50% 'u' 'u' 'u' 'u' 'u' 
0.25 ± +++ +++, 50% 'u' 'u' 'u' 'u' 
0.50 ± ++ +++ +++, 50% 'u' 'u' 'u' 
0.75 ± + ++ +++ +++, 50% 'u' 'u' 
1.00 + + ++ +++ +++ 
1.50 ± + ++ +++ +++ 
2.00 + ++ +++ +++ 
2.50 ± + ++ +++ 
3.00 ± + ++ +++ 
3.50 ± + ++ +++ 
4.00 ± + ++ +++ 
4.50 ± + + +++ 
5.00 ± + + +++ 
>S.00 - ± + ++ 
3.3.5. Transfection of pLSD-Gpt into LSDV-infected CFK-cells 
Cells infected with LSDV and incubated without selection-medium 
exhibited many virus-foci as demonstrated by indirect irnmunoperoxidase 
staining with anti-LSDV serum (Fig. 3.9a.). The nuclei of the cells were 
counterstained with haematoxylin which gave it a blue appearance (not clearly 
visible on photographs) . This made it possible to distinguish between the 
cytoplasm and the nuclei. The virus foci, which stained dark brown, could be seen 
in the cytoplasm of the cells. This was expected as poxviruses multiply within the 
cytoplasm of mammalian cells. Some cells exhibited diffused staining, but most 
appeared to be viral factory-stains. 
Fig. 3.9a. Indirect 
imrnunoperoxidase stain of 
CFK-cells infected with LSDV 
without MP A-selection. 
Fig. 3.9b. Indirect 
imrnunoperoxidase stain of 
CFK-cells infected with LSDV 
with MP A-selection. 
Fig. 3.9c. Indirect 
imrnunoperoxidase stain of 
CFK-cells infected with virus 
(harvested originally from cells 
infected with LSDV and 
transfected with the pLSD-Gpt 
construct) with MP A-selection. 
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However, no definite virus foci could be detected in the control cells 
infected with LSDV-virus (that had been passaged six times through selection 
medium) and incubated with selection medium (Fig. 3.9b.). The abscence of 
indirect immunoperoxidase staining in these cells also indicated that there was no 
detectable endogenous peroxidase activity present in the cells. Normal uninfected 
cells should not exhibit dark brown staining in the cytoplasm after indirect 
immunoperoxidase staining. Virus, obtained from cells that were infected with 
LSDV and transfected with the pLSD-Gpt construct, was passaged six times 
through selection medium. Cells infected with this virus (presumed to contain 
recombinants) at passage no. 6 were subjected to in situ indirect­
immunoperoxidase staining (Fig. 3.9c.) which confirmed the presence of viral-foci. 
3.4. Discussion and conclusions 
3.4.1. Virus propagation 
In order to obtain a successful transfection reaction, it is necessary to start 
of with a high enough virus concentration (at least 0.05 FFU/cell), since in vivo 
recombination in viruses occurs at a low frequency. In vivo recombination in W 
occurs with a frequency of 0.196 (Piccini and Paoletti, 1988). Therefore several 
attempts were made to obtain a good stock of pure LSDV with a high titer. Due to 
the unavailability of CFK- or LT -cells at the time (as previously mentioned) LSDV 
was propagated in MDBK-cells. Several attempts had to be made to get a good 
virus-titre, since most LSDV-titers obtained with MDBK-cells were in the region of 
1 x 103 -1 x 104 PFU/ml, which was too low. Very good virus-yields are obtained 
with W when propagation of the virus are done on the CAM's of eggs of 
domestic hens. Therefore it was decided to try and propagate LSDV on CAM's. 
However, no virus could be isolated. Few strains of capripoxvirus will grow on 
the CAM of the developing chick embryo (Kitching et al., 1986). According to 
Davies (1991) LSDV will grow in embryonated hens eggs, but the system is 
insufficiently sensitive for primary virus isolation. 
A higher titre was obtained when the virus stock, obtained by propagation 
in MDBK-cells, was titrated on CFK-cells instead of MDBK-cells. This could be 
attributed to a higher susceptibility of the CFK-cells to the virus. However, more 
titrations on both cell-Jines would be required to make a definite conclusion, since 
different batches of cells can differ in their susceptibility to the v�s. The focal 
cytopathic changes caused by LSDV in CFK-cells tended to remain localized and 
had to be searched for carefully. Plowright and Witcomb (1959) found that LSDV 
grew better in LT-cells than CFK-cells. They could usually obtain virus titres 
approximately one log unit higher in testis cells than in kidney cells. According to 
Plowright and Witcomb (1959) the amount of free virus was always less than the 
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virus present in the cells throughout virus-proliferation. They concluded that the 
virus was probably released slowly and continuously from the cells so that it did 
not lead to rapid death and detachment of a large proportion of the infected cells. 
Therefore to obtain maximum yields the virus should not only be harvested from 
the infected medium, but also from infected cells. 
3.4.2. Construction of recombinant plasmids 
The f3-gal gene-containing fragment, as in the case with the Gpt-gene 
containing fragment, were cloned into the pLSDTK vector to enable the insertion 
of each of these genes into the LSDV-genome by homologous recombination 
between the TK-segments. Both genes were placed under the control of the P 7.5 
promoter. The integrity of these construct were determined by restriction enzyme 
analysis. The Gpt-gene appeared to have suffered a mutation resulting in the loss 
of the internal Kpnl-site. 
3.4.3. Transfection of pLSD-(3-gal into LSDV-infected LT-cells 
Whether transfection be judged by transient expression or stable 
recombination, the frequency of recombination in general varies with the 
conditions and multiplicity of infection, the amount and form of plasmid DNA 
introduced and the interaction between homologous sequences (Spyropoulos et 
al., 1988). The frequency of recombination is significantly increased when the 
plasmid and intact viral genomic DNAs are coprecipitated onto infected cells 
(Spyropoulos et al., 1988). 
Efficiency of transient and stable transfection varies widely between 
different cell types, cell lines and promoters used (Ray and Gage, 1992). The 
lipofectin method was used in the transfection procedures because it was found to 
be better than calcium phosphate precipitation and electroporation methods in 
terms of higher transfection efficiency and convenient use (Ray and Gage, 1992). 
Liposome-mediated transfection is efficient for the delivery of DNA to the cell 
cytoplasm (the site for LSDV-proliferation) although it is inefficient for nuclear 
delivery (Rodriguez et al., 1992). Although incubation of the mammalian cells 
with DNA/Lipofectin mixture can be done for up to 24 hours (according to the 
protocol supplied with the Lipofectin-reagant), it was found that incubation with 
CFK-cells and LT-cells could be performed for a maximum time of 5 hours at 37°C. 
Even with an incubation-time of 5 hours some cell-death of the CFK--cells could be 
observed. This would lead to a lower transfection efficiency. 
The L T--cells transfected with the pLSD-f3-gal construct displayed higher 
levels of f3-galactosidase activity than the uninfected/untransfected control cells 
when the X-gal stain was performed in situ (refer to Figs. 3.8a., 3.8b. and 3.8c.). 
This indicated that the f3-gal-gene was getting expressed under the control of the P 
7.5 promoter and could be an indication that such cells contain a recombinant 
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construct harbouring the f3-ga1 gene. The observed activity could, however, also 
be the result of transient expression of the [3-gal gene. Moderate background f3-
galactosidase activity was observed in uninfected/untransfected control cells. 
According to MacGregor et al. (1991), certain tissues like the kidney and testes 
exhibit higher endogenous b-galactosidase activity than others. This is apparently 
due to the presence of lysosomal b-galactosidases. The cells also had to be 
incubated in the substrate solution of the X-gal stain for quite a long period of time 
to obtain a clear difference between the positives and negatives. The choice of the 
right promoter for each virus type is very important for optimal expression of the 
gene. It is possible that expression of the f3-gal gene is not sufficient enough under 
the control of the P 7.5 promoter to give easily distinguishable blue foci (Boyle, 
1992). An advantage of the X-gal stain is that expression of f3-galactosidase can be 
detected in individual cells, although it is not as sensitive as immunocytological 
methods (MacGregor et al., 1991). Expression of the gene in a high proportion of 
the cells is thus not a prerequisite for detection. 
A different assay was subsequently performed to yield more informative 
data on the suitability of f3-gal as a reporter-gene. This assay, performed on cell-
extracts, is based on the conversion of o-nitrophenol-f3-D-galactosidase (ONPG) to 
yield o-nitrophenol and galactose. The chromophore o-nitrophenol can be 
spectrophotometrically detected by measuring of the absorbance at 420 nm 
(MacGregor et al., 1991). This is a sensitive assay which can be applied to 
quantitate the activity of f3-galactosidase in cell-extracts. However, expression of 
[3-galactosidase is needed in a higher percentage of cells than required for the X-
gal stain. A possible explanation for the failure to detect endogenous f3-gal activity 
with this assay in cell-extracts from uninfected CFK-cells, is that the activity may 
have occurred at a too low level to be detected. f3-gal activity was detected in the 
cells transfected with the pLSD-f3-gal construct (Table 3.2.), which provided 
evidence that the gene in the pLSD-[3-gal construct was functional, although at a 
low level. The high level of f3-galactosidase activity that was detected in the 
extracts from cells transfected with the pal-1 construct was probably due to more 
efficient expression of the gene under the control of the late 11 K promoter of W. 
It was found that higher levels of proteins, expressed from foreign genes, are 
obtained with late or early and late poxvirus-promoters. Based on the specific 
activity of pure f3-galactosidase (300 000 u/mg), the bacterial enzyme produced 
under the control of the P 11 promoter by W-infected cells is more than 3% of the 
total cellular protein (Falkner and Moss, 1988). This amount should be easily 
detectable by appropriate staining methods. A lower expression of the lacZ gene 
is however obtained with the P 7.5 promoter indicating that the P 11 promoter is 
more efficient than the P 7.5 promoter. Unfortunately late promoters cannot be 
used in selection experiments where DNA replication is dependent on the 
selectable marker-gene (like for example the Gpt-gene), since the early expression 
of the gene selected for are required. However, other genes/recombinant proteins 
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(like the (3-gal gene) could be expressed more efficiently under the control of the 11 
K promoter. Further work should be done, since this was only a preliminary 
experiment. Another reporter gene should be co-expressed with the !3-gal gene to 
"normalise" the system for differences in transfection. This will allow more 
accurate assessment of the results. If verification of the data confirm poor 
expression of the ~gal gene under the VV F 7.5 promoter, another promoter 
should be found for the expression of genes in LSDV. The fowlpox virus (FFV) 
early and late promoter (P E/L) seemed to be an ideal candidate for the expression 
of foreign genes in VV recombinants (Boyle, 1992; discussed in section 3.1.4.) and 
may be a promising candidate for the expression of genes in LSDV. 
The ~gal gene was not expressed strongly enough under the control of the 
F 7.5 promoter. It was therefore not a useful reporter gene for the selection of 
LSDV recombinants in this syst C' rn Another di sqw1lif yi ng factor of the 0-gal-gene 
was the endogenous expression of the enzyme delected by X-gal staining. 
3.4.4. Determination of the MP A-concentration necessary for 
virus-inhibition 
The CFK-cells seemed to be quite tolerant to the different MFA-
concentrations applied, although it appeared as if the MFA-concentration should 
not be raised above 30 µg/ml without having a harmful effect on the cells. LSDV-
propagation could be reasonably successfully inhibited for a period of up to 3 
days with MPA-concentrations of 2.5 µg/ml and higher. However, virus-
inhibition by MPA was not complete at any of the concentrations after six days. 
After 4 days definite virus foci could be observed in all the cells incubated with 
different MF A-concentrations. This may be caused by MFA-depletion/break 
down in the medium after 3 days. It has been speculated that cellular break-down 
may also cause the release of some kind of substance which may enable the virus 
to overcome the MPA-block to some extent (Prof. K. Dumbell - personal 
communication). This might cause some problems with back-ground virus in the 
transfection experiment, since the MPA-concentration could not be raised without 
damaging the cells. Fresh selection medium should thus be added to the cells 
every third day. Most of the wild type virus should be eliminated with 
subsequent passages through selection medium. The virus-titre used in the 
transfection-experiments (0 .1 PFU of LSDV per cell) were also much lower than 
the titre used for the determination of the MPA-concentration required for virus-
inhibition (1 PFU of LSDV per cell) . Problems with background virus may thus be 
eliminated. 
3.4.5. Transfection of pLSD-Gpt into. LSDV-infected CFK-cells 
After indirect immunoperoxidase staining of cells, incubated with MFA-
containing selection medium and infected with LSDV that had been passaged six 
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times through selection medium (Fig. 3.9b.), no definite viral foci could be 
observed. In contrast to this, lots of viral foci could be observed in the LSDV-
infected cells that had been incubated without selection medium (Fig. 3.9a.). This 
indicated that selection against wild-type LSDV was complete providing the virus 
had been passaged for several times through selection medium. The in situ 
indirect immunoperoxidase stain indicated definite viral foci in CFK-cells infected 
with virus obtained from cells originally transfected with the pLSD-Gpt construct 
(Fig. 3.9c.). This ability of the virus to propagate in the presence of MPA indicated 
that the LSDV may have acquired the Gpt-gene through homologous 
recombination in the TK-region. It has been reported that plasmid replication 
occurs in poxvirus-infected cells (De Lange and McFadden, 1986 - as referred to by 
Stellrecht, Sperber and Pogo, 1992), but transient expression of the Gpt-gene 
would not be expected at such a high level after the virus has been passaged for 
several times through selection medium, although the presence of some plasmid 
could not be ruled out completely. Unsuccessful attempts to purify adequate 
quantities of viral DNA for analysis obstructed verification of the results. The 
mutational event which occurred within the Gpt-gene in the pLSD-Gpt construct 
could effect it's functional expression. Virus stored at -20°C for later use lost its 
viability. Therefore transfection experiments with the pLSD-Gpt construct and 
subsequent DNA isolation were repeated in parallel with the pGS20-VP7:Gpt 
construct as described in Chapter 4.2.5. When Gpt is coupled in tandem with 
another gene of interest, positive selection of LSDV carrying both genes, should be 
possible. These results were considered as an indication that Gpt would be 
suitable as a selectable marker-gene for the selection of LSDV recombinants in this 
system. 
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CHAPTER 4. CONSTRUCTION OF A BLUETONGUE 
VIRUS VIRAL PROTEIN 7 POXVIRUS 
RECOMBINANT 
4.1. Introduction 
4.1.1. Rationale for the construction of a poxvirus recombinant 
encoding a BTV protein 
Bluetongue virus (BTV) belongs to the genus Orbivirus of the Reoviridae 
family (Knudson and Monath, 1990; Oldfield, Adachi, Urakawa, Hirasawa and 
Roy, 1990). Twenty-four distinct serotypes of the virus have been identified 
which vary in some characteristics. However, they all have antigens in common 
and cause the characteristic bluetongue disease that allow them to be grouped 
together (Oldfield et al., 1990; St George, Alexander and Gard, 1991). 
The virus is transmitted by arthropod vectors (Culicoides species) and 
causes disease in sheep and cattle (domestic and wild ruminants) with serious 
economic consequences (Knudson and Monath, 1990; Oldfield et al., 1990; Roy, 
1992). Besides the loss of domestic stock due to bluetongue, it is also a critical 
barrier to the international trade in livestock and livestock products. The virus is 
not readily transmitted by semen and embryos, since properly washed embryos 
obtained from infected cattle do not transmit the virus and infected bulls only 
shed virus in semen while viraemic (St George et al., 1991). The disease occurs 
over an extensive area that includes Africa, America, Australia, the Middle East, 
South Eastern Asia and the Caribbian islands. It appears as if orbivirus infection 
of ruminants exists in most of the tropical zone of the world, with or without 
concurrent disease (Loudon, Hirasawa, Oldfield, Murphy and Roy, 1991; St 
George et al., 1991). 
Multivalent vaccines consisting of live attenuated BTV strains have been 
used widely due to the plurality of serotypes (24 serotypes - Kowalik and Li, 
1991; Knudson and Monath, 1990; St George et al., 1991). There are several 
problems associated with live attenuated BTV vaccine usage, like for e.g. 
teratogenicity, insect transmission and the potential for gene reassortment. There 
is thus a pressing need for more stable, reliable and safe BTV vaccines. 
Theoretically these problems could be overcome by the construction of a 
recombinant vaccine. The construction of a BTV poxvirus recombinant could 
also serve as a model for studying recombinant poxvirus vaccines. Several genes 
encoding BTV proteins are suitable candidates for the construction of such 
recombinant vaccines. The major group-specific core antigen, VP7, of BTV has 
several characteristics which renders it highly suitable for the construction of a 
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recombinant vaccine. The properties of this antigen and its potential use will be 
discussed in the following sections. 
4.1.2. The major group-specific core antigen VP7 of bluetongue 
virus. 
4.1.2.1. Virion structure and the position of VP7 within the virion. 
BTV, like other members of the Reoviridae family, has a double-capsid 
structure and lacks an envelope (Knudson and Monath, 1990; Oldfield et al., 1990). 
The viral genome consists of 10 discrete double stranded RNA (dsRNA) segments 
which are located in the inner-core. 
The outer shell is composed of two major proteins, VP2 and VPS which are 
loosely bound to the inner shell, forming an ill-defined outer structure (refer to 
Fig. 4.1.). The genes encoding VP2 and VPS are the most variable in BTV 
(Knudson and Monath, 1990; Roy, 1992). The highly diverse outer capsid protein, 
VP2, induces the production of neutralizing antibodies in animals, plays a role in 
hemagglutination and has serotype-specific epitopes (Huismans, Van der Walt, 
Cloete and Erasmus, 1987a; Yang, Johnson, Mecham, Tam and Li, 1992). The 
outer shell can be easily removed from the single-shelled particle enclosed within 
during purification procedures (Loudon and Roy, 1991; Oldfield et al., 1990; 
Prasad, Yamaguchi and Roy, 1992). 
The single-shelled virion (core or BTV particle without the outer shell) is 
composed of two major proteins, VP3 and VP7, and three minor proteins, VPl, 
VP4 and VP6 (Huismans, Van Dijk and Els, 1987; Prasad et al., 1992). The 
diameter of this spherical single-shelled virion is 69 nm (Roy, 1992). The three-
dimensional structure of the single-shelled virion exhibits icosahedral symmetry 
with a triangulation number of 13 in a left-handed configuration (Prasad et al., 
1992). The single-shelled virion's three dimensional structure can be divided into 
two concentric layers of protein surrounding the innermost core or subcore 
(Prasad et al., 1992; Roy, 1992). 
The outer layer of this single shelled-virion has 260 prominent knoblike 
capsomeres which can be located at all the local and strict threefold axes. These 
knoblike capsomeres consist of trimers of VP7, giving a total of 780 molecules of 
VP7 per virion (Eaton, Gould, Hyatt, Coupar, Martyn and White, 1991; Loudon 
and Roy, 1991; Prasad et al., 1992). Conclusive evidence for the trimers formed by 
VP7, was derived from crystallographic studies, together with solution studies 
(Basak, Stuart and Roy, 1992; Roy, 1992). 
VPl - -,.,.~..., ~~ 
VP6 ---"~@i'IIIC 
yp4 ...,... 
VP3 
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Fig. 4.1. Schematic diagram of the BTV particle (adapted from Roy, 1992). The outer shell is 
composed of two major proteins, VP2 and VPS. Knoblike capsomeres, consisting of trimers of 
VP7, are located on a smooth bed of pentameric VP3 molecules. These two major core proteins, 
VP7 and VP3, form two concentric layers of protein which surround the innermost core or 
subcore. The innermost core contains three minor proteins, VPl, VP4 and VP6, as well as ten 
discrete segments of genomic dsRNA. 
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The VP7 structures are the sites for the deposition of the two proteins, VP2 
and VPS, of the outer shell of the virus (Roy, 1992). The capsomeres are arranged 
in such a way that there are 132 aqueous channels at all the five- and six-
coordinated positions (Prasad et al., 1992). Some channels penetrate the inner 
layer and they may provide pathways for the transportation of metabolites and 
mRNA during transcription (Hewat et al., 1992). 
The inner layer is a smooth bed upon which the capsomeres are located. 
This layer is about 70 nm thick and consists predominantly of the major protein, 
VP3 (60 molecules per core), which are arranged as 12 pentamers (Prasad et al., 
1992; Roy, 1992). The gene encoding VP3 is conserved between serotypes 
(Knudson and Monath, 1990). Except for the indentations in register with the 
channels of the outer layer, the surface of the inner layer is featureless. Some 
channels terminate inside the inner layer in small indentations at a radius of 25 
nm, while others cross this layer into the subcore. 
It seems as if VP7 requires close interaction with VP3, since VP7 expressed 
on it's own does not form icosahedral structures (Prasad et al., 1992). VP3 forms a 
scaffold for the assembly of the VP7 capsomeres (Loudon and Roy, 1991). Correct 
VP7 protein-protein interactions may be unable to form in the absence of VP3, 
which may lead to non-specific aggregation due to hydrophobic interactions 
between VP7 molecules (Oldfield et al., 1990). However, if VP7 and VP3 are co-
synthesized in cells infected with a recombinant virus containing both genes, 
empty core-like particles (CLPs) are formed (French and Roy, 1990; Hewat et al., 
1992; Loudon et al., 1991; Oldfield et al., 1990). It has been concluded that the 
presence of the three minor core proteins, the dsRNA genome or the four non-
structural proteins are not required for their formation (Prasad et al., 1992; Roy, 
1992). According to Huismans et al. (1987) parental double-shelled virions are 
converted to single-shelled particles of 470S shortly after infection. These 470S 
single-shelled particles are converted to smaller particles containing VP3 and 
other minor proteins (VPl, VP4 and VP6). The smaller particles are supposedly 
composed of the inner layer and the subcore and consist predominantly of VP3 
(Huismans et al., 1987; Loudon and Roy, 1991). In single-shelled virions VP7 is 
more abundant than VP3 and accounts for 36% of the core protein (Basak et al., 
1992; Roy, 1992). 
The subcore is enclosed by these two layers and consist of the three minor 
proteins, VPl, VP4 and VP6, and the ten segments of genomic dsRNA (Loudon 
and Roy, 1992; Prasad et al., 1992). At least four different, highly conserved, non-
structural proteins (NSl, NS2, NS3 and NS3A) have been identified in BTV-
infected cells, but their significance is unresolved (He, Wang, Doi, Maia, Osburn 
and Chuang, 1991; Roy, 1992; Thomas, Booth and Roy, 1990). Viral synthesis and 
maturation occurs in the cytoplasm of infected cells (Knudson and Monath, 1990). 
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4.1.2.2. VP7 
4.1.2.2.1. The VP7 gene 
The major core protein VP7 is the sole translational product encoded by the 
small RNA segment 7 (S7) of the BTV genome (Eaton et al., 1991; Knudson and 
Monath, 1990; Kowalik and Li, 1991; Oldfield et al., 1990; Roy, 1992). Kowalik 
and Li (1991) designated the VP7-encoding fragment as S1. In this chapter, 
however, it will be referred to as S7 which appears to be preferred by most other 
authors. The nucleotide and deduced amino acid sequences of the S7 segments of 
five United States BTV serotypes (BTV-2, -10, -11, -13 and -17) have been 
determined (Kowalik and Li, 1991). Each segment is 1156 bp long and contains an 
open reading frame (ORF) encoding the 349-amino acid VP7 protein, followed by 
a single termination codon. No deletions or insertions were found in any of the S7 
segments. 
Of the total nucleotide residues, 46.3 - 47.0% consists of G and C residues 
(Kowalik and Li, 1991). The VP7 proteins are well-conserved with O - 22 amino 
acid differences between the serotypes. Comparison of the African horsesickness 
virus serotype 4 (AHSV-4) VP7 sequence with that of BTV serotype 10 revealed an 
overall similarity of 44%, with the amino- and carboxy-terminal regions exhibiting 
the greatest levels of similarity (Roy, Hirasawa, Fernandez, Blinov and Sanchez-
Vixcain Rodrique, 1991). An evolutionary rate of approximately 2.2 x 10-3 
nucleotide substitutions/site/year is predicted for BTV (Kowalik and Li, 1991). 
This evolutionary rate implies that there is no proof-reading activity associated 
with the BTV RNA polymerase. No polymerase proofreading functions are 
known in single-strand RNA (ssRNA) viruses (Kowalik and Li, 1991). A stable 
stem-loop structure can be formed near the translational termination codon in the 
segment Sl coding strand. The last few codons and part of the 3' noncoding 
region are included in this stem-loop. The significance of the stem-loop structures 
is not known but they may be common in RNA viruses (Kowalik and Li, 1991). 
4.1.2.2.2. Protein structure and properties 
Most of the VP7 proteins consist of 25 acidic, 27 basic and 6 histidine 
residues, which result in a slight positive charge ( + 1.0 to + 1.5) at pH 7.0 (Kowalik 
and Li, 1991). Hydrophobic and hydrophilic stretches found throughout the 
central regions of the protein may assume a structural role. A putative eight-
stranded f3-barrel is maintained by the VP7 protein from BTV-2, -11 and -17 
(Kowalik and Li, 1991). This eight-stranded antiparallel ~barrel (the primary 
structural motif) is present in the cores of all ssRNA viruses with known three-
dimensional structures, suggesting a common origin of ssRNA viruses found in 
plants and animals. The presence of this structure in BTV VP7 supports the 
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contention that dsRNA and ssRNA viruses may have a common origin (Kowalik 
and Li, 1991). 
The protein may exist in the cytosol of infected cells as an oligomer of 
which the constituent VP7 molecules are not linked together via intermolecular 
disulfide bonds (Eaton et al., 1991). A striking feature of the BTV VP7 protein is 
that it contains only one lysine residue (K 255) which is conserved amongst the 
sequenced BTV serotypes (Roy, 1992). This positively charged residue at position 
255 may have a particular structural role. Three cysteine residues are found at 
positions 15, 65 and 154. The cysteines at positions 15 and 65 may be linked via an 
intramolecular disulfide bond (Eaton et al., 1991). 
The hydrophobic nature of the VP7 protein makes it possible to purify the 
protein (Mr = 38,550 kDa) by a low percentage ammonium sulphate precipitation 
as the first step and subsequent ion-exchange chromatography (Oldfield et al., 
1990; Prasad et al., 1992; Roy, 1992). Material with a purity of at least 95% can be 
obtained with this method. 
4.1.2.2.3. Antigenic properties 
The fact that VP7 is highly conserved amongst BTV serotypes and at least 
partly conserved amongst three serogroups of orbiviruses, contributes to its 
suitability as an antigen for vaccination (Oldfield et al., 1990). Purified VP7 
antigen is furthermore highly immunogenic. It cross-reacts with the antisera of all 
24 BTV serotypes, as well as an antiserum raised to African horsesickness virus 
type 4 (AHSV-4), a member of another serogroup of the orbiviruses (Oldfield et al., 
1990). A monospecific antiserum raised against the expressed VP7 protein, 
reacted with two serotypes of the most closely related orbivirus to BTV, epizootic 
haemorrhagic disease virus (EHDV), in addition to it's reaction with the other BTV 
serotypes (Oldfield et al., 1990). Sequence data obtained for the VP7 proteins of 
BTV, AHSV and EHDV indicate that the viruses are closely related at the genetic 
level and derived from a common ancestor (Iwata, Chuma and Roy, 1992). It has 
been suggested that BTV and EHDV should be considered as members of the 
same serogroup (Iwata et al., 1992). AHSV and BTV have much in common with 
referral to pathogenesis, pathology and vectors (Oldfield et al., 1990; St George et 
al., 1991). 
An additional advantage of VP7 for the construction of recombinant 
vaccines is that the protein is accessible on the surface of bluetongue virus 
particles. The surface layer or outer shell of BTV can be considered as a net which 
only partially obscures the underlying core particle (Eaton et al., 1991). The 
serogroup-reactive epitope was located in the amino-terminal half of the VP7 
protein (Eaton et al., 1991). There is strong evidence that the epitope may be 
located in the VP7 protein near or between the cysteine residues at positions 15 
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and 65 which are linked via a disulfide bond (Eaton et al., 1991). It was suggested 
that the amino-terminal portion of VP7 may be exposed and not located on the 
inside of the core particle (Eaton et al., 1991). The major reactive epitopes of VP7 
are apparently conformational, since cross-reactivity between VP7 proteins were 
observed in ELISA and immunoprecipitation tests, but not under denaturing 
conditions in Western blot analysis (Iwata et al., 1992; Kowalik and Li, 1991). 
4.1.3. Aim of this study 
The aim of this study was to construct a recombinant LSDV /W virus 
containing the BTV4 VP7 gene under the control of the WP 7.5 promoter. This 
recombinant virus could be tested as a potential vaccine against BTV and LSDV 
(in the case of a LSDV-recombinant). It would also serve as a model for studying 
recombinant poxviral vaccines. Employment of the Gpt-gene as a dominant 
selectable marker for the selection of recombinant poxviruses should be possible. 
It was also attempted to compare the effectiveness of homologous and 
heterologous TK-sequences to direct recombination with the viral TK-gene. 
Therefore two different constructs, one containing LSDV TK-sequences and the 
other W TK-sequences, was each transfected separately into both LSDV and W. 
This was done to determine if heterologous W TK-based constructs could be used 
for the construction of LSDV-recombinants, since many W vectors encoding 
foreign proteins are available. Using existant constructs would save time and 
progress on projects involving the construction of LSDV-recombinants would thus 
be quicker. 
4.2. Materials and methods 
4.2.1. Viruses, mammalian cells and domestic hens' eggs 
The vaccine strain of LSDV was obtained and maintained as described in 
Chapter 3.2.1. Vaccinia virus, a South African strain, was supplied by Prof. K.R. 
Dumbell, Department of Medical Microbiology, Medical School, UCT. Vaccinia 
virus was propagated in eggs of domestic hens (Chapter 2.2.1.) and titrated on CV-
1 cells (Chapter 2.2.7.). 
The CFK-cells were prepared and maintained as described in Chapter 3.2.1. 
The CV-1 cell-line, derived from an African Green Monkey kidney, is a continuous 
fibroblast-like cell line (ATCC Catalogue, ref. CCL 70) and were supplied by the 
Department of Medical Microbiology, Medical School, UCT. All the cells were 
grown in DMEM, supplemented with 10% FCS and 0.5% PSN (Appendix A.13.). 
The cells were maintained in DMEM supplemented with 0.5% PSN and 2 or 4% 
FCS. Selection medium consisted of maintenance medium supplemented with 250 
µg Xanthine/ml, 14 µg Hypoxanthine/ml and MPA at the required concentration. 
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The eggs of domestic hens, used for the propagation of W was obtained as 
described in Chapter 3.2.1. 
4.2.2. Genes, vectors and host bacterial cells 
The Bluetongue virus serotype 4 viral protein 7 (BTV4VP7)-gene was 
obtained from Dr. A. van Dijk, Onderstepoort Veterinary Institute (OVI), Pretoria. 
This gene was supplied as a pMC50-construct which consisted of the BTV4VP7-
gene cloned into the Pstl site of pUC-4K. The pGS20 vector was obtained from Dr. 
M. Mackett, Paterson Laboratories, Christie Hospital and Holt Radium Institute. 
The competent E. coli LKl 11 cells were supplied by the Department of Medical 
Microbiology, Medical School, UCT. Refer to Chapter 3.2.2. for the suppliers of 
the xanthine-guanine phosphoribosyl transferase (Gpt)-gene and pLSDTK vector. 
4.2.3. Construction of a plasmid containing the VP7- and the 
Gpt-gene 
4.2.3.1. General strategy 
The BTV VP7-gene was cloned into a suitable plasmid vector for the 
construction of a lumpy skin disease virus (LSDV; discussed in Chapter 1.3.) - or a 
vaccinia virus (W; discussed in Chapter 1.2.) - recombinant vaccine. The plasmid 
insertion vector used for this purpose, pGS20 (Mackett, Smith and Moss, 1984), 
has unique BamHl and Smal sites for the insertion of foreign DNA adjacent to the 
W 7.5 K gene promoter (P 7.5, Chapter 3.1.4.). The EcoRl fragment of pGS20, 
containing P 7.5 and the BamHl and Smal sites, is flanked on both sides by 
segments of the W thymidine kinase (TK) gene. These sequences can direct 
homologous recombination with W DNA, and presumably also with other 
poxvirus-DNA, to insert the foreign DNA into the TK gene of the viral genome. 
The similarity at the nucleotide/amino acid levels between the capripoxvirus TK-
gene and the TK-gene of VV was found to be 68.4/64.6% (Gershon and Black, 
1989). Therefore the similarity should be sufficient to allow for recombination 
between the two mentioned TK-genes, since as few as 4 matching base pairs are 
sufficient to support intermolecular strand transfer (Shuman, 1992). 
To enable selection of recombinant virus containing the foreign gene of 
interest (VP7), the transient dominant selection (TDS) strategy (Fig. 4.2.) described 
by Falkner and Moss (1990) was employed. 
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Fig. 4.2. Schematic outline of the transient dominant selection (TDS) strategy (adapted from 
Falkner and Moss, 1990). The foreign gene of interest is cloned into a plasmid so that it is 
flanked by TK-sequences. The dominant selectable marker-gene, Gpt, is inserted into the 
plasmid outside the TK gene. When the plasmid is transfected into a cell that has been infected 
with wild type virus, recombination can occur. A single crossover event between the TK-
sequences present in the plasmid as well as the virus would result in the insertion of the full-
length plasmid into the virus-genome. A second cross-over event between direct repeats will 
result in the formation of either wild type virus or recombinant virus containing the foreign 
gene of interest. 
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The dominant selectable marker-gene Gpt (Chapter 3.1.2.), under the 
control of the P 7.5 promoter, was cloned into the Hindlll site of the pGS20-
vector. The marker gene was thus not flanked by W DNA and would not be 
stably integrated into the virus-genome by double crossover or gene conversion 
events. A single, crossover event between the TK-sequences present in the circular 
insertion vector (pGS20) as well as the poxvirus genome, should result in the 
insertion of the full-length plasmid into the virus genome. Selection for virus 
containing the Gpt-gene (mycophenolic acid resistance) could then be applied. 
After a single crossover event, the Gpt-gene would be flanked by an uninterrupted 
TK-gene on the one side and an interrupted TK-gene on the other side. The Gpt-
gene would thus be lost if a second crossover event should occur between these 
TK sequences, resulting in the formation of either wild-type virus or recombinant 
virus containing the foreign gene (VP7 in this case). 
4.2.3.2. Cloning of the BTV 4VP7-gene into pGS20 
A large scale DNA extraction (Chapter 2.1.1.2.) was performed on the 
pMCSO-clone containing the BTV4VP7-gene (referred to as VP7, Section 4.2.1.). 
The VP7 gene was excised from this construct as a BamHl fragment which was 
isolated and purified by agarose gel-electrophoresis (Chapter 2.1.4. - 2.1.6.). 
The pGS20 vector was linearized with BamHl, phenol/chloroform 
extracted twice, ethanol precipitated and resuspended in ultra-pure water 
(Chapter 2.1.2. - 2.1.4.). The VP7 BamHl fragment (1160 bp) was ligated into the 
BamHl site of pGS20 (ca 7500 bp) as described in Chapter 2.1.7.2. (Fig. 4.3a.). 
Competent LKl 11 cells were used for the transformation reaction (Chapter 
2.1.7.4.). Small scale DNA preparations of randomly picked colonies were 
performed to screen for colonies harbouring the recombinant plasmid (Chapter 
2.1.1.1.2., 2.1.7.5.) . The DNA was digested with BamHl and analyzed by agarose-
gel electrophoresis (Chapter 2.1.4. - 2.1.5) to verify the presence of the VP7 insert. 
Liquid cultures of colonies identified as harbouring the recombinant plasmid, 
were frozen away as stock (Chapter 2.1.7.6.). 
The published map of pGS20 (Mackett, Smith and Moss, 1984) does not 
show all the restriction enzyme sites. Therefore mapping by single and multiple 
restriction digest-patterns were performed on pGS20 and recombinant plasmids 
harbouring the VP7 gene. This was done to determine the orientation of VP7, 
relative to P 7.5, in pGS20. The vector pGS20 was subjected to single digests with 
BamHl, Hindlll, Smal and Sall. Multiple digests of pGS20 were performed with 
BamHl + Hindlll, Hindlll + Sall, BamHl + Sall, Smal + Hindlll, Smal + Sall and 
BamHl + Hindl 11 + Sall. The digests were performed as described in Chapter 
2.1.4. A restriction map of pGS20 based on information from these digests was 
compiled. 
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Fig. 4.3a. Schematic representation of the cloning of the BTV4VP7-gene containing BamHl-
fragment into the pGS20 vector, followed by the cloning of the Hindl 11-fragment comprising 
the Gpt-gene under the control of the VV P 7.5 promoter into the pGS20-VP7 construct (refer to 
Fig. 4.3b). 
Fig. 4.3b. Schematic representation of the pGS20-VP7:Gpt construct, with the BTV4VP7-gene 
cloned into the BamHl site and the Gpt-gene (under the control of the VV P 7.5 promoter) 
cloned into the Hindll 1 site of the pGS20 vector. 
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Five recombinants harbouring the VP7 gene were selected and digested 
with Sall, Smal + Sall and Hindlll + Sall. One of these recombinants, with the 
VP? gene in the sense orientation relative to P 7.5 in the pGS20 plasmid 
(designated pGS20-VP7) was used for a large scale preparation (Chapter 2.1.1.2.) 
of recombinant DNA. This DNA was used for all the subsequent manipulations. 
4.2.3.3. Cloning of the Gpt-gene into the pGS20 vector containing 
the BTV 4VP7 gene. 
The E. coli Gpt-gene, under the control of P7.5, was cloned into the EcoRl 
site of the pMTL25 vector (refer to Chapter 3.2.5.). From this construct, designated 
pMTL25-Gpt (Chapter 3 Fig. 3.Sa.), the Gpt-containing fragment was excised with 
Hindlll and purified by agarose-gel electrophoresis (Chapter 2.1.5. - 2.1.6.). The 
recombinant construct pGS20-VP7 (Section 4.2.3.2.) was linearized with Hindlll 
and subsequently treated with calf intestinal phosphatase (CIP, Chapter 2.1.7.1.). 
The Gpt-containing Hindlll fragment (ca. 2000 bp) was ligated (Chapter 
2.1.7.2.) into the Hindlll site of the linearized, dephosphorylated pGS20-VP7 
vector (Figs. 4.3a. and 4.3b.) . Competent E. coli LKlll-cells were used for the 
transformation-reaction (Chapter 2.1.7.4.) . Twenty-four transformant colonies 
were picked randomly from plates containing cells that were transformed with the 
pGS20-VP7:Gpt ligation mixture. These were subjected to small scale plasmid 
DNA extractions (Chapter 2.1.1.1.2.). The DNA was checked for the presence of 
the VP7- and the Gpt-gene by agarose-gel electrophoresis after double digestion 
with BamHl and Hindll 1. Stock glycerol cultures of identified recombinant 
colonies were frozen away as described in Chapter 2.1.7.6. A large scale DNA 
preparation (Chapter 2.1.1.2.) was performed on one of the identified recombinant 
colonies (designated pGS20-VP7:Gpt), harbouring the recombinant pGS20 vector 
containing the VP7- and the Gpt-gene (Figs. 4.3b.). The orientation of the Gpt-gene 
in the pGS20-VP7:Gpt plasmid was determined by restriction analysis using Smal. 
4.2.4. Titration of MP A to determine the concentration needed 
for the inhibition of LSDV and VV growth 
The tolerance of the CFK cells to different concentrations of MP A and the 
MPA concentration required to inhibit LSDV multiplication in CFK cells were 
determined as described in Chapter 3.2.6. Determination of the tolerance of CV-1 
cells to different concentrations of MP A and the MP A concentration required to 
inhibit VV multiplication in CV-1 cells were performed as described in Chapter 
2.2.9. with the following modifications: The cells were infected with a virus-
concentration of 1 PFU of VV / cell. The MP A concentrations that were tested 
ranged from 0.1 µg MPA/ml to 5 µg MPA/ml. The cells were constantly 
monitored for any signs of cell-deterioration or virus multiplication during the 
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incubation period with the different MPA concentrations. After 48 hours the cells 
were stained with ZN Carbolfuchsin (Chapter 2.2.7.) to check for plaque-
formation due to virus growth. The MP A concentration used in the transf ection 
experiment was determined based on the results obtained. 
4.2.5. Transfections into mammalian cells 
4.2.5.1. Transfection of LSDV-infected CFK-cells 
Infections and transfections of cells were performed as described in Chapter 
2.2.8., except for the following modifications. Almost confluent monolayers of 
CFK-cells were prepared in 35 mm-diameter tissue culture dishes. The cells were 
infected with 0.05 PFU of LSDV per cell for 80 minutes at 37°C. (A low virus-input 
titre was used in order to minimize the amount of background virus yielded by 
the transfection reaction.) The DNA/Lipofectin TM reagent complex consisted of 3 
µg of the recombinant pGS20-VP7:Gpt plasmid (Section 4.2.3.3.), and 40 µg 
Lipofectin™ reagent/35 mm tissue culture dish. A second transfection was 
performed as described for the first one, except that the DNA-Lipofectin complex 
consisted of 3 µg of the recombinant pLSD-Gpt plasmid (refer to Chapter 3.2.5.) 
and 50 µg Lipofectin ™ reagent/35 mm dish. After an incubation period of 5 
hours at 37°C, the DNA-containing opti-MEM was replaced with maintenance 
medium (section 4.2.1.), supplemented with 2% FCS, 1 µg MPA/ml, 250 µg 
Xanthine/ml and 14 µg Hypoxanthine/ml. Of each transfection performed, 
control cells were kept with maintenance medium, containing 2% FCS but no 
MPA. LSDV infected cells (0.05 PFU/cell) were also kept as controls with 
selection and no selection medium, together with uninfected cells. 
After an incubation period of 2 days at 37°C, the virus was passaged onto 
fresh cells (prepared in 35 mm tissue culture dishes and almost confluent) as 
follows. The transfected and control cells were microscopically screened for any 
signs of infection or deterioration of the cell-layer. After freeze-thawing the cells 
once to release more virus from the cells, the supernatant was used for the 
infection of fresh cells (Chapter 2.2.8.). Selection medium and non selection 
medium was added as before and incubation was continued at 37°C This 
passaging of the virus onto new cells was repeated every third day. 
Total DNA extractions were performed separately on cells infected with the 
possible recombinant virus, cells infected with the wild type virus and uninfected 
cells at passage nos. 4, 5 and 6. Extractions were performed 48 hours after 
infection of the cells as described in Chapter 2.2.11. with the following 
modifications. The lysate was incubated with proteinase K for 5 hours at 55°C. 
After the first addition of pre-warmed phenol, the lysate-phenol mixture were left 
at room temperature for 15 minutes, while inverting the tube every now and 
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again, before the two phases were separated by centrifugation. The DNA pellets 
were resuspended in ultra pure water at 4°C overnight. 
Of the total DNA harvested from the cells in a 35 mm tissue culture dish, 
40% was digested with lu/µl Hindlll (Chapter 2.1.4.) in a total volume of 100 µl 
for 24 hours in an incubator at 37°C. After digestion, the volume was made up to 
500 µl with ultra pure water and two phenol/ chloroform extractions were 
performed (Chapter 2.1.2.). The DNA was precipitated with 0.3 M Sodium-acetate 
and 2 volumes absolute ethanol at -20°C for 18 hours (Chapter 2.1.3.). The pellet 
was resuspended in 10 µl ultra pure water at 4°C for 6 hours. 
The digested DNA was loaded onto an 0.8% agarose-gel together with 
appropriate markers and electrophoresis was carried out in 1 x T AE-buffer at 
room temperature for 18 hours at 25 volts. After ethidium bromide staining and 
photographing of the gel, it was cut smaller to a size of 183 x 110 mm so that it 
only contained the lanes with nucleic acid bands of interest. The DNA was 
transferred to a nylon membrane (Hybond N, Amersham) by overnight Southern 
blotting (Chapter 2.1.8.1.). The membrane was prehybridized for 48 hours at 42°C 
with shaking, as described in Chapter 2.1.8.3. for non-radioactive labelling. 
The DNA was screened for the presence of the Gpt- and the VP7-genes 
respectively by means of separate non-radioactive hybridizations (Chapter 
2.1.8.3.). The first probe was prepared by the non-radioactive labelling of the 
fragments obtained by Hindl 11-digestion of 0.8 µg of the pLSD-Gpt clone (Chapter 
3.2.5.). The second probe was prepared by the non-radioactive labelling of the 
fragments obtained by Hindl 11-digestion of 0.8 µg of the pGS20-VP7 clone 
(Section 4.2.3.2.) . Non-radioactive labelling of DNA with digoxigenin-dUTP (DIG-
labelling) was performed as described in Chapter 2.1.8.2. The reactions were 
scaled up according to the amount of DNA used and the denaturing steps were 
performed at 95°C for 15 minutes. 
After hybridization with the first probe, the washed membrane was 
subjected to chemiluminescent detection (Chapter 2.1.8.3.). Exposure to Curie RP 
1 X-ray film (Agfa, West Germany) was done for 30 minutes at room temperature 
(Chapter 2.1.8.4.). The membrane was prepared for reprobing (Chapter 2.1.8.5.) 
and put up to prehybridize at 42°C for 48 hours with hybridization solution 
containing 5% blocking reagent (Chapter 2.1.8.3.) . After hybridization with the 
second probe, the membrane was again subjected to chemiluminescent detection 
and exposure to X-ray film as described above. 
4.2.5.2. Transfection of VY-infected CVl-cells 
About 80-90% confluent monolayers of CVl-cells were prepared in 35 mm-
diameter tissue culture dishes on a 6-well Nunclone tissue culture plate. The 
infection- and transfection- reactions were performed as described in Chapter 
2.2.8., wit_h the following modifications: The cells were pre-treated by incubation 
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with selection medium (DMEM, containing 2% FCS, 0.5%PSN, 250 µg 
Xanthine/ml, 14 µg Hypoxanthine/ml and 1 µg MPA/ml), at 37°C overnight. The 
cells were infected with 0.05 PFU of VV per cell for 80 minutes at 37°C. The DNA, 
consisting of the recombinant pGS20-VP7:Gpt plasmid (Section 4.2.3.3.; 3 µg 
DNA/35 mm-diameter tissue culture dish) was diluted to 62 µl with ultra pure 
water, mixed with 60 µg of Lipofectin TM reagent and left at room temperature for 
20 minutes. The DNA/Lipofectin reagent complex was added dropwise to the 
cells after the addition of 500 µl opti-MEM/35 mm-diameter dish to the cells. A 
second transfection was performed as previously described, except that the DNA 
was replaced with the recombinant pLSD-Gpt plasmid (Chapter 3.2.5.) at a 
concentration of 3 µg DNA/35 mm-diameter dish. Incubation was performed at 
37°C for 5 hours 30 minutes. The DNA containing opti-MEM was removed from 
the cells and selection medium (Appendix A.10.) containing 1 µg MPA/ml was 
added. Maintenance medium without MPA was added to a control dish with 
transfected cells. Vaccinia virus infected cells (0.05 PFU/cell) and uninfected cells 
were kept as separate controls, each with selection medium and non-selective 
medium respectively. The controls were further treated exactly as the transfected 
cells. 
After 48 hours incubation at 37°C, the virus were passaged onto new CVl-
cells as follows. Almost confluent monolayers of CVl cells were prepared in 35 
mm tissue culture dishes, which were not pre-treated prior to infection. The 
medium, into which virus would have been released from the cells, was removed 
from the transfected cells and 500 µl/35 mm dish was used for the infection of 
fresh CVl cells. After 1 hour incubation at 37°C, the virus-inoculum was removed 
and selection/ non-selection media were added after which incubation was 
continued at 37°C. (The MFA-concentration in the selection medium was lowered 
to 0.3 µg/ml after the first passage, because the CV-1 cells appeared to be very 
sensitive to the MP A and deteriorated to quickly at the higher concentration.) The 
virus-infected control cells was subjected to the same treatment. The cells, from 
which the medium was removed, was stained with ZN-Carbolfuchsin (Chapter 
2.2.7) and compared with respect of the number of plaques observed in each dish. 
After 3 days incubation of the newly infected cells, the released virus was again 
passaged to freshly prepared cells as described above. This step was repeated for 
a few times and after each passaging step the cells were stained and compared. 
Separate total DNA extractions were performed (Chapter 2.2.11.) on cells 
infected with recombinant virus, cells infected with wild-type virus and 
uninfected cells at passage 5, 6, 7 and 8 with the following modifications. The 
lysate was incubated with proteinase Kat a concentration of 100 µg/ml at 55°C for 
2 hours, after which incubation was left to proceed overnight at 42°C. After the 
first addition of prewarmed phenol, incubation was performed at 37°C for 1 hour 
with regular mixing of the two phases, before the separation of the two phases by 
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centrifugation. The second phenol-extraction was done as usual without any 
incubation steps. 
The total DNA, extracted as described previously, was digested with 
Hindlll as follows: Forty percent of the total DNA harvested from a 35 mm tissue 
culture dish (except where indicated differently) was digested with Hindlll (1 
u/µl) in a total volume of 100 µl for 24 hours at 37°C. Some more digests were also 
performed with Pstl and Sall similarly to the Hindlll digest. After digestion, the 
reaction-volume was made up to 500 µl with ultra pure water and 
phenol/chloroform extracted (Chapter 2.1.2.). The DNA was ethanol-precipitated 
(Chapter 2.1.3.) and the pellet was resuspended overnight in 10 µl of ultra pure 
water at 4°C. The digested DNA was loaded onto an 0.8% agarose gel in 1 x TAE-
buffer, together with appropriate markers. The DNA was run into the gel at 100 
volts for 15 minutes, after which electrophoresis was continued at room 
temperature for 18 hours at 23 volts. The gel was stained with ethidium bromide, 
photographed and cut smaller so that it only contained the lanes with nucleic acid 
bands to be transferred. Several gels were run with different combinations of 
digested DNA. The DNA was transferred to a nylon membrane (Hybond N, 
Amersham) by Southern blotting (Chapter 2.1.8.1 ., acid method) overnight. 
The DNA was screened for the presence of the Gpt- and the VP7-genes by 
probing of the membranes with DIG-labelled probes as follows: The first probe 
was prepared by DIG-labelling of 0.8 µg pGS20-VP7:Gpt DNA digested with Smal. 
Two additional probes were prepared by the non-radioactive labelling of 0.2 µg 
BamHl-fragment (the BTV4 VP7-gene) and 0.2 µg Hindlll-fragment (containing 
the Gpt-gene under the control of the W P 7.5 promoter) separately. DIG-
labelling was performed as described in the protocol supplied with the DNA 
Labelling Kit (Boehringer Mannheim, Cat. No. 1175 033) with the following 
modifications. The reaction-volumes were scaled up according to the amount of 
DNA used. Denaturation steps were performed at 95°C for 15 minutes in a 
waterbath. The labelling reaction was left to proceed in an incubator at 37°C for 24 
hours. (The probe was not precipitated afterwards in the case of the first probe.) 
Labelled probes were stored at -20°C until needed. 
Pre-hybridization and hybridization were performed as described in 
Chapter 2.1.8.3. The blocking reagent were used at a concentration of 3% in the 
hybridization solution. After hybridization to the probe of choice, the washed 
membrane was subjected to chemiluminescent detection (Chapter 2.1.8.3.). The 
membrane was kept wet and the probe was removed (Chapter 2.1.8.5.) so that it 
could be re-probed with a different probe. 
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4.3. Results 
4.3.1. Construction of the pGS20-VP7:Gpt plasmid 
4.3.1.1. Cloning of the VP7-gene into the pGS20-vector 
The BTV4VP7-gene was isolated as a 1.160 kb BamHl-fragment (Fig. 4.4a. 
lane 1) from the original plasmid pMC50. This VP7-containing fragment was 
cloned into the BamHl-site (adjacent to the P 7.5 promoter) of the pGS20-vector. 
Recombinant plasmids were identified by restriction enzyme analysis with BamHl 
(Fig. 4.4a. lane 4) which were expected to yield a 7.5 kb and a 1.160 kb fragment 
respectively. The 7.5 kb fragment corresponded with the size of the BamHl-
Iinearized pGS20-vector (Fig. 4.4a. lane 11) and the 1.160 kb fragment with the size 
of the VP7-gene (Fig. 4.4a. lane 1). 
It was necessary to compile a restriction map of pGS20 (based on restriction 
enzyme analysis) in order to determine the orientation of the VP7-gene relative to 
the P 7.5 promoter in the pGS20-vector. The pGS20-vector was subjected to single 
digests with BamHl (Fig. 4.4a. lane 11), Hindlll (Fig. 4.4a. lane 12), Smal (Fig. 4.4a. 
lane 13) and Sall (Fig. 4.4a. lane 14). Multiple digests of pGS20 were performed 
with BamHl + Hindlll (Fig. 4.4b. lane 10), Hindlll + Sall (Fig. 4.4b. lane 11), 
BamHl + Sall (Fig. 4.4b. lane 12), Smal + Hindlll (Fig. 4.4b. lane 13), Smal + Sall 
(Fig. 4.4b. lane 14) and BamHl + Hindlll + Sall (Fig. 4.4b. lane 15). The fragment 
sizes yielded for pGS20 by each of the aforementioned restriction enzyme 
digestion-reactions are shown in Table 4.1. A restriction map of pGS20 based on 
these results, was compiled. 
The Sall site within the VP7-gene was exploited to determine the 
orientation of the VP7-gene relative to the P 7.5 promoter of the pGS20-vector as 
follows: Five recombinant plasmids (identified by restriction enzyme analysis 
with BamHl) were digested separately with Sall; Smal + Sall; and Hindlll + Sall. 
The orientation of the VP7-gene could be determined based on the sizes of the 
restriction enzyme fragments obtained with the aforementioned digest-reactions. 
(The expected fragment sizes for the sense- and non-sense orientation are 
indicated in Table 4.1 .) One of these recombinants (designated pGS20-VP7), with 
the VP7-gene in the sense orientation relative to the P 7.5 promoter in the pGS20-
vector, was .selected. The sense orientation of the VP7-gene relative to the P 7.5 
promoter was verified by the fragment-sizes yielded upon restriction enzyme 
analysis with Sall (Fig. 4.4a. lane 7), Smal + Sall (Fig. 4.4a. lane 8) and Hindlll + 
Sall (Fig. 4.4a. lane 9). The aforementioned fragment sizes correspond with the 
sizes expected for the sense orientation as indicated in Table 4.1. 
108 
TABLE 4.1. Expected fragment sizes of plasmid constructs digested with different 
restriction enzymes. 
Plasmid construct 
pGS20 
pGS20-VP7 
pGS20-VP7:Gpt 
Restriction enzyme(s) 
BamHl 
Hindlll 
Smal 
Sall 
BamHl + Hindlll 
Hindlll + Sall 
BamHl + Sall 
Smal + Hindl 11 
Smal + Sall 
BamHl + Hindl 11 + Sall 
BamHl 
Hindlll 
Smal 
Sall 
Smal + Sall 
Hindl 11 + Sall 
BamHl 
Hindlll 
Smal 
Sall 
Smal + Hindl 11 
Expected fragment size(s) 
(bp)# 
7500 
7500 
7500 
2310 + 5190 
1130 + 6370 
840 + 2310 + 4350 
2020 + 5190 + 290 
6370 + 1130 
290 + 2020 + 5190 
840 + 290 + 2020 + 4350 
1160 + 7500 
8657 
8657 
* sense orientation: 1247 + 2220 + 5190 
* non-sense orientation: 490 + 2977 + 
5190 
* sense orientation: 1247 + 200 + 2020 + 
5190 
* non-sense orientation: 490 + 957 + 2020 
+ 5190 
* sense orientation: 840 + 1247 + 2220 + 
4350 
*non-sense orientation: 840 + 490 + 2977 
+ 4350 
1160 + 6370 + 2000 + 1130 
2000 + 8657 
6370 + 4287 
* sense orientation: 1247 + 2220 + 4350 + 
2000 + 840 
* non-sense orientation: 490 + 2977 + 
4350 + 2000 + 840 
6370 + 2000 + 2287 
Fig. 4.4. 
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LEGENDS 
Gel-electrophoresis of DNA employed in the construction of pGS20-
VP7:Gpt. 
(a) Lane 1, BamHl-fragrnent containing the BTV4VP7-gene. Lane 2, 
Hindlll-fragment containing the Gpt-gene under the control of the 
VV P 7.5 promoter. Lane 3, A-DNA digested with Styl. Lane 4, 
pGS20-VP7 digested with BamHl. Lane 5, pGS20-VP7 digested 
with Hindlll . Lane 6, pGS20-VP7 digested with Smal. Lane 7, 
pGS20-VP7 digested with Sall. Lane 8, pGS20-VP7 double-
digested with Smal and Sall. Lane 9, pGS20-VP7 double-digested 
with Hindlll and Sall. Lane 10, A-DNA digested with Styl. Lane 
11, pGS20 digested with BamHl. Lane 12, pGS20 digested with 
Hindlll. Lane 13, pGS20 digested with Smal. Lane 14, pGS20 
digested with Sall 
(b) Lane 1, BamHl-fragrnent containing the BTV4VP7-gene. Lane 2, 
Hindlll-fragment containing the Gpt-gene under the control of the 
VV P 7.5 promoter. Lane 3, A-DNA digested with Styl. Lane 4, 
pGS20-VP7:Gpt digested with BamHl . Lane 5, pGS20-VP7:Gpt 
digested with Hindlll. Lane 6, pGS20-VP7:Gpt digested with 
Smal. Lane 7, pGS20-VP7:Gpt digested with Sall. Lane 8, pGS20-
VP7:Gpt double-digested with Smal and Hindlll. Lane 9, A-DNA 
digested with Styl. Lane 10, pGS20 double-digested with BamHl 
and Hindlll. Lane 11, pGS20 double-digested with Hindlll and 
Sall. Lane 12, pGS20 double-digested with BamHl and Sall. Lane 
13, pGS20 double-digested with Smal and Hindlll. Lane 14, 
pGS20 double-digested with Smal and Sall. Lane 15, pGS20 
triple-digested with BamHl , Hindlll and Sall. 
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4.3.1.2. Cloning of the Gpt-gene into pGS20-VP7. 
The ca. 2 kb Hindlll-fragment (containing the Gpt-gene under the control 
of the P 7.5 promoter) isolated from the pMTL25-Gpt plasmid is shown in Fig. 
4.4b. lane 2. The cloning of this fragment into the Hindl 11 site of the pGS20-VP7 
plasmid was verified by restriction analysis of the resulting plasmid ( designated 
pGS20-VP7:Gpt). Restriction enzyme analysis of pGS20-VP7:Gpt with BamHl (Fig. 
4.4b. lane 4), Hindl 11 (Fig. 4.4b. lane 5), Smal (Fig. 4.4b. lane 6), Sall (Fig. 4.4b. lane 
7) and Smal + Hindl 11 (Fig. 4.4b. lane 8) all generated the expected fragment sizes 
(deduced from the compiled restriction map of pGS20) as indicated in Table 4.1. 
The orientation of the Gpt-gene in the pGS20-VP7:Gpt plasmid could be 
deduced from the fragment-sizes generated upon digestion of the plasmid with 
Smal. The original Gpt-containing EcoRl-fragment (which was cloned into the 
EcoRl site of the pMTL25-vector to construct the pMTL25-Gpt plasmid, Chapter 
3.2.5.) contained a Hindlll site within a multiple cloning site downstream of the 
Gpt-gene (Boyle and Coupar, 1988). Refer to Chapter 3 Fig. 3.5a. The Gpt-gene, 
linked to the P 7.5 promoter, was excised from pMTL25-Gpt with Hindlll to be 
cloned into the Hindl 11 site of pGS20-VP7. Due to the presence of the additional 
Hindlll site downstream of the Gpt-gene (derived from the original fragment), 
only one Smal site from the multiple cloning site of the pMTL25-vector (upstream 
of the Gpt-gene) should be retained within the isolated Hindl 11-fragment. The 
following Smal restriction fragments would thus be expected (deduced from the 
compiled restriction map of pGS20-VP7:Gpt, Fig. 4.3b.), if the two promoters 
present in the plasmid were in the same orientation relative to one another: ca. 
6370 + ca. 4287 bp. If the promoters were present in the opposite orientation 
relative to one another, the following fragments would be expected: ca. 8370 + ca 
2287 bp. Fragments obtained with Smal digestion of pGS20-VP7:Gpt (Fig. 4.4b. 
lane 6) indicated that the two promoters were present in the same orientation (as 
schematically depicted in Fig. 4.3b ). 
4.3.2. Virus propagation and the determination of the MP A 
concentration necessary for virus inhibition 
The propagation of LSDV, the tolerance of the CFK-cells to different 
concentrations of MPA and the MFA-concentration necessary for LSDV-inhibition 
were as described in Chapter 3.3.1. and 3.3.4. 
Good yields of VV, with a titre of 2.5 x 107 PFU / ml, were obtained when 
propagated on the CAM's of domestic hens. Monolayers of CV-1 cells were used 
for the titration of VV. Plaques formed by VV can be counted after staining of the 
cell-monolayer with ZN-Carbolfuchsin for the determination of the titre. 
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The CV-1 cells were found to be very sensitive to MPA. Even with a 
concentration as low as 0.5 µg MPA/ml a harmful effect on the cells could be 
detected with incubation for up to 3 days. After the third day of incubation with 
1.0 µg MP A/ ml the cells began to deteriorate and die off quickly. It appeared as if 
the concentration to be used should not exceed 0.3 µg MP A/ ml. The propagation 
of VV in CV-1 cells appeared to be inhibited relatively effectively by MP A for up 
to 3 days, even at concentrations as low as 0.1 µg MP A/ ml. However, with 
prolonged incubation some virus plaques started to appear in the wells incubated 
with MPA concentrations of up to 0.3 µg MPA/ml, from the third day onwards. It 
was not possible to test the inhibitory effect of MPA concentrations higher than 0.5 
µg/ ml on the propagation of VV for prolonged periods, because of the deleterious 
effect of the MP A on the cells as mentioned before. 
4.3.3. Transfection of LSDV-infected CFK-cells 
Virus stocks presumed to contain recombinants (originally obtained from 
cells infected with LSDV and transfected with the pGS20-VP7:Gpt or pLSD-Gpt 
construct) were passaged six times through MPA-containing selection medium as 
described in section 4.2.5.1. Wild type LSDV was passaged in parallel through 
selection medium. CFK-cells infected with wild type LSDV and virus presumed 
to contain recombinants were subjected to total DNA-extractions at passage nos. 4, 
5 and 6. Total DNA was also harvested from uninfected cells. Viral foci could be 
observed in all the cells infected with virus up to passage no. 6. As expected, viral 
foci were not detected in the uninfected control cells. 
The total DNA extracts were digested with Hindl 11 and subjected to 
agarose-gel electrophoresis. A smear of digested DNA was observed in each lane 
(Fig. 4.5a.). This was expected as the extracts contained genomic DNA. The 
Southern-blot of this gel was probed with a DIG-labelled probe consisting of 
Hindl 11-fragments of the pLSD-Gpt clone. These fragments contained the Gpt-
gene linked to the P 7.5 promoter and LSDV TK-gene sequences (Fig. 3.Sb.). No 
recombinant virus could be detected (Fig. 4.Sb.) . However, the TK-gene without 
an insert (no band shift) could be detected in all the DNA samples harvested from 
cells infected with LSDV. This indicated the presence of wild type virus. Selection 
was thus not complete. In the DNA sample harvested from the uninfected control 
cells no signal could be detected. This was expected due to the abscence of virus. 
By reprobing of the blot with a DIG-labelled (Hind111-linearized) pGS20-VP7 
fragment (containing the VP7-gene, the P 7.5 promoter and VV TK-gene 
sequences) a single faint band, in the same position as the band detected when 
probed with the pLSD-Gpt probe (described earlier), could be detected in all the 
DNA samples harvested from cells infected with LSDV (results not shown) . 
Fig. 4.Sa. 
Fig. 4.Sb. 
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LEGENDS 
Agarose gel-electrophoresis of total DNA extracted (Hind111-digested) 
from CFK-cells. Lane 1 (DNA molecular weight marker), 1..-DNA digested 
with Hind111 . Lane 2, *pGS20-VP7:Gpt (#6). Lane 3, *pLSD-Gpt (#6). 
t * * Lane 4, LSDV (#6). Lane 5, pGS20-VP7:Gpt (#4). Lane 6, pLSD-Gpt 
t * * (#4). Lane 7, LSDV (#4). Lane 8, pGS20-VP7:Gpt (#5). Lane 9, pLSD-
Gpt (#5) . Lane 10, tLSDV (#5). Lane 11, uninfected CFK-cells. 
* 
t 
CFK cells were pre-infected with LSDV and transfected with the 
indicated plasmid construct. The presumptive recombinant virus was 
passaged several times through MFA-selection medium. Total DNA 
was subsequently extracted from the infected cells at the indicated 
passage number(#) after transfection and digested with Hind111. 
LSDV was passaged several times through MFA-selection medium on 
CFK-cells. Total DNA was subsequently extracted from the infected 
CFK-cells at the indicated passage number(#) through selection medium 
and digested with Hind111. 
Southern blot of the agarose-gel shown in Fig. 4.5a. The blot was probed 
with DIG-labelled Hind111-digested pLSD-Gpt fragments (refer to legends 
of Fig. 4.5a. for descriptions of lanes). 
(bp) 
ca. 2750-
(bp) 
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9 416-
6 557-
2 322-
2 027-
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4.3.4. Transfection of VV-infected CV-1 cells 
In order to obtain W recombinants, W-infected CV-1 cells were 
transfected with the pGS20-VP7:Gpt and the pLSD-Gpt constructs separately as 
described in section 4.2.5.2. Virus harvested from these cells was passaged several 
times through MPA selection medium. At passage nos. 5, 6, 7 and 8 total DNA 
extractions were performed on the virus-infected CV-1 cells. This process was 
repeated in parallel with untransfected wild type W. Total DNA-extractions 
were also performed on uninfected CV-1 cells. 
The total DNA-extracts were digested with different restriction enzymes 
and subjected to agarose-gel electrophoresis. A smear of digested DNA could be 
observed in each lane due to the presence of genomic DNA (Figs. 4.6a., 4.7a.I., 
4.7a.II. and 4.8a.). A Southern blot of the gel shown in Fig. 4.6a. was probed with a 
DIG-labelled pGS20-VP7:Gpt Smal digested plasmid. 
Bands corresponding to the size of the intact W Hindlll ]-fragment (a 5 kb 
fragment encompassing the TK-gene - Mackett et al., 1982), could be observed in 
the lanes containing DNA harvested from W-infected cells (Fig. 4.6b.). However, 
these bands could also be observed in lanes containing DNA harvested from cells 
infected with Wand transfected with the pGS20-VP7:Gpt construct or the pLSD-
Gpt construct. This indicated the presence of non-recombinant virus (i.e. viruses 
with an intact TK-gene). No further bands could be observed in lanes containing 
DNA harvested from cells transfected with the pLSD-Gpt construct and it can be 
deduced that no recombination took place between the LSDV TK-gene and the W 
TK gene. Apart from the 5 kb band, two additional bands of ca. 6.5 kb and 3 kb 
respectively could be observed in lanes containing DNA harvested from cells 
transfected with the pGS20-VP7:Gpt construct. 
The 6.5 kb band corresponded approximately to the size of the 5 kb W 
Hindlll J-fragment containing the ca. 1.2 kb VP7-insert, which indicated the 
presence of a recombinant virus. The presence of the VP7-gene in the 6.5 kb 
Hindl 11 band observed was confirmed by probing of the Southern blot ( of the 
lanes shown in Fig. 4.7a.I. and Fig. 4.7a.1I.) with a DIG-labelled VP7 BamHl-
fragment. A signal corresponding to a size of ca. 6.5 kb could be detected in the 
lanes containing Hind111-digested DNA harvested from cells transfected with the 
pGS20-VP7:Gpt construct (Fig. 4.7b.I.). No signal could be detected in lanes 
containing DNA harvested from W-infected cells or uninfected cells (Fig. 4.7b.II.). 
The presence of the 3 kb band (Fig. 4.6b.) could not be readily explained, 
since the size did not correspond to the size of the expected 2 kb Gpt Hindl 11-
fragment. 
Fig. 4.6a. 
* 
t 
Fig. 4.6b. 
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Agarose gel-electrophoresis of total DNA (HindJJJ-digested) extracted from CVl-
cells. Lane 1 (DNA molecular weight marker), A-DNA digested with 
Hind111. Lane 2, *pGS20-VP7:G.;t (#8). Lane 3, *pGS20-VP7:Gpt (#5). 
Lane 4, *pLSD-Gpt (#8). Lane 5, pLSD-Gpt (#5). Lane 6, tw (#8). Lane 
7, tw (#5). Lane 8, total DNA from uninfected CVl-cells. 
CVJ-cells were pre-infected with Wand transfected with the indicated plasmid construct. 
The presumptive recombinant virus was passaged several times through MPA-selection 
medium. Total DNA was subsequently extracted from the infected cells at the indicated 
passage number(#) and digested with Hindlll . 
W was passaged several times through MPA-selection medium on CVJ-cells. Total DNA 
was subsequently extracted from the infected CVl-cells at the indicated passage number 
after transfection (#) and digested with Hindll 1. 
Autoradiograph of the Southern blot of the agarose-gel shown in Fig. 4.6a. 
The blot was probed with a DIG-labelled (SmaJ-digested) pGS20-VP7:Gpt 
plasmid (refer to legends of Fig. 4.6a. for descriptions of lanes). 
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LEGENDS 
Agarose gel-electrophoresis of total DNA [Hind111-digested) extracted 
from CVl-cells. 
I. Lane 1 (DNA molecular weight marker), I-DNA digested with 
Hind111. Lane 2, *pGS20-VP7:Gpt (#8). Lane 3, *pGS20-VP7:Gpt 
(#7). 
II. Lane 4, t VV (#8). Lane 5, total DNA from uninfected CV-1 cells 
Lane 6, PGS20-VP7:Gpt plasmid digested with BamHl . 
CVJ-cells were pre-infected with Wand transfected with the indicated plasmid construct._ 
The presumptive recombinant virus was passaged several times through MPA-selection 
medium. Total DNA was subsequently extracted from the infected cells at the indicated 
passage number after transfection (#) and digested with Hindl 11. 
W was passaged several times through MPA-selection medium on CVJ-cel/s. Total DNA 
was subsequently extracted from the infected CVJ-cells at the indicated passage number 
through selection medium (#)and digested with Hindl 11 
Southern blot of the agarose-gel shown in Fig. 4.7a. The blot was probed 
with a DIG-labelled BamHl-fragment containing the VP7-gene (refer to 
legends of Fig. 4.7a. for descriptions of lanes). 
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LEGENDS 
Agarose gel-electrophoresis of total DNA (digested with different restriction 
enzymes as indicated) extracted from CVl-cells. Lane 1 (DNA molecular 
weight marker), >..-DNA digested with Hind111. Lane 2, *pGS20-VP7:Gpt 
* (#9) digested with Hind111. Lane 3, pGS20-VP7:Gpt (#9) digested with 
* . . * Sall. Lane 4, pGS20-VP7:Gpt (#9) digested with Pstl. Lane 5, pLSD-Gpt 
(#8) digested with Hind111. Lane 6, tvv (#9) digested with Hind111. 
Lane 7, tvv (#9) digested with Sall. Lane 8, tvv (#9) digested with Pstl. 
Lane 9, pLSD-Gpt digested with Kpnl. 
CVJ-cells were pre-infected with Wand transfected with the indialted plasmid construct. 
The presumptive recombinant virus was passaged several times through MPA-selection 
medium. Total DNA was subsequently extracted from the infected cells at the indialted 
passage number after transfection (# ). 
W was passaged several times through MPA-selection medium on CVJ-cells. Total DNA 
was subsequently extracted from the infected CVJ-cells at the indicated passage number 
th rough selection medium ( # ). 
Southern blot of the agarose-gel shown in Fig. 4.8a. probed with a DIG-
labelled Hindl 11-fragment containing the Gpt-gene under the control of 
the VV P 7.5 promoter (refer to legends of Fig. 4.8a. for descriptions of 
lanes). 
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After probing of the Southern blot of the gel shown in Fig. 4.8a. with a DIG-
labelled Hindlll-fragment (containing the Gpt-gene under the control of the VV P 
7.5 promoter), the following signals were observed (Fig. 4.Sb.): A strong signal 
corresponding to the size of a band of ca. 3 kb was detected in the lane containing 
Hindlll-digested DNA harvested from VY-infected cells transfected with the 
pGS20-VP7:Gpt construct. This confirmed the presence of the Gpt-gene in the 3 kb 
Hindlll band. Digests of DNA harvested from VY-infected cells transfected with 
the pGS20-VP7:Gpt construct with Pstl and Sall yielded the expected fragment-
size of ca. 2 kb (Figs. 4.3b and 4.Sb.). No signal could be detected in the lanes 
containing DNA harvested from VY-infected cells or uninfected cells. A signal 
corresponding to the size of the expected 2 kb Gpt-gene was observed in the 
positive control lane containing Kpnl-digested pLSD-Gpt plasmid. 
A possible explanation for the presence of the Gpt-gene in the ca. 3 kb 
Hindll 1-fragment detected is that a Hindl 11 site could have been lost on either 
side of the Gpt-gene during the recombination event. Restriction enzyme analysis 
indicated that both Hindl 11 sites were present in the original clone (Fig. 4.4b. lane 
5) . Upon examination of the autoradiographs shown in Fig. 4.6b. and 4.Sb., it was 
found that the lost Hindlll site was probably the site situated between the Gpt-
gene and the 5' end TK-fragment of the pGS20 plasmid in the pGS20-VP7:Gpt 
construct (Fig. 4.3b.). If this interpretation is correct, recombination probably took 
place close to the Gpt-gene in the fragment stretching from the Gpt-gene to the VP7 
gene (encompassing the 5' end of the TK-gene) of the pGS20-VP7:Gpt construct. A 
loss of the Hindl 11 site upstream of the Gpt-gene would have lead to the presence 
of a ca. 6350 bp Gpt-containing fragment in a Southern blot of Hindl 11-digested 
recombinant DNA (Fig. 4.3b.), assuming recombination occurred between the TK-
sequences. This fragment size was not obtained. 
4.4. Discussion and conclusions. 
4.4.1. Construction of the recombinant plasmid 
A plasmid (designated pGS20-VP7:Gpt) was constructed so that it 
contained the VP7-gene (under the control of the P 7.5 promoter and flanked by 
VV TK-sequences), as well as the Gpt-gene (under the control of a separate P 7.5 
promoter). The pGS20-vector, containing VV TK-sequences, was used for the 
construction of the pGS20-VP7:Gpt plasmid. Restriction enzyme mapping was 
performed on the native pGS20 vector, the vector containing the VP7-insert and 
subsequently the vector containing both the VP7- and the Gpt-inserts to determine 
the orientation of the inserted genes. A plasmid was selected in which the VP7-
gene was inserted in the sense orientation, relative to the P 7.5 promoter in the 
pGS20-vector, to ensure expression in poxvirus-infected mammalian cells. The 
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orientation of the VP7-gene relative to the P 7.5 promoter could easily be 
determined by restriction enzyme analysis due to the presence of a Sall-site within 
the VP7-gene. The orientation of the two genes relative to one another was not 
important, since each gene was linked to a P 7.5 promoter. The orientation of the 
Gpt-gene could, however, be determined based on the sizes of the fragments 
generated by Smal digestion of the pGS20-VP7:Gpt plasmid. The orientation of 
the two inserts, Gpt and VP?, and their respective P 7.5 promoters were found to 
be in the same direction relative to one another. In general it would be better to 
have the promoters back to back or two different promoters in the same direction 
to avoid recombination between direct repeats resulting in the loss of DNA. 
Recombination can thus occur between the two P 7.5 promoters resulting in the 
loss of the Gpt-gene. In this case, however, it is not important to retain the Gpt-
gene in the final recombinant virus, since it is only required for the selection of the 
recombinants. 
4.4.2. Virus propagation and the determination of the MP A 
concentration necessary for virus inhibition 
The propagation of LSDV, the tolerance of the CFK-cells to different 
concentrations of MPA and the MFA-concentration necessary for LSDV-inhibition 
were as discussed in Chapter 3.4.2. and 3.4.4. Good yields were obtained when 
VV was propagated on the CAM's of domestic hens. The CV-1 cells appeared to 
be much more sensitive to MPA than the CFK-cells. With incubation of up to 3 
days at 37°C harmful effects could be detected in CV-1 cells with concentrations as 
low as 0.5 µg MPA/ml, whereas concentrations up to 30 µg MPA/ml could be 
used with CFK-cells. Lower concentrations of MPA was required for VV-
inhibition in CV-1 cells for up to 3 days than for LSDV-inhibition in CFK-cells 
(refer to section 4.3.2. and Chapter 3.4.4.). 
4.4.3. Transfection of LSDV-infected CFK-cells 
CFK-cells were infected with LSDV and transfected separately with the 
pGS20-VP7:Gpt and the pLSD-Gpt constructs. Transfection with the pGS20-
VP7:Gpt construct was performed to obtain a recombinant LSDV virus containing 
the Gpt- and/or the BTV VP7-gene. The pGS20 vector contains VV TK-gene 
sequences. The capripoxvirus TK-gene and the TK-gene of VV are 68% similar on 
the nucleic acid level (Gershon and Black, 1989). This level of similarity was 
considered to be sufficient for heterologous recombination between the two genes 
(Schuman, 1992). Transfection with the pLSD-Gpt construct, containing LSDV TK-
gene sequences (Chapter 3.2.8.), was repeated to obtain a LSDV recombinant 
containing the Gpt-gene. Virus harvested from the transfected cells were passaged 
six times through MFA-selection medium in parallel with wild type virus. 
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Total DNA was extracted from the following sources: 
Uninfected CFK cells 
CFK cells infected with LSDV at passage nos. 4, 5 and 6. 
CFK cells infected with virus that have presumably acquired the VP7 
and/or the Gpt gene(s) through recombination at passage nos. 4, 5 and 6. 
The extracted DNA was digested with Hindlll and subjected to agarose-gel 
electrophoresis and Southern blotting. No recombinant LSDV could be detected 
by probing of the blot with a DIG-labelled pLSD-Gpt probe (containing the Gpt-
gene under the control of the P 7.5 promoter and LSDV TK-gene sequences), as 
described in sections 4.2.5.1. and 4.3.3. 
A signal detected in all the lanes containing DNA harvested from LSDV-
infected cells, corresponded in size to the intact TK-gene of LSDV (Fig. 4.Sb.). 
According to Gershon and _Black (1989) the TK-gene is located in the capripoxvirus 
DNA Hindl 11 fragment S. The Hindl 11 fragment S of LSDV was found to be 2.75 
kbp in size (Black et al., 1986). Hybridization presumably occurred between the 
TK-sequences shared by the probe and the LSDV-DNA. No difference was 
apparent between DNA from cells containing native LSDV and DNA from cells 
containing putative recombinant virus. This implied that no recombination had 
occurred between the resident LSDV TK gene and the TK sequences present in the 
pLSD-Gpt and pGS20-VP7:Gpt constructs. No signal was detected in lanes 
containing DNA from uninfected cells. Wild type virus was thus still present even 
after several passages through selection medium. After the first transfection 
experiment no wild type LSDV could be detected by indirect immunoperoxidase 
staining with anti-LSDV serum after six passages of the virus through selection 
medium (Chapter 3 Figs. 3.9a., 3.9b. and 3.9c.). The only possible explanation for 
this observation could be that a lower MFA-concentration (1 µg MPA/ml) was 
used for the selection of recombinant LSDV in the second transfection experiment 
than for the first experiment (2.5 µg MPA/ml). The concentration were lowered 
because a lower virus input titre were used in the second transfection experiment 
with the pLSD-Gpt construct and to allow the Gpt-gene to get expressed 
sufficiently in order to overcome inhibition by MPA. If recombinant virus was 
present it occurred at a much lower concentration than the wild type virus, which 
prevented detection by hybridization. 
The poor hybridization signal observed when linearized pGS20-VP7 
plasmid (containing the VP7-gene, P 7.5 promoter and W TK sequences) was 
used as a probe, could be attributed to the low degree of homology (68%) between 
the W TK-sequences (of the pGS20 plasmid) and the LSDV TK gene. 
A probable reason for the failure to obtain a recombinant LSDV virus is that 
the virus titre used in the transfection experiments was too low. Another possible 
explanation may be that the mutation, resulting in the loss of the internal Kpnl site 
of the Gpt-gene in the pLSD-Gpt construct, may have resulted in the gene being 
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less effective even though it appeared to be functional. Recombination is a rare 
event even under favourable circumstances. 
4.4.4. Transfection of VY-infected CV-1 cells 
The construction of a recombinant VV containing a Gpt- and/or a BTV4 
VP7-gene under the control of the WP 7.5 promoter, was pursued as described in 
section 4.2.5.2. Two constructs were transfected separately into W-infected CV-1 
cells. The first construct, pGS20-VP7:Gpt, contained W TK-sequences, the BTV4 
VP7-gene and the Gpt-gene. Each of the latter two genes were under the control of 
a P 7.5 promoter (Fig. 4.3b.). The second construct, pLSD-Gpt, contained LSDV TK 
sequences, as well as the Gpt-gene linked to the P 7.5 promoter (Chapter 3 Fig. 
3.Sb.) . Transfection studies with both the constructs were performed in parallel. 
Transfection with the second construct was performed to test the feasibility of 
heterologous recombination between the TK-genes of Wand LSDV. 
Virus presumed to contain recombinants was harvested from the cells and 
passaged several times through selection medium. Total DNA extractions were 
performed at passages 5, 6, 7 and 8. Total DNA was also extracted from 
uninfected cells and CV-1 cells infected with wild type W by an identical method. 
The DNA was subjected to non-radioactive Southern analysis using three distinct 
DIG labelled probes. 
No recombinant virus was obtained from the transfection experiment with 
the pLSD-Gpt construct. It thus appears that heterologous recombination did not 
occur between the LSDV TK and the VV TK. However, in the experiment using 
the pGS20-VP7:Gpt construct homologous recombination did occur as anticipated, 
resulting in a recombinant virus. 
The VP7 probe hybridized to a HindIII fragment of approximately 6.5 kb. It 
can be assumed that a single homologous recombinational event occurred 
between the W TK sequences shared by the virus and the pGS20-VP7:Gpt 
construct. The observed 6.5 kb fragment is thus in fair agreement with the size of 
6.2 kb expected for the HindIII fragment consisting of the VP7 gene (ca 1.2 kb) 
flanked by VV TK gene sequences (5 kb - Gershon and Black, 1989; Figs. 4.3b. and 
4.7b.1.). 
A DIG-labelled Gpt probe hybridized to HindIII-digested DNA to reveal a 
strong signal in the ca 3 kb position. This was rather unexpected, since the Gpt-
containing HindIII-fragment was expected to occur in the 2 kb position. It 
appeared as if a Hindll 1 site on one side of the Gpt-gene cassette (Fig. 4.3b.) was 
lost during the recombination event, since digests with Pstl and Sall yielded the 
expected fragment-size of 2 kb for the excised Gpt-insert (Fig. 4.8b.) . Both Hindlll 
sites were present in the original clone (Fig. 4.4b. lane 5). Interpretation of 
poxvirus recombination experiments is not a trivial matter, since the molecular 
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mechanism of homologous DNA recombination in poxvirus infected cells is still 
poorly understood (Ball, 1987; Fathi et al., 1991; Spyropoulos et al., 1988). 
It is likely that a single recombinational event occurred, as multiple or 
double recombinational events would theoretically result in a variety of fragment 
sizes (including Gpt-containing bands in the 2 kb position). This is due to the fact 
that the recombinational events can theoretically occur anywhere in the TK region 
shared by VV and the construct. 
No plaque purification steps were included as this was only a preliminary 
screening for the presence of recombinant virus(es) . It was thus not surprising 
that a mixture of viruses would be present. 
Southern blot analysis using a DIG-labelled pGS20-VP7:Gpt probe 
(containing VV TK sequences) revealed a 5 kb band which corresponded to the 
size of the intact VV Hindl 11 ]-fragment (Fig. 4.6b.) . This was an indication of the 
presence of wild type virus, which meant that selection was not complete. 
However, a selection ad vantage in favour of the recombinant viruses was evident. 
The signal corresponding to the intact 5 kb TK gene appeared weaker with 
subsequent passages whereas the signal associated with the recombinant virus 
progressively became more pronounced. This selection advantage of the 
recombinant virus over the wild type virus showed that the Gpt-gene can be 
employed successfully as a dominant selectable gene in the construction of 
recombinant poxviruses, even though selection was not complete. 
Additional restriction enzyme analysis and sequencing of the viral DNA 
region spanning the TK-gene are required to determine the exact nature of the 
recombination event. The virus would need to be plaque purified and expression 
of the VP7-gene should be further investigated before this recombinant could be 
tested in animal vaccine-trials for efficiency. 
The results obtained with the transfection of the pGS20-VP7:Gpt construct 
into the LSDV-infected CFK-cells (heterologous recombination) or the VV-infected 
CV-1 cells (homologous recombination), indicated that homologous TK-sequences 
may direct recombination at a higher frequency. The VV and the LSDV TK-genes 
exhibit a relatively low level (68%) of nucleotide sequence similarity (Gershon and 
Black, 1989). Theoretical predictions do, however, not rule out the possibility of 
obtaining recombinants between heterologous TK sequences exhibiting sequence 
similarity at this level (Shuman, 1992). According to G. Viljoen of the OVI, 
Pretoria (personal communication), they had succeeded in inserting the BTV-VP7 
gene into LSDV by heterologous recombination between VV-TK and LSDV-TK 
sequences. A recombinant capripoxvirus expressing Rift Valley Fever Virus 
(RVFV) glycoproteins was obtained by heterologous recombination between 
capripoxvirus TK- and VV TK-sequences U.C. DeMartini - abstract, IXth 
International Congress of Virology, 1993). 
Romero et al. (1993) reported the construction of a recombinant 
capripoxvirus vaccine that protects cattle against rinderpest and lumpy skin 
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disease. Construction of the aforementioned capripoxvirus recombinant was 
achieved by exploiting a capripoxvirus TK to direct homologous recombination 
with the Pirbright Capripoxvirus vaccine TK. 
At the moment LSDV is investigated as a vector for the construction of 
veterinary vaccines. An interesting possibility for future research, however, may 
be to investigate the potential of highly attenuated LSDV as a non-replicating 
vector in humans, as was reported for avian poxvirus by Cadoz et al. , 1992. LSDV-
based vectors may provide an important basis for the development of safe and 
effective future recombinant vaccines against a wide spectrum of antigens. 
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APPENDIX A. BUFFERS, MEDIA AND SOLUTIONS 
A.1. Activated Trypsin Versene (ATV) 
Sterile glass-distilled water 
Trypsin Base (section A.20.) 
Trypsin stock (5%; section A.19.) 
PSN (section A.13.) 
88.5 ml 
10ml 
1 ml 
0.5ml 
The above were mixed aseptically and stored at 4°C (Freshney, 1987). 
A.2. Cell-freezing media 
FCS 
PSN (section A.13) 
HEPES (section A.4.) 
DMSO 
DMEM (section A.3.) 
10% (v/v) 
0.5% (v/v) 
0.02M 
7.5% 
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DMEM, PSN and the HEPES buffer (1 M stock solution) was filter-sterilized 
separately by filtering through an 0.2 µm filter. FCS was supplied sterily and 
DMSO was sterilized by autoclaving. The mentioned ingredients were mixed 
together aseptically and the media was stored at 4°C (Freshney, 1987; Lennette 
and Schmidt, 1979). 
A.3. Dulbecco's Modified Eagle's Essential Medium (DMEM) 
DMEM, obtained from Highveld Biologicals, Pretoria, South Africa, was made 
according to the manufacturer's specifications. Ten liter medium was made up 
and sterilized through an 0.2 µm filter when needed. Fetal calf serum and 
antibiotics (PSN) were added as required. 
A.4. HEPES Buff er (1 M) 
HEPES 
NaOH (0.3M) 
23.8g 
80ml 
The HEPES powder was dissolved in the 0.3 M NaOH and the pH was adjusted to 
7.2. Distilled water was added to a final volume of 100 ml and the solution was 
sterilized by filtration through an 0.2 µm filter. The buffer was kept at 4°C. 
A.5. ZN-Carbolfuchsin stain 
Basic fuchsin 
Phenol (crystalline) 
Alcohol (95%) 
Water 
5g 
25g 
50ml 
500ml 
145 
The fuchsin was mixed with the phenol and heated in boiling water for 5 minutes. 
The alcohol was added to the solution after it was mixed. The solution was 
filtered through a Whatman No.1 filter before it was used 
A.6. Loading buffer (10 x concentrated) 
Ficoll (Type 400, Pharmacia) 
Na2EDT A (pH 8.0) 
SDS 
Bromophenol blue 
Xylene Cyanol 
20% 
0.1 M 
1% 
0.25% 
0.25% 
The above mentioned ingredients were mixed with distilled water to the required 
volume. The solution were dispensed into 10 ml aliquots and kept at room 
temperature (Ausubel et al., 1987). 
A.7. Luria media 
Bacto Tryptone 
Bacto Yeast extract 
NaCl 
Agar 
10 g 
5g 
5g 
15 g 
For the preparation of Luria broth the tryptone, yeast extract and NaCl were 
dissolved in 800 ml distilled water. After adjusting the pH to 7:5 with 10 M 
NaOH, distilled water was added to a final volume of 1 000 ml. Luria agar was 
prepared as follows: The agar was dissolved separately in 500 ml distilled water 
by heating in a microwave. The tryptone, yeast extract and NaCl were dissolved 
in 300 ml distilled water. The two solutions were mixed and the pH was adjusted 
to 7.5 with 10 M NaOH. Distilled water was added to a final volume of 1 000 ml. 
The Luria-broth and -agar were sterilized by autoclaving and kept at room 
temperature. Antibiotics were added to the media after autoclaving and cooling 
to 50°C as required (Sambrook et al., 1989). 
A.8. L ysis buff er 
Tris-HCl (1 M, pH 7.8) 
NaCl (5 M) 
EDTA (0.5 M) 
SDS (10%) 
25ml 
5 ml 
2.5ml 
25ml 
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Distilled water was added to a final volume of 250 ml. The buffer was sterilized 
by filtering through an 0.2 µm filter or by autoclaving and kept at room 
temperature in 10 ml aliquots. 
A.9. Mcllvain's buffer, pH 7.4 
Solution A: 0.1 M Citric acid 
Solution B: 0.2 M Na2HP04.12H20 
Of solution A, 1.83 ml was mixed with 18.7 ml of solution B. Distilled water (800 
ml) was added and the pH was adjusted to 7.4 with either solution A or B. 
Distilled water was added to a final volume of 1 000 ml. The buffer was sterilized 
by autoclaving and kept at 4°C. 
A.10. Mycophenolic Acid (MP A)-containing selection media 
Stock solutions: 
MPA (10 mg/ml) 
MPA 
NaOH (0.1 N) solution 
100mg 
10ml 
The MPA was dissolved in the NaOH solution, filter sterilized through an 0.2 µm 
filter and kept in the dark at 4 °C. 
Xanthine (10 mg/ml) 
Xanthine 
NaOH (0.1 N) solution 
100mg 
10 ml 
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The xanthine was dissolved overnight at room temperature in the NaOH solution. 
After filter-sterilizing through an 0.2 µm filter, it was kept at room temperature. 
Hypoxanthine (10 mg/ml) 
Hypoxanthine 
NaOH (0.1 N) solution 
100mg 
10 ml 
The hypoxanthine was dissolved overnight at room temperature in the NaOH 
solution and filter sterilized through an 0.2 µm filter. The solution was kept at 
room temperature. 
Selection medium: 
DMEM (Section A.3.) 
PSN stock (Section A.13) 
'FCS 
Hypoxanthine (10 mg/ml) 
Xanthine (10 mg/ml) 
MPA (10 mg/ml) 
93ml 
0.5ml 
4ml 
2,5ml 
140 µl 
10 - 25 µl (as indicated in 
text) 
The selection medium was freshly prepared when required. 
A.11. Phenol 
Commercial phenol was liquidified at 56°C. Hydroxyquinoline was added to a 
final concentration of 0.1 %. Several subsequent extractions were done with an 
equal volume of 1 M Tris (pH 8.0) buffer until the pH of the aqueous phase was 
higher than 7.8. The phenol was stored in 5 ml aliquots under an equal volume of 
1 M Tris (pH 8) buffer containing 2% f3-mercaptoethanol at -20°C (Sambrook et al., 
1989). 
A.12 Phosphate Buffered Saline (PBS) 
NaCl 
KCl 
KH2P04 
Na2HP04 (anhydrous) 
OR 
Na2HP04.2H20 
OR 
Na2HP04.12H20 
8.0 g 
0.2 g 
0.12g 
0.91 g 
1.14g 
2.28g 
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The above ingredients were dissolved in 900 ml of distilled water and the pH was 
adjusted to 7,5. Distilled water was added to a final volume of 1 000 ml and the 
solution was dispensed into 100 ml volumes. PBS was sterilized by autoclaving 
and stored at room temperature. 
A.13. Penicillin Streptomycin Neomycin (PSN) Solution 
Penicillin 
Streptomycin 
Neomycin 
2 x 106 Units 
2g 
2g 
The above mentioned antibiotics were reconstituted in 100 ml of physiological 
saline. After filter-sterilization through an 0.2 µm filter, the solution was stored at 
-20°C in 2.5 ml aliquots. PSN was used at a final concentration of 100 U Penicillin, 
100 µg Streptomycin and 100 µg Neomycin per ml (0.5 ml stock PSN solution/100 
ml). 
A.14. Solutions used for X-gal-based histochemical assay 
The solutions were prepared according to MacGregor et al. (1991). 
Stock solutions: 
Stock solutions of 50 mM potassium ferricyanide (K3Fe(CN)6) and 50 mM 
potassium ferrocyanide (K4Fe(CN)6) were prepared in double-distilled water 
(ddH20) and stored in foil-wrapped glassware at 4°C for up to 3 months. 
Stock solutions of 1 M MgC12, 1 M Na2HP04 and 1 M NaH2P04 were prepared in 
ddH20 and stored at room temperature. 
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The 5-bromo-4-chloro-3-indolyl-(3-D-galactoside (X-gal) was dissolved in N,N-
dimethyl formamide (DMSO) at a concentration of 20 mg/ml and stored in a 
glass-container in the dark at -20°C. 
Paraformaldehyde (4%) was prepared in a fume hood (gloves and a mask should 
be worn when handling paraformaldehyde) as follows: 8 g of powder was 
dissolved in 150 ml of 0.1 M sodium phosphate, pH 7.3 (77 mM Na2HP04, 23 mM 
NaH2P04) by stirring and heating to 60°C. To this 10 M NaOH was added at a 
rate of 1 drop/minute until the solution cleared. The volume was adjusted to 200 
ml with 0.1 M sodium phosphate, pH 7.3, and the solution was stored at 4°C for 
up to 1 month. 
PBS was prepared as in section A.12. 
Working solution: 
X-gal 
K3Fe(CN)5 
K4Fe(CN)5 
MgC12 
PBS 
1 mg/ml 
5mM 
5mM 
2MM 
The working solution was freshly prepared in PBS, filtered through an 0,2 µm 
filter and used immediately. 
A.15. Tris-acetate (T AE) Buffer 
50 x concentrated: 
TRIS 
Glacial acetic acid 
EDTA (0.5 M, pH 8.0) 
242g 
57.1 ml 
100ml 
The above mentioned ingredients were mixed together in distilled water to a final 
volume of 1 000 ml, autoclaved and stored at room temperature (Sambrook et al., 
1989). 
A.16. Tris-borate (TBE) Buffer 
5 x concentrated: 
Tris base 
Boric acid 
EDTA (0.5 M, pH 8.0) 
54g 
27.Sg 
20ml 
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The above mentioned ingredients were mixed together in distilled water to a final 
volume of one litre, autoclaved and stored at room temperature. The buffer were 
disgarded if a precipitate formed after prolonged storage (Sambrook et al., 1989). 
A.17. TE Buffer (pH 8 or 9) 
TRIS (1 M, pH 9.0) 
EDTA (0.5 M) 
10ml 
0.5ml 
The TRIS and EDTA were mixed with 600 ml of distilled water and the pH was 
adjusted to pH 8 or 9. Distilled water was added to a final volume of 1 000 ml and 
the buffer was sterilized by autoclaving. 
A.18. Trypan Blue Solution 
Trypan Blue powder 
Physiological saline 
Sg 
100 ml 
The powder was dissolved in the saline solution and filtered through Whatman 
number 1 paper. The dye was sterilized by filtering through a 0.2 µm filter, 
dispensed into 2 ml amounts and stored at 4°C. 
A.19. Trypsin Stock 
Trypsin powder 
Trypsin base 
Distilled water 
Sg 
10ml 
90 ml 
The trypsin base was added to the water and concentrated HCl was added to 
acidify the solution to a bright yellow colour. The trypsin powder was sprinkled 
onto the surface of this solution and left to dissolve slowly (without stirring or 
agitation). The solution was filter-sterilized through an 0.2 µm filter and stored at 
-20°C in 1 ml aliquots. 
151 
A.20. Trypsin Base 
NaCl 30g 
KCl 2g 
KH2P04 1.2g 
Na2HP04 9.1 g 
OR 
Na2HP04.2H20 11.2 g 
OR 
Na2HP04.12H20 22.8 g 
Phenol (0.4% solution) 25ml 
Glucose 5g 
EDTA 2g 
The EDTA was dissolved separately in 100 ml of distilled water. After the rest of 
the chemicals were dissolved in 700 ml of distilled water, the EDTA solution was 
added to it. The pH was adjusted to 7.8 with 1 N NaOH. Distilled water was 
added to a final volume of 1 000 ml and the solution was filter-sterilized through 
an 0.2 µm filter. The trypsin base was stored at -20°C in 20 ml aliquots. 
A.21. Virus diluent 
HEPES Buffer (1 M; section A.4.) 
PSN (section A.13) 
DMEM (section A.3) 
1 ml 
0.5ml 
98.5 ml 
The HEPES buffer and PSN was added to the media (without fetal calf serum) and 
the pH was adju;ted to 7.4 with HCl or NaOH. The diluent was filter sterilized 
through an 0.2 µm filter and stored at 4°C. 
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APPENDIX B. MATERIALS 
The endonudease restriction enzymes BamHl, EcoRl, Hindlll, Kpnl, Pstl, Sall 
and Smal, together with the appropriate buffers and bovine serum albumin (BSA, 
special quality for molecular biology) were supplied by Boehringer Mannheim, 
Mannheim, Germany and Amersham International, Amersham, United Kingdom 
(UK) . 
Proteinase K, the DNA Labelling Kit (Cat. No. 1175 033), the DIG Luminescent 
Detection Kit (Cat. No. 1363 514) and the DIG Nucleic Acid Detection Kit (Cat. No. 
1175 041) were supplied by Boehringer Mannheim, Mannheim, Germany. The 
nylon membranes (Hybond N and Hybond N+) and the Nick Translation Kit were 
obtained from Amersham International, Amersham, United Kingdom. Gamma 
labelled 32p ATP was supplied by the Department of Biochemistry, University of 
Cape Town (UCT), South Africa (S.A.). 
Sigma Chemicals, St Louis, United States of America (USA) supplied the 
following: Cyanol, bromophenol blue, HEPES, hypoxanthine, ribonudease A, 
SDS, trypan blue and xanthine. 
The following chemicals were obtained from BD H, Poole, England: [)-
mercaptoethanol, citric acid, EDTA, glycerol, HCl, KH2P04, MgS04, Na-acetate, 
NaHC03, NaH2P04, Na-n-lauryl sarcosinate and sucrose. 
Merck, Darmstadt, Germany supplied the following: acetic acid, acetone, 
concentrated HCl, chloroform, ethanol (absolute), ethidium bromide, 
formaldehyde, glacial acetic acid, glycerol, isoamylalcohol, KCl, methanol, NaCl, 
phenol, TRIS salt and xylol. 
Ilford, Cheshire, England was the supplier of the black and white negative film 
and the developer and autoradiographs used with it. The X-ray film, developer, 
fixer and hardener were obtained from May Baker, Port Elizabeth, South Africa. 
Agarose, Dextran TlO and Sephadex G50 were obtained from Pharmacia, Fine 
Chemicals, Upsala, Sweden. Luria-agar /-broth, tryptone broth and ZN 
Carbolfuchsin stain were supplied by the Department of Medical Microbiology, 
UCT, S.A .. Unilab Saarchem, Krugersdorp, S.A., supplied the Haematoxylin stain. 
The enriched medium of Dulbecco,s Modified Eagle's Essential Medium (DMEM), 
used for the maintenance and growth of mammalian cells, was obtained from 
Highveld Biologicals, Pretoria, S.A. . The fetal calf serum was supplied by Delta 
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Bioproducts, Kempton Park, S.A., and the State Vaccine Institute, Pinelands, S.A .. 
Glaxo Pharmaceuticals, Wadeville, S.A., and Scherag, Isando, S.A., supplied the 
antibiotic powders Penicillin, Streptomycin and Neomycin. Trypsin powder was 
obtained from Difeo Laboratories, Detroit, USA. Fluka BioChemika, Buchs, 
Switzerland supplied the Mycophenolic Acid (MPA). 
The tissue culture flasks and multi-well plates were obtained from Falcon, 
Oxnard, USA; Nunclone, Roskilde, Denmark and Sterilin, Hounslow, UK. 
APPENDIX C. SIZES OF DNA-FRAGMENTS USED AS 
MARKERS 
Lambda DNA digested withHindlll 
(bp) 
23130 
9416 
6 557 
4361 
2 322 
2027 
564 
125 
Lambda DNA digested with Styl 
(bp) 
19 329 
7 743 
6 223 
4254 
3472 
2 690 
1882 
1489 
925 
421 
74 
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